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ABSTRACT 
Infectious diseases are responsible for an overwhelming number of deaths and morbidity 
worldwide. In tropical regions of the world, in particular, developing countries like 
Zambia, poor health is prevalent and diseases such as malaria, meningitis, pneumonia, 
tuberculosis and gastrointestinal infections strongly persist. Folkloric medicines are still 
actively used against some of these infections as primary care before seeking 
conventional treatment at hospitals. Members of the genus Ficus (Moraceae) are 
traditionally used in Zambia against many diseases caused by bacterial, fungal and 
protozoal infections. Thus according to the plant parts used traditionally for herbal 
preparations, aerial and root parts of eight Ficus species namely; F. ingens, F. lutea, F. 
natalensis, F. ovata, F. sansibarica subsp. macrosperma, F. sycomorus subsp. 
gnaphalocarpa, F. sycomorus subsp. sycomorus and F. wakefieldii were collected from 
different parts of Zambia. 
The main aim of this thesis was to evaluate the medicinal potential of members of the 
genus Ficus. This was achieved by three objectives, which involved the phytochemical 
profiling of the crude extracts and subextracts of the Ficus for their constituents using 
chromatographic methods such as thin layer chromatography (TLC), proton Nuclear 
Magnetic Resonance (
1
H NMR) and high performance liquid chromatography (HPLC). 
Secondly, the extracts were screened for various biological activities after which they 
were evaluated against recombinant FAS-II elongation enzymes, FabG, FabI and FabZ as 
potential targets in liver stage malaria parasites. 
In this case, finely ground dried plant material was extracted with methanol (MeOH) to 
yield the crude methanol extracts (CR-MeOH) which, were further partitioned to provide 
a coarse separation of the crude extracts according to polarity. The three subextracts 
obtained included n-hexane, chloroform (CHCl3) and aqueous methanol (aq-MeOH). The 
obtained extracts and subextracts were screened for biological activities such as: 
antifungal and antibacterial activities using the broth dilution and agar disc diffusion 
assays, antitubercular activity using the MTT assay, antischistosomal activity using the 
microscopic in vitro assay. In addition, antiprotozoal activitites which included 
antileshmanial activity using an assay against amastigotes of L. donovani strain 
5 
MHOM/ET/67/L82, trypanocidal activity against T. cruzi and T. brucei rhodesiense STIB 
900 strain, and antiplasmodial activity by modified [
3
H]-hypoxanthine incorporation 
assay, using the chloroquine/pyrimethamine resistant K1 strain were performed. 
Cytotoxity activity was also performed using rat skeletal myoblasts L6-cells. The 
chemical profiling was done by TLC, NMR and RP-HPLC. Meanwhile the chemical 
compound isolation for F. sansibarica was attempted by different chromatographic 
techniques and characterization by spectroscopic methods. 
The phytochemical profiling revealed the presence of closely related polyphenolic 
compounds to which some of the biological activities were attributed to. For instance, the 
antibacterial and the FAS-II enzyme inhibition activities were mostly retained in the aq-
MeOH subextracts, which were composed of very polar metabolites including flavonoids.  
Antiplasmodial activity was observed mostly in the less polar metabolites which were 
retained in the hexane and CHCl3 subextracts of the stem barks. This pattern was similar 
with antitrypanosomal and antileishmanial activities, though with lesser sensitivity. The 
same subextracts including those of the root barks showed the most activity against M. 
tuberculosis with MIC values of 256 and 128 μg/ml, and against Schistosoma, for both 
larval and adult worms. The extracts did not exert any antifungal activity by the agar disc 
diffusion method we used. 
Detailed phytochemical investigation of the leaves of F. sansibarica was performed, and 
led to the isolation of two compounds; epicatechin and apigenin-6-C-glucoside from the 
chloroform and aq. MeOH subextracts respectively. The predominant constituent of the 
CR-MeOH extract of F. sansibarica was identified as having a molecular weight of 432 
g/mol by LC-MS analysis which could be set as an identification chemical marker for F. 
sansibarica. 
The results highlight the potential that Ficus species could have as a valuable source for 
potent compounds which can be identified as scaffolds for the development of novel liver 
stage antimalarial drugs. Our results support previous research on the antimicrobial 
activity of Ficus species and they also provide an in vitro scientific basis supporting the 
use of Ficus species in traditional herbal preparations against some bacterial and parasitic 
infections.  
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1. INTRODUCTION 
Infectious diseases account for an overwhelming number of deaths and morbidity 
worldwide. Infectious diseases that thrive in hot and humid conditions are referred to as 
tropical diseases and these include malaria, leishmaniasis, schistosomiasis, 
onchocerciasis, lymphatic filariasis, chagas disease, African trypanosomiasis and dengue 
(WHO, 2013). These illnesses are caused by pathogenic microorganisms such as viruses, 
bacteria, fungi, protozoa and other multicellular parasites. Of the main parasites, 
schistosoma and protozoa cause some chronic disabling conditions termed as neglected 
tropical diseases (NTDs). These diseases thrive and spread easily in communities with 
inadequate sanitation, mainly in poor regions of the world. Thus, over one billion people 
worldwide, mainly in Africa are affected.  The most vulnerable groups of people affected 
by the diseases are young children and pregnant mothers. Over the years, delivery of 
healthcare has greatly improved, so have the pathogenic microorganisms also evolved to 
adapt to their ever disturbed environments. This has greatly compromised the 
advancements that have been made in the diseases management due to efficacious drug 
interventions. Suffice it to say, the challenge to manage diseases is more pronounced in 
poor regions of the world where most infectious diseases are prevalent. According to the 
World Health Organisation (WHO, 2010), these infections contribute to more than 40% 
of health problems worldwide. As a consequence, rigorous and efficient methods to 
control the diseases should be established, as the discovery and development of new 
drugs is key factor to achieving this goal. 
 
Infectious diseases are more widespread and persistent in tropical regions of the world 
which are endowed with high levels of biodiversity. These are regions that also 
accommodate most of the developing and poor countries which have inadequate health 
facilities and services. Zambia falling in this category, poor health is prevalent and 
diseases such as malaria, meningitis, pneumonia, tuberculosis and gastrointestinal 
infections have remained a challenge and hence continued to debilitate individuals in 
most communities. The human immunodeficiency virus (HIV) and Acquired 
immunodeficiency syndrome (AIDS) epidemics have also exacerbated the situation. 
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Another factor that contributes to poor health is that many communities especially in 
rural areas have to travel very long distances to access the most basic healthcare, meaning 
that complicated and severe infections are mostly never remedied. Hence the use of 
traditional medicine for primary healthcare is practiced. 
 
The use of plants to alleviate the mentioned diseases has always been practiced 
worldwide (Heinrich et al., 2004). The work presented in this thesis thus involves the 
screening of crude extracts and subextracts of the aerial plant parts and root barks of eight 
selected Ficus species for antibacterial, antifungal, antimycobacterial and antiparasitic 
activities. In addition, the extracts were screened for the inhibition of three recombinant 
FAS-II enzymes and the malaria prophylactic activities. Furthermore, the chemical 
compound isolation and characterization of the extracts are also presented. This 
introduction will thus give a brief overview of the pathogenic organisms which were 
screened for. These include dermatophytes, yeasts, moulds, gram-positive and gram-
negative bacteria, mycobacteria, and parasites like protozoa. The brief description of the 
selected eight Ficus species will be outlined. 
 
1.1 FUNGAL INFECTIONS 
Mycotic infections have increased over the years because of the increase and widespread 
use of therapies that depress the immune system such as organ transplants and also the 
frequent and often indiscriminate use of broad-spectrum antibacterial agents (Johann et 
al., 2007; Maschmeyer and Haas, 2006; Ghannoum and Rice, 1999). Antibacterial agents 
generally destroy the body’s natural microflora which, inhibit the thriving of certain 
fungi. In most cases, fungal infections are opportunist and are usually classified by the 
nature of tissues they colonize. Tissue colonization can be categorized at five levels, 
which include:  
i) superficial colonization which is restricted to the outer layers of the skin and hair 
ii) cutaneous colonization which develops a little deeper into the epidermis, hair and 
nails 
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iii) subcutaneous colonization which affects the dermis, subcutaneous tissues and 
muscles 
iv) systemic colonization which generally originates from the lungs 
v) opportunistic infection which develops because there is already an underlying 
compromising site where the immune system has been weakened  
In this thesis, focus is mostly on communicable fungi from human to human of which the 
anthropophylic fungal taxa of interest include dermatophytes in particular, members of 
the genera Trichophyton such as Trichophyton interdigitale and Trichophyton tonsurans, 
which cause Tinea capitis (scalp ringworm). Yeasts from the genus Candida and also a 
mould, Aspergillus which is acquired from the environment will be screened.  
1.1.1 Dermatophytes 
Dermatophytes occur worldwide and are responsible for many fungal infections affecting 
the skin, nails and hair (Pakshir et al., 2009; Ferńandez-Torres et al., 2003). They are a 
homogenous group of fungi with numerous species belonging to three main genera; 
Microsporum, Epidermophyton and Trichophyton. Dermatophytes feed on keratinized 
material for their proliferation, to cause a wide range of clinical symptoms of which 
dermatophytosis (tinea or ringworm) is one of the most common fungal infections, 
especially in children (Pakshir et al., 2009).   
1.1.1.1 Treatment 
There are several types of drugs used to treat dermatophytosis. They include amines, 
azoles and carbamates. Examples of these drugs are shown in Figure 1. Many infections 
respond to topical antifungal therapy and the most common azoles used include 
miconazole, clotrimazole and ketoconazole. Other types of antifungal moieties that have 
been added to treatment regimens include tolnaftate and terbinafine hydrochloride which 
are synthetic carbamates and allylamines respectively. However, serious and chronic 
infections of Tinea capitis (scalp ringworm) and Tinea unguium (nail) may require 
systemic treatment with oral medications even though sometimes treatment may fail due 
to resistance (Pakshir et al., 2009). 
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a)              b)                  c)  
d)       e)       f)  
g)        h)  
Figure 1: Common antifungal drugs. (a) Amine. (b) Azole. (C) Carbamate. (d) Terbinafine ([(2E)-6, 
6-dimethylhept-2-en-4-yn-1-yl](methyl)(naphthalen-1-ylmethyl) amine). (e) Clotrimoxazole (1-[(2 
chlorophenyl) (diphenyl) methyl]-1H-imidazole). (f) Miconazole (RS)-1-(2-(2, 4-Dichlorobenzyloxy)-2-(2, 
4 dichlorophenyl) ethyl)-1H-imidazole). (g) Tolnaftate (synthetic thiocarbamate) (O-2-naphthyl methyl-(3-
methylphenyl) thiocarbamate). (h) Nystatin 
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1.1.2 Yeasts (Candidiasis) 
Candidiasis is a fungal condition caused by yeasts of the genus Candida. The most 
common species that cause adverse health problems is Candida albicans, a diploid 
fungus (a yeast) and a causal agent for opportunistic oral and genital infections in 
humans. Systemic fungal infections are one of the main causes of morbidity and mortality 
in immunocompromised patients infected with HIV and suffering from AIDS, those with 
cancer and are on chemotherapy, those having to undergo organ or bone marrow 
transplantation, as well as the elderly (Samie et al., 2010; Johann et al., 2007). The 
extensive use of broad-spectrum antibiotics, corticosteroids and anticancer agents has 
also added to the increase in yeast infections (Gisela et al., 1994), since these agents tend 
to destroy the natural microflora in the body. 
1.1.2.1 Treatment 
Candidiasis is mostly treated with antifungal agents that possess an azole moiety (Figure 
1b). These include topical agents like clotrimazole and ketoconazole, fluconazole and 
topical nystatin whose images are shown in Figure 2. There have been several 
suggestions on the mode of action of azoles. One such established thought is how azoles 
initially target the heme protein which, together with cytochrome P-450 inhibits 14α-
demethylase enzyme to cause the disruption of ergosterol biosynthesis.  This leads to the 
accumulation of toxic sterol precursors, which in turn alter the integrity of the structure 
and function of the plasma membrane (Ghannoum and Rice, 1999). 
 
 
Figure 2: Common drug for candidiasis – Nystatin 
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1.1.3 Moulds (Aspergillosis) 
Aspergillosis is the group of diseases caused by fungi of the genus Aspergillus. 
Aspergillosis infection varies in that it can be due to allegy (e.g asthma or sinusitis) or be 
invasive due to ones weakened immune system. The most common of these diseases is 
that caused by the species Aspergillus fumigatus, a filamentous fungus which is present in 
the environment, but does not normally cause illness. Other causes of aspergillosis 
include Aspergillus flavus, A. niger and A. terreus (Richardson, 2005). However, diseases 
surface as a result of immunosuppression in individuals and also in those who already 
have other lung conditions (Richardson, 2005). 
1.1.3.1 Treatment 
While the treatment of mycotic infections depends on the tissues affected, many are 
treated with drugs that have an azole moiety. Of the most widely used are members of the 
triazole family (Figure 3a), and voriconazole (Figure 3c) is the first-line drug used for 
invasive aspergillosis (Denning and Hope, 2010). Triazoles have been useful owing to 
their wide spectrum of activity in that they are effective against invasive aspergillosis, 
candidiasis, some dermatophyte infections and other endemic mycoses. Also triazoles are 
said to have potent pharmacokinetic profiles which include rapid absorption and oral 
bioavailability of more than 90%, and to top it all, it is well tolerated with mild side 
effects (Maschmeyer and Haas, 2006).  
a)                 b)                   c)  
Figure 3: Common drugs for Aspergillosis. a) Triazole moeity. b) Fluconazole. c) 
Voriconazole 
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1.2 BACTERIAL INFECTIONS 
1.2.1 Bacterial infections 
Bacteria are part of the normal human microflora and are beneficial to the body existing 
on the skin and mucous membranes without causing any harm. However, when allowed 
entry into the body, or the immune system of the individual fails to fight off the invasion, 
bacteria becomes pathogenic and thereby causing deseases. Diseases caused by bacteria 
can include skin infections, chest infections, cerebral and food-borne illnesses. 
Bacteria are normally classified according to the structure of their cell walls. In this case, 
they can be classified as; gram-positive bacteria which have up to about twenty times as 
much murein or peptidoglycan in their cell walls compared to gram-negative bacteria, the 
second class. The classification thus relies on the positive or negative results from 
Gram’s staining method, which uses complex purple dye and iodine. Gram-positive 
bacteria are identified when they retain the dye due to the many layers of complex 
polymers of amino sugars which are cross-linked to the  amino acids alanine, glutamate, 
lysine or diaminopimelic acid.  
1.2.1.1 Treatment 
Bacterial infections are treated with a wide range of drugs, and due to the inappropriate 
and irrational use of some of the drugs, favourable conditions for resistant strains to 
emerge have been provided. Over the years, bacterial strains have developed new 
resistance mechanisms which have made them less susceptible to antibacterial drugs, 
making it difficult and expensive to treat bacterial infections (WHO, 2013). As a result 
high percentages of hospital-acquired infections have been caused by the resistant 
bacterial strains (WHO, 2013).  
The treatment for MRSA includes glycopeptides such as vancomycin and teicoplanin. 
These act as inhibitors to the second stage of bacterial cell wall synthesis and it is also 
evidenced that vancomycin selectively inhibits ribonucleic acid synthesis by altering the 
permeability of the cell membrane (Watanakunakorn, 1984). Linezolid (Figure 4) is a 
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newer antibiotic that is the first available oxazolidinone antibacterial agent which disturbs 
the protein synthesis by interfering with the binding of messenger ribonucleic acid 
(mRNA) to ribosomal ribonucleic acid (rRNA) during the initiation stage of translation 
(Shinabarger et al., 1997).  It is active against MRSA and is a potent option to 
vancomycin which normally causes renal toxicity in some patients and is poorly absorbed 
when intravenously administered (Tsiodras et al., 2001). Daptomycin, a cyclic 
lipopeptide antibacterial agent is another drug considered potent in the treatment of 
MRSA infection and it is believed to have a dual mechanism of action, one of which is 
the inhibition of cell wall synthesis and the other is to establish multiple ion gradients 
across the cytoplasmic (Streit et al., 2005). 
 
Antibiotic resistance is one of the world’s most pressing public health problems because 
there is a high proportion of resistance worldwide (WHO, 2014; Cornaglia, 2009). There 
is thus an urgent need to discover new generation of antimicrobial compounds which 
have different chemical structures and perhaps novel mechanisms of action to treat the 
new emerging infectious diseases. 
 
 
 
Figure 4: Antibiotic – Linezolid 
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1.2.2 Tuberculosis  
Tuberculosis (TB) is the second most infectious disease after HIV/AIDS with a high 
morbidity and mortality (WHO, 2012). It is a contagious bacterial infection that mainly 
affects the lungs, but can spread to other organs. TB is caused by Mycobacterium 
tuberculosis, an obligate aerobic pathogen that is spread by coughs or sneezes of infected 
persons and be inhaled by uninfected subjects. On first contact with the pathogenic 
bacteria, also known as primary TB infection, the person may not develop the symptoms; 
however, the bacteria can remain dormant in the body. This is referred to as latent TB. 
About one-third of the world’s population asymptomatically harbors the latent TB which, 
can be reactivated anytime (Koul et al., 2011). In most cases, however, the latent TB is 
activated when the body’s immune system weakens causing characteristic symptoms of 
the disease to appear. Such symptoms may include chest pains which maybe 
accompanied by dyspnea, persistent cough (which may produce phlegm), or coughing up 
blood, night sweats, tiredness, fever, loss of appetite and drastic weight loss. 
According to the updated WHO (2012) report about 8.6 million people suffered from TB, 
while 1.3 million died from it in 2012. This record is, however, a decline in comparison 
to the 1.4 million people who died from the scourge in 2011, and a further decline from 
the 1.7 million who died in 2009 with the highest number of deaths occurring in Africa 
(WHO, 2012 and 2010). As much as TB is more prevalent in the world today than it has 
ever been (Koul et al., 2011), the diagnosis and treatment strategies have helped in 
reducing deaths. However, the prevalence is compounded by the worldwide emergence of 
multidrug-resistant (MDR) strains which has seen an increase by 10 000 infections to 
approximately 450,000 new cases of MDR-TB emerging in 2012, with one third of the 
world’s total population being infected with TB bacilli (WHO, 2014 and 2010). One in 
every 10 of those people will become sick with active TB in their lifetime (WHO, 2010). 
People living with HIV are at a much greater risk of contracting TB because HIV 
associated TB and multidrug-resistant-TB are harder to diagnose and cure (WHO, 2010), 
leading to a higher number of deaths as a result of the infection.  
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1.2.2.1 Treatment 
The treatment of Tuberculosis is done in two phases. The treatment regimens for TB 
constitute a combination of four drugs (Figure 5) which include isoniazid, rifampicin, 
pyrazinamide, and either streptomycin, ethambutol or ethionmide as secondary drugs for 
the first two months. Then then a follow up retreatment (second phase) with isoniazid and 
rifampicin for a further four months is done. Although the combination regimen has been 
effective even against resistant forms (MDR-TB), non compliance to the treatment has 
resulted in some extensive multiple resistant strains (XDR-TB) of M. tuberculosis to 
surface as has been identified in 92 countries (WHO, 2014), which are even more 
challenging to treat. Hence the imperative need for the discovery of new anti-TB drug 
regimens. 
 
a)            b)     c)  
d)             e)  
Figure 5: Drugs used for treatment of Tuberculosis. (a) Isoniazid. (b) Pyrazinamide. (c) 
Ethambutol. (d) Streptomycin. (e) Rifampicin 
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1.3 PARASITIC INFECTIONS 
Parasitic diseases are infection caused by parasites. Parasites are organisms that live in 
another organis (host) often causing damage to it. They can either live inside the body of 
the host as endoparasites, or live on the outer surface of the host body as ectoparasites. 
Endoparasites such as helminths and protozoa constitute the major causes of diseases to 
humans in most affected regions of the World. Helminths can be in the form of 
roundworms (nematodes), flatworms (trematodes) and tapeworms (cestodes), while there 
are many genera of protozoans which are pathogenic to humans. In this thesis, the focus 
will be on helminths that belong to the genus Schistosoma and protozoans of the genera 
Leishmania, Trypanosoma and Plasmodium. 
1.3.1 Schistosomiasis 
Schistosomiasis, also called bilharzia is one of the tropical diseases caused by digenetic 
trematodes of the genus Schistosoma. It is prevalent in about 74 nations mostly those 
occurring in tropical and sub-tropical regions of the World, with Africa having the largest 
disease cases (WHO, 2013; Chitsulo et al., 2000).  According to the WHO report (2013), 
over 240 million people were infected worldwide (highest rates in children) in 2012, with 
highest prevalence in the tropical and sub-tropical regions (Gryseels et al., 2006). Sub-
saharan Africa in particular records more than 200 000 deaths annually due to 
schistosomiasis (WHO, 2013). The infection thrives mostly in densely populated and 
poor communities which have inadequate sanitation (WHO, 2013). The World Health 
Organisation actually describes it as ‘a disease of poverty’. Schistosomiasis is highly 
prevalent even though it has variable and low morbidity (Gryseels et al., 2006).  
There are five main members of this genus that cause schistosomiasis, which is in two 
forms. One is the intestinal schistosomiasis caused by Schistosoma mansoni, Schistosoma 
japonicum, Schistosoma mekongi and Schistosoma guineensis, and the other is the 
urogenital schistosomiasis mainly caused by Schistosoma haematobium found in Africa 
and the Arabian Peninsula (Gryseels et al., 2006). 
Transmission of schistosomiasis occurs through the skin. Thus infectious larval forms 
(cercarie) of the parasitic blood flukes when released by freshwater snails penetrate the 
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skin of people who have been exposed to the contaminated water. While in the skin the 
cercarie transform into schistosomula and then migrate to the liver where they mature 
into adult worms. The microscopic adult worms live in the veins where the females 
produce eggs which are then shed through the intestines and the urinary tract (Coultas 
and Zhang, 2012). Most of the eggs they lay are trapped in the tissues and the body’s 
reactions to them cause massive organ damage, to which the schistosome maturation and 
fecundity depend on this immune response (WHO, 2013; Pearce and MacDonald, 2002). 
Meanwhile, some of the eggs are excreted in the feaces or urine to continue their life-
cycle, and they can remain viable for up to 7 days once excreted. 
1.3.1.1 Treatment 
Schistosomiasis is one of the greatest neglected tropical diseases and is currently being 
treated and managed with Praziquantel, as recommended by the World Health 
Organisation (WHO, 2013). This drug is safely co-administered with albendazole or 
ivermectin, in areas where these drugs have been used separately for preventive 
chemotherapy. Praziquantel is an acylated quinoline-pyrazine (Figure 6), which has little 
or no effect on larvae and immature worms, but has a broad spectrum of activity against 
all mature human trematodes and cestodes (Doenhoff and Pica-Mattoccia, 2006). The 
effect that Praziquantel is believed to have on the worm, is that it increases the cell 
permeability to calcium in schistosomes. This then causes strong contractions and 
paralysis of the worm’s musculature, leading to detachment and dislodgement of the 
suckers from the blood vessel walls. The molecular target of Praziquantel has however, 
remained unknown even though it has been used for over 20 years (Aragon et al., 2009). 
 
Figure 6: Common drug for schistosomiasis - Praziquantel 
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1.3.2 Protozoal Infections 
Protozoal infections are caused by single celled parasites called Protozoa. These parasites 
predominantly occur in the tropical and sub-tropical regions of the world to cause a lot of 
debilitating diseases (Wright and Phillipson, 1990). The most widespread and common 
protozoal diseases include leishmaniasis, trypanosomiasis and malaria which is the most 
troublesome. 
1.3.2.1 Leishmaniasis 
Leishmaniasis is caused by parasitic protozoa that belong to the genus Leishmania. It 
occurs in about 88 countries, many of which are in tropical and sub-tropical regions. 
Members of this genus are intracellular pathogens which affect macrophages and 
dendritic cells. The parasite is transmitted by the bite of a blood-sucking female sandfly 
of the genus Phlebotomine (family: Psychodidae). Of the five hundred known species of 
Phlebotomus, only about thirty are vectors of leishmaniasis (WHO, 2012; Anderson, 
2003). 
There are four main types of leishmaniasis. These include visceral leishmaniasis, 
cutaneous leishmaniasis, diffuse cutaneous leishmaniasis and mucocutaneous 
leishmaniasis. Visceral leishmaniasis, also called kala-azar is caused by Leishmania 
donovani and is the most fatal of the four types. It is characterized by weight loss, high 
temperatures, anemia and hepatosplenomegaly. The disease develops in a short period of 
time such that, patients can die within months of getting infected unless they receive 
treatment. It is widespread, occurring in many parts of the world and affects millions of 
people (Tasdemir et al., 2005). 
1.3.2.1.1 Treatment 
Leishmaniasis is a difficult disease to manage and treatment is quite limited. The drugs 
normally used for treatment include antimony derivatives, diamidines and amphotericin B 
( 
Figure 7). For instance visceral leishmaniasis can be treated with antimonides such as 
sodium stibogluconate (Pentostam®) and meglumine antimoniate (Glucantim®). 
However, there is growing resistance against sodium stibogluconate. In addition, the 
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period of treatment is relatively long and painful, and it can cause undesirable side effects 
(Witschel et al., 2012). Most of the anti-protozoal drugs are inadequate because of their 
toxicity, lack of efficacy and inability to elimimnate all life cycle stages of the parasites 
from the host (Tasdemir et al., 2005). 
a)  
 
b)    
 
Figure 7: Drugs for Leishmaniasis.  a) Amphotericin B. b) Diamidine furamidine 
 
1.3.2.2 Trypanosomiasis 
Trypanosomiasis is a vector-borne parasitic disease caused by pathogenic protozoa 
belonging to the genus Trypanosoma. It manifests in many forms depending on the 
Trypanosoma species involved. The most common is the human African 
Trypanosomiasis, also known as African sleeping sickness, which is transmitted to 
humans by a bite of various species of tsetse flies belonging to the genus Glossina, which 
are endemic only to sub-saharan Africa (WHO, 2013), but have spread to other parts of 
Africa that have accommodated the species with favourable conditions for survival . 
Sleeping sickness is thus caused either by Trypanosoma brucei gambiense or 
Trypanosoma brucei rhodesiense. The former occurs mainly in west and central Africa 
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and accounts for 95% infections (WHO, 2012). Meanwhile, the latter occurs in eastern 
and southern Africa, representing 5% of cases. Another type of trypanosomiasis is caused 
by Trypanosoma cruzi and it occurs in the Latin American countires. It is transmitted to 
humans by blood-sucking triatomine bugs endemic to those countries. It is called 
American trypanosomiasis or Chagas disease and is characterized by neurological 
disorders, including dementia, damage to the heart muscle leading to cardiac failure, 
sometimes dilation of the digestive tract and weight loss in its chronic form. 
1.3.2.2.1 Treatment 
There are four registered drugs of choice for the treatment of African sleeping sickness. 
These are pentamidine and suramin which are used in the early stage of the infection, that 
is when the parasites are only restricted to the blood and lymph (Witschel et al., 2012). 
Pentamidine is used for the treatment of T. brucei gambiense while Suramin for the 
treatment of T. brucei rhodesiense. The other two drugs are Melarsoprol (Figure 8) and 
Eflornithine which are used in the advanced-stage of the disease, which includes the 
parasite’s invasion into the central nervous system (CNS) (Hubert and Barrett, 2001).  
The two latter are most effective for complicated infections against all Trypanosomal 
infections. Melarsoprol is an organoarsenic drug that targets the parasite by crossing the 
blood-brain barrier. It is however, very toxic and quite difficult to administer because it is 
only by intravenous means. Because of its toxicity, Melarsoprol causes some serious 
unwanted effects among others encephalitis in about 10% of patients and about 5% die as 
a result (Witschel et al., 2012; Wright and Phillipson, 1990). With these limitations, there 
is need for more less toxic drugs. 
Meanwhile, Chagas disease caused by T. cruzi has two first line drugs available for 
treatment. These are Nifurtimox and Benznidazole (Figure 8), which like Melarsoprol 
have limitations such as toxicity, poor drug activity, and possible emerging parasite 
resistance (WHO, 2012). On top of that, they are also poorly tolerated and the length of 
time needed to complete the course is long (Witschel et al., 2012). Furthermore, 
treatment is really only effective when given during the acute stage of the disease, which 
maybe detrimental to the patient. There has been recently introduced a combination 
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treatment of nifurtimox and eflornithine even though it is only effective against T. brucei 
rhodesiense (WHO, 2012). 
a) b) c)  
Figure 8: Common drugs for trypanosomiasis. a) Melarsoprol. b) Nifurtimox. c) 
Benznidazole 
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1.3.2.3 Malaria 
Malaria is another infectious disease that remains a serious global health problem 
(Wright, 2010). At least one in every five (20%) children is affected by the disease, such 
that an African child suffers from malaria about 2 to 5 times every year (WHO, 2009). 
Being the most prevalent and deadly parasitic disease, some successes in terms of 
transmission reduction have been recorded. There has been a reduction of malaria cases 
worldwide as can be observed by World Health Organisation figures from 2011 to 2012. 
According to the WHO (2014) estimates, malaria cases reduced from about 219 million 
in 2011 to about 207 million in 2012, and the mortality rates were recorded at about 
627 000 during the same period. Malaria is prevalent in over 100 countries in tropical and 
sub-tropical regions of the world as can be seen in Figure 9A (WHO, 2010).  
 
In Africa, malaria is not only a health problem, but also an economical and food security 
challenge as it consumes up to 40% of public health expenditure in most affected areas 
(Kitua et al., 2011). In Zambia, as it remains the number one killer disease, especially to 
children under the age of five, pregnant mothers and immune compromised individuals, 
with the highest transmission rate falling within the season of cultivating the staple food 
(between the months of November and early April), the disease is a burden and 
household food security is heavily affected.  
 
The clinical manifestations of malaria are caused by the blood stage parasites. They 
include periodic episodes of chills, fever followed by intermittent sweating which are 
usually accompanied by headache, nausea and vomiting. These symptoms come about 
when some toxic elements and hemozoin pigments accumulate in the infected 
erythrocytes during the parasites’ development. When these erythrocytes lyse, they 
release into the blood stream invasive merozoites and the toxic elements which induce 
cytokines and other tumor necrosis factors that cause the symptoms. Thus the destruction 
of the red blood cells leads to anemia and hypoxemia (Kaur et al., 2009). The effects 
include hypoglycemia and cerebral complications, which if left untreated can cause death. 
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Figure 9: A) World distribution map of Malaria. B) Plamsodium species. C) A mosquito 
having a blood meal. D) Schizontes infected erythrocytes. 
(http://www:traveldoctor.co.uk/malaria.htm; 
http://www.primehealthchannel.com/mosquito bites pictures 
http://www.henry4school.fr/Body_and_Health/health/malaria.htm) 
A B 
C D 
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1.3.2.3.1 Plasmodium 
Malaria is caused by single-celled organisms that penetrate host tissues to obtain food. 
These are parasitic organisms called protozoa which belong to the phylum Apicomplexa, 
which holds more than 5,000 species (Surolia et al., 2002). The most documented 
apicomplexans are malaria parasites of the genus Plasmodium (Figure 9B), of which five 
species cause malaria. These include; Plasmodium falciparum, Plasmodium vivax, 
Plasmodium ovale, Plasmodium malariae and Plasmodium knowlesi. The most common 
ones being P. falciparum which causes malignant malaria and P. vivax causes benign 
malaria, even though P. falciparum is the most predominant and deadly parasite causing 
the most malaria-linked deaths especially in sub-Saharan Africa (Wells et al., 2009; 
WHO, 2012). 
1.3.2.3.2 The life cycle 
The life cycle of the P. falciparum is completed in two hosts, the human host for the 
asexual stage and the mosquito host for the sexual stage (Figure 10). The parasite is 
transmitted into the host through a bite by a female mosquito, mostly the Anopheles 
gambiae and other species, in which hundreds of sporozoites are released into the 
bloodstream of the host to infect the hepatic parenchymal cells. The invasion of the 
hepatocytes is referred to as the liver stage malaria. In the liver the sporozoites develop 
into merozoites and a period of massive growth ensues to produce more than 10,000 per 
liver schizont (Singh et al., 2009; Spalding and Prigge, 2008). This liver stage also called 
the exoerythrocytic stage is asymptomatic and lasts between 2-16 days after the bite, 
depending on the Plasmodium species. It takes about 6-7 days in P. falciparum (Tasdemir 
et al., 2011). Upon maturation, the merozoites invade erythrocytes where they 
periodically replicate asexually while, at the same time progressively breaking down the 
red blood cells (Figure 9D). This causes episodes of fever, chills and anaemia in the 
infected individual. This is the symptomatic stage and the cycle is completed within 48 
hrs for P. falciparum and P. vivax, 72 hrs for P. malaraie and 24 hrs for P. knowlesi 
(Wells et al., 2009). In severe cases however, blood vessels in the brain get obstructed by 
infected red blood cells to cause the deadly cerebral malaria. In all this, some merozoites 
differentiate to form male and female gametocytes, which are then taken up by the female 
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mosquito during a blood meal (Figure 9C) to continue its life cycle in its second host (the 
mosquito). In this form they can also live quiescently in the bloodstream for weeks.   
Whilst in the mosquito gut, the female and male gametes develop and then fuse to form 
diploid ookinetes. These then, migrate to the midgut and pass through the gut wall to 
form oocyts. After a meiotic division, sporozoites are born, which migrate to the salivary 
glands waiting to be deposited into the human host to start the cycle over again. 
 
Figure 10: Malaria parasite’s life cycle in the humans and in the Anopheles mosquito 
(Winzeler, 2008). 
1.3.2.3.3 Malaria Prophylaxis 
Malaria prophylaxis is not absolute as infection can still occur. This is because the 
complicated life cycle of the plasmodium parasite in two hosts has made it difficult to 
develop vaccines against malaria (Wells et al., 2009). Thus protection against infected 
mosquito bites would be the best option, as there is no long term prophylaxis available 
yet. However, there are some vaccines that are currently under phase 3, phase 2 and 
phase1 clinical trials (WHO, 2011). Malaria prophylaxis can be divided into two 
categories; suppressive prophylaxis and causal prophylaxis.  The former is when drugs 
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eradicate and suppress blood stage parasites from causing symptoms, while in the latter; 
parasites are eradicated at liver stage, thus preventing the symptomatic blood stage 
infection. 
Suppressive prophylaxis 
The World Health Organization (WHO, 2010) recommends the combination of 
Atovaquone with proguanil as suppressive prophylaxis for travelers. Atovaquone is very 
effective but quite expensive to manufacture, hence it may not be susutainable to poor 
countries where malaria is most prevalent (Leitao and Rodriguez, 2010). Other 
chemoprophylactics that have been used include chloroquine, mefloquine and 
doxycycline (Well et al., 2009).  
Causal prophylaxis 
The only licensed drugs available to kill dormant liver stages and gametocytes for causal 
prophylaxis are 8-aminoquinolines, in particular Primaquine and tefenoquine (Leitao and 
Rodriguez, 2010). Since the parasitic load in the liver tends to be low, the population 
would take a bit longer to multiply to massive loads thereby reducing the chances of drug 
resistant forms from developing.  However, some of the 8-aminoquinolines are reported 
to be toxic, poorly complied to when taking them, and to add on causes hemolytic 
anaemia in patients with glucose-6-phosphate dehydrogenase (G6pDH) deficiency 
(Leitao and Rodriguez, 2010; Singh et al., 2009; Wells et al., 2009). This enzyme 
deficiency is a red cell polymorphism that is common to populations in Africa, Asia and 
the Mediterranean regions; in essence the malaria bug-ridden regions, because it is 
associated with some form of immunity against the malaria disease (Ruwende et al., 
1995; Allison and Clyde, 1961). Primaquine is effective for liver stage parasites and 
radically cures P. vivax infection (Winzeler, 2008).  Mefloquine is a drug with a long 
half-life and can thus provide effective prophylaxis when administered weekly; but is not 
well tolerated in that it has unpleasant side effects of gastrointestinal and psychiatric 
effects (Well et al., 2009). 
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1.3.2.3.4 Treatment 
Malaria has been treated with a wide range of drugs. There have been successes in the 
treatment for as long as resistant parasitic strains have been at bay. The types of drugs 
that have had success stories include quinine and its derivatives such as chloroquine; 
antifolates such as sulfadoxine/pyrimethamine and the current artemisinin in combination 
with other agents, lumefantrine being the most common. However, some earlier 
generation medicines like chloroquine and antifolates such as sulfadoxine/pyrimethamine 
have developed some resistance against the parasites, but they are still being used in some 
regions. For instance, the antifolate, sulfadoxin/pyrimethamine is still being used in 
Zambia in rural health centers and also for prophylaxis in pregnant mothers. Their 
continued use is however, is risky because the development of resistant strains may not 
be noted easily in areas where healthcare provision is already inadequate (WHO, 2010). 
Quinine 
Quinine (Figure 11A) was the first widely used antimalarial drug for complicated malaria 
for some time (Wells et al., 2009). It is a natural product extracted from the bark of the 
trees of the genus Cinchona L. (Rubiaceae). Members of the genus which are sources of 
quinine include; Cinchona calisaya Wedd., C. ledgeriana Moens ex Trimen and C. 
pubescens Vahl. amongst others (van Wyk and Wink, 2004). The use of the Cinchona 
bark has been known as far back as the 17th century, and since then, it has been the only 
source of quinine (Adams et al., 2011). Even though, resistance has been reported, it has 
remained useful in the treatment of complicated malaria. More importantly, quinine has 
been used as a scaffold for the production of other successful synthetic derivatives such 
as Chloroquine and Mefloquine, which are also still being used in some regions. Other 
derivatives include 8-aminoqionoline primaquine and 4-aminoquinoline chloroquine 
which are also used for prophylaxis. In addition chloroquine-like drugs such as 
lumefantrine, piperaquine, pyronaridine, amodiaquine, mefloquine and halofantrine have 
been produced and are being used mostly in combination with other drugs (Wells et al., 
2009). 
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a)           b)   
Figure 11: Quinine and its derivatives  (a) Quinine. (b) Primaquine 
 
Fansidar 
Fansidar (SP), a drug that contains sulphadoxine (slow eliminated sulphonamide) and 
pyrimethamine (a slow-acting 2, 4-diamino-sulphadoxine) which eliminates the blood 
schizontes ( 
Figure 12) has been used widely. Unfortunately, resistance for this drug arose quite 
rapidly (Wells et al., 2009), even though it is still being used, mostly for prophylaxis. 
These two drugs belong to the group of antifolate drugs, which interfere with nucleic acid 
synthesis, by blocking enzymes involved in the synthesis of folate in the cytoplasm of the 
parasite (Brown, 1971; Ferone, 1970).  
 
a)                        b)  
 
Figure 12: Antifolate antimalarial drugs. (a) Sulfadoxine. (b) Pyrimethamine 
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Malarone 
Malarone is another combination drug of choice which constitutes proguanil and 
atovaquone (Figure 13) and is used to treat acute uncomplicated malignant malaria. It is 
also used for causal prophylaxis because it is effective against both drugs sensitive and 
drug resistant prarasitic strains. Malarone works as a blood schizonticide and 
transmission blocker in particular; affecting the biosynthesis of pyrimidines required for 
nucleic acid replications (Wells et al., 2009). The asymptomatic liver stage has emerged 
as a good causal prophylactic target because the interference of this phase would prevent 
the symptomatic stage, hence reducing the chances of parasite transmission because the 
production of gametocytes is interrupted. Additionally, the low parasitic load with limited 
multiplication significantly reduces the likelihood for drug resistant strains to develop. 
One further area which is important for targeting the liver stage is the elimination of 
schizontes for P. vivax and P. ovale, which remain dormant in the hepatocytes for several 
years and they usually cause relapses. Theses are referred to as hypnozoites. Malarone 
unfortunately has not been found to be effective against these Plasmodium species. 
 
     b)  
Figure 13: Prophylactic malarial drugs. (a) Proguanil. (b) Atovaquone 
 
Artemisinin combination therapies 
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Artemisinin is sourced from the aerial parts of Artemisia annua (commonly known as 
sweet wormwood) which belongs to the family Asteraceae. Artemisinin was first isolated 
in 1972 and characterized in 1979 (Golenser et al., 2006). It is the current effective 
treatment for malaria, however, in combination with other chemical moieties. Thus 
artemisinin-based combination therapies (ACTs) ( 
Figure 14) are the first line treatment options recommended by the World Health 
Organization in 2005 (WHO, 2009). The five ACTs that are recommended include; 
artemether-lumefantrine (Coartem), artenusate-mefloquine, artesunate-amodiaquine 
(Carsucam or ASAQ), artesunate-SP and DHA-piperaquine (EUrartesim or Artekin). 
Artemisinin (qinghaosu) is a sesquiterpene trioxane lactone which contains an 
endoperoxide bridge known to be essential for activity. However, the most effective 
antimalarial principle for the treatment of P. falciparum is in the form of 
dihydroartemisin (DHA) and its semisynthetic derivatives artemether and artesunate 
(White, 2008). Artemisinin in its pure form has poor oral availability, poor solubility both 
in water and oil, and is less active (Held et al., 2011). Meanwhile, when reduced, its 
active form, DHA is generated. This form is very potent as it is readily absorbed, is fast 
acting and can reduce the parasite load by a factor of approximately 10, 000 per asexual 
cycle or below detectable levels compared to 100 –1,000-fold for other antimalarials 
(WHO 2010; Willcox, 2009). The rapid parasite load reduction in turn reduces the rate of 
parasite transmission and results in the shortest fevr clearance times (Well et al., 2009), a 
characteristic that can be used as an indicator for artemisinin resistance (White, 1997). 
Other than its rate of activity, DHA, exhibits an unusual broad spectrum of activity 
against all the asexual blood stages of the parasite from young rings to schizonts and to 
gametophytes in P. faciparum malaria (Wells et al., 2009; Golenser et al., 2006). 
 
With all the rich activity profile for DHA, it still cannot be used as a monotherapy, 
because it has a very short half-life and short elimination half-time (about an hour), hence 
not all the parasites are likely to be eliminated within that time. This factor unfortunately 
increases the chances of recrudescence (Willcox, 2009; Golenser et al., 2006). 
Consequently, to continue keeping DHA’s profile viable, a second slow-acting drug is 
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usually combined with it to completely eliminate all the remaining parasites including 
possible arisen artemisinin-resistant ones, thus preventing the re-emergence of the disease 
and that of resistance (WHO, 2010; Wells et al., 2009).  
 
The mechanism of action of artemisinin and its derivatives is still not very clear. 
However, there are several targets that have been suggested for the mode of action. They 
have been attributed to interference of the parasite transport proteins, in particular the 
only plasmodial sarcoplasmic/ endoplasmic calcium ATPase gene (SERCA-pfATPase6) 
(Chaponda et al., 2009; Golenser et al., 2006), and disruption of parasite mitochondrial 
function by inhibiting the respiratory chain (Krungkrai et al., 1999; Li et al., 2005), 
modulation of host immune function, inhibition of angiogenesis and heme 
polymerization. 
Artemisinin combination therapies, like other antimalarial drugs have not being spared 
from parasitic resistant strains emerging. Four Southeast Asian countries (the Thai-
Cambodian border, Myanmar, Thailand and Vietnam) have reported emergency of 
resistance (WHO, 2010; Al-Adhroey et al., 2010). To add on, the production of 
artemisinin is not cost effective as the yields are very low, less than 2% of dry plant 
material. This inevitably raises isolation and purification costs (Weathers et al., 2011). 
With the highest malaria mortality rate being recorded in countries with high poverty 
levels, it therefore, becomes an expensive drug both to manufacture and to use. It is 
therefore, imperative to discover more drug targets and agents to manage the disease 
before the present drugs become resistant and lose efficacy.  
 
a)      b)         c)  
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Figure 14: Blood stage malaria drugs.  (a) Artemisinin. (b) Artemether. (c) Artenusate 
 
 
1.3.2.3.5 Prevention 
Malaria is treatable and is also preventable. The prevention of malaria can be at different 
levels. Firstly, personal protection against mosquito bites presents the first line of malaria 
prevention. This can be done by applying mosquito repellants to the body, spray 
insecticide in the room where you are or close windows before dusk. Secondly, at 
community level, vector control is the main way to reduce malaria transmission (WHO 
2011). The insecticide-treated mosquito bed nets (ITNs) and indoor residual spraying 
(IRS) are two main forms of vector control that have so far been quite effective at 
community level (Ranson et al., 2011). Nowadays, there are even insecticide-treated 
mosquito window laces and mosquito repellant wall paint (personal observation). Of the 
ITNs for public health distribution programmes, the long-lasting insecticidal nets (LLINs) 
are the preferred and recommended ones by WHO (2011), the custodians of health 
matters worldwide. These nets are mainly distributed for free to vulnerable individuals, 
who include children under the age of five and pregnant mothers.  
The other vector control intervention is the indoor residual spraying (IRS) with 
insecticides. It is a powerful way to reduce the transmission of parasites since the vectors 
are removed from the environment. This method is effective beyond 3 months, depending 
on the insecticide used and the type of surface on which it is sprayed (WHO, 2011). For 
instance, DDT (most commonly used) is one of the insecticides used and it can be 
effective for 9–12 months in some cases. Another class of insecticides currently being 
depended on is the pyrethroids (Ranson et al., 2011). There are however, challenges of 
resistance development by vectors to insecticides just like the parasites are developing 
resistance to antimalarial drugs (Corbel et al., 2012). There is therefore, need for the 
development of other classes of insecticides to lessen seriousness of the malaria problem 
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should the current pyrethroids become ineffective. With these prevention measures, 
Zambia has recorded a major reduction in malaria cases. 
1.3.2.3.6 Fatty acid biosynthetic pathway II (FAS II) as drug target 
In as much as successes have been recorded in reducing malaria, the ever evolving for 
survival parasites still pose a great challenge to the eradication of the disease. Thus the 
search for new drugs to prevent and treat malaria is still on. As such, the discovery of the 
apicoplast, a non photosynthetic plastid organelle of cyanobacterial endosymbiont origin, 
brought in a new prospect for drug development against Plasmodium falciparum (Surolia 
et al., 2004; Waller et al., 1998). This organelle which is essential for the functioning of 
the malaria parasite is the site of several vital anabolic processes such as cell growth, 
differentiation and homoeostasis (Surolia et al., 2002). A fatty acid biosynthetic pathway 
different from the known traditional one (FAS I) was discovered to occur in Plasmodium. 
This pathway called the type II or dissociation fatty acid biosynthesis (FAS II) occurs in 
the apicoplast of the Plasmodium (Waller et al., 1998; Ralph et al., 2001; Surolia and 
Surolia, 2001). FAS II, mainly present in prokaryotes, plants, and some protozoans, is 
markedly different from FAS I (Vaughan et al., 2008), which is present in eukaryotes 
including humans, yeast, and some mycobacteria. The type II FAS consists of seven 
small, monofunctional enzymes, each encoded by separate genes and each catalysing one 
single reaction, while type I (or associative) FAS consists of a single multifunctional 
protein derived from a single gene in which various domains catalyze different reactions 
of the biosynthetic pathway. Thus, the fundamental differences between the human type I 
and the plasmodial type II FAS pathways make the latter a striking target for antimalarial 
drugs, just as the FAS enzymes have been studied as targets for antimicrobials (Perrozo et 
al., 2002). 
The de novo FAS-II pathway was found to be important for the survival of the 
plasmodium parasite in the late liver stage, particularly in its transition from liver to blood 
stage (Tasdemir et al., 2010; Singh et al., 2009; Yu et al., 2008). It thus emerges to be the 
practical drug target for causal prophylaxis and perhaps vaccines which have not been 
successfully developed. This was evidenced in an experiment carried out by Vaughan et 
al. (2008), in which the deletion of critical elongation enzymes such as FabB/F and FabZ 
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in Plasmodium yoelii caused the parasites not to complete its liver stage development. In 
another similar work, the role of FabI in Plasmodium berghei caused a delay in 
development of parasites to develop into blood stages. Of the seven enzymes involved in 
the FAS II pathway, FabI has been the widely studied because it is the rate-limiting 
enzyme and it catalyzes the final enzymatic reaction in the fatty acid elongation process.  
Figure 15 illustrates the FAS II pathway in P. falciparum. In brief, the fatty acid synthesis 
is initiated by the carboxylation of acetyl-CoA to malonyl-CoA by acetyl-CoA 
carboxylase (ACC). Malonyl-CoA is then transferred to acetyl-carrier protein (ACP) by 
FabD (ACP transacylase) enzyme. The first step in the elongation pathway is the 
condensation of malonyl-ACP with acetyl-CoA catalyzed by FabH (β-ketoacyl-ACP 
synthase III) to form acetoacyl-ACP. The second step is the reduction of acetoacyl-ACP 
by FabG (β-ketoacyl-ACP reductase) in a NADPH-dependant reaction to form β-
hydroxyacyl-ACP. A dehydration process catalyzed by FabA (β-hydroxydecanoyl-ACP 
dehydratase) or FabZ (β-hydroxyacyl-ACP dehydratase) follows to form trans-2-enoyl-
ACP. The final and rate-determining step in the elongation process is another reduction 
catalyzed by FabI (enoyl-ACP reductase) in a NADH-dependent reaction. It reduces 
trans-2-enoyl-ACP to acyl-ACP. 
 
 
Figure 15: Type II fatty acid biosynthetic pathway system of Plasmodium falciparum. 
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Subsequent cycles are started by the condensation of malonyl-ACP with acyl-ACP by 
either FabB (β-ketoacyl-ACP synthase I) or FabF (β-ketoacyl-ACP synthase II). The 
cycles then continue until the required length of fatty acid chain is achieved.  
The biosynthetic pathway has shown that, there are more enzymes and stages of parasite 
growth that can be targeted to prevent the parasites reaching the blood stage. For our 
study we selected three elongation enzymes (FabI, FabB and FabZ) as targets for enzyme 
spectrophometric inhibition assays. 
1.3.2.3.7 Traditional plants and their use against malaria 
The use of medicinal plants by traditional healers to treat illnesses is an important part of 
primary healthcare in most rural communities in Africa (Ndubani and Hojer, 1999). This 
practice has been recorded from ancient times and many different plant species (about 
400) have been used and are still being used for the treatment of fever which is associated 
with malaria (Kaur, 2009; Ndubani and Hojer, 1999) and for malaria itself as compiled 
by Neuwinger, (2000). Other plant species are also used as mosquito repellent. The most 
successful conventional malaria drugs of all times have been sourced from plants. These 
include quinine, from which derivatives like chloroquine were generated and the present 
artemisinins which are successfully used in combination with other drugs to treat blood 
stage malaria. 
There are several members of the genus Ficus L. (Moraceae) that have been reportedly 
used against malaria. For instance, the aerial parts of F. asperifolia Miq. and F. 
sycomorus L. (mixed with Detarium microcarpum Guill and Perr. and Piliostigma 
thonningii Schumach, Milne-Redh.) have been used to calm fevers caused by malaria. 
These are steeped in water for bathing (Neuwinger, 2000). The decoction of the leaves, 
bark and roots of F. polita vahl subsp. polita (synonym = F. megapoda), F. melleri, F. 
pyrifolia are also used for fevers caused by malaria. The root decoction of F. natalensis 
and the aerial parts is drunk to alleviate malaria symptoms (Randrianarivelojosia et al., 
2003). 
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Some of the plant species reportedly used against malaria by the Masai people of Kenya 
include: Acacia tortilis (Forssk.) Hayne (Fabaceae), Fuerstia africana T.C.E Fr. 
(Lamiaceae), Manilkara discolor (Sond.) J.H. Hemsl (Sapotaceae), Pentas lanceolata 
Deflers (Rubiaceae), Sericocomopsis hilderbrandtii Schinz (Amaranthaceae), for which 
in vitro antimalarial and cytotoxity activities have been documented (Kigondu et al., 
2011). 
1.4 THE GENUS FICUS 
The genus Ficus L. belongs to the family Moraceae. It is one of the most populous 
species in number of all plant genera (Lansky and Paavilainen 2011). It has over 750 
different species, of which 500 occur in Asia and Australia, 150 reportedly occur in 
tropical America and 100 are in Africa and Madagascar. Of the 92 documented in sub-
saharan Africa, Zambia has 34 indigenous species (Fowler, 2007; Klopper et al., 2006; 
Phiri, 2005; Burrows and Burrows, 2003; Leister, 2000; Launert and Pope, 1991). Figs 
are all perennial trees or shrubs, mainly evergreen but with some deciduous. They are 
divided into three categories depending on their growth form. They can grow as rock-
splitters, stranglers or free standing terrestrial trees. They are characterized by latex that 
exudes from the bark, branches, leaves and fruits on injury. The leaves are mostly entire, 
some rarely lobed with irregular margins. The other characteristic feature of the genus, 
which runs in the whole family Moraceae is the fruit termed the syconium. This is a 
closed receptacle which forms a hollow sphere with inner surfaces lined with male and 
female flowers (dioecious figs) or flowers of a single sex (monoecious figs). Monoecious 
figs are essentially females which are also the edible ones (Lansky and Paavilainen 
2011). The existence of the syconium is a feature that makes figs unique, and 
interestingly, each Ficus species has co-evolved with its specific wasp pollinator 
(Burrows and Burrows, 2003). 
1.5 FOLKLORIC USE OF THE GENUS FICUS 
Many people still use plant traditional medicine to treat a variety of diseases caused by 
different pathogens. The genus Ficus is no exception as it has worldwide use, because 
members of this genus are one of the earliest sources of cultivated medicines and food by 
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both humans and animals (Lansky and Paavilainen, 2011; Ipulet, 2007). The members of 
the genus Ficus are used to treat many health conditions, as well being used for food. For 
instance, the fruits, fresh leaves and young stems are reportedly eaten as vegetables (Aref 
et al., 2010). Some members have also been used domestically for ropes, as dye for 
leather, and also as lime for bait to hunt down birds (Burrows and Burrows, 2003). 
Another use has been of ecological significance in that they can be indicators of ground 
water (Ipulet, 2007). Thus the occurrence of Ficus species in an area may indicate high 
ground water table. Mostly of interest in this research, is their ethnomedicinal use for 
curative purposes.  
There are many Ficus species reportedly been used for food, some of which are the fruits 
and leaves of F. dicranostyla Mildbr., F. sur Forssk. (synonym: Thunb.), F. natalensis 
Hochst., F. sycomorus L. and F. wakefieldii Hutch.  Edible fruits are chewed for 
dyspepsia, while leaves (also edible) or bark and root infusions are used in the treatment 
of infectious diseases, abdominal pains and diarrhoea (Kuete et al., 2011). 
Many reports however, come from the use of the genus as folk medicines throughout the 
continent of Africa and a few for domestic purposes (Rubnov, 2000; Burrows and 
Burrows 2003; Ipulet, 2007). As folk medicine, they have been used as astringents, 
laxatives, antihelmintics (de Amorin et al., 1999), for skin inflammations and warts. For 
example, the milky latex mixed with the bark of F. sycomorus and F. wakefieldii have 
antifungal properties which are used against some skin infections such as ringworms 
(Burrows and Burrows, 2003). In Ghana, the bark infusions of F. asperifolia Miq. are 
reportedly used for washing sores and ulcers and applied to circumcision wounds, while 
the rough leaves are used for scraping patches of ringworm before further treatment 
(Annan and Houghton, 2008). Decoctions of the bark of F. virgata are used in treating 
various skin diseases and ulcers (Abdul et al., 2008). It is also said to be effective in the 
treatment of piles, asthma, gonorrhea, hemoptysis, and urinary diseases. Decoctions of 
some Ficus fruits (F. carica L. and F. natalensis), the barks (F. trichopoda Baker, F. 
asperifolia, F. craterostoma Warb. ex Mildbr. & Burret., F. exasperata Vahl, F. 
thonningii Blume (synonym: F. iteophylla Miq.)), leaves (F. sagittifolia Warb. ex Mildbr. 
& Burret and F. populifolia Vahl), roots (F. sur Forssk. (synonym: F. capensis)) and the 
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milky latex of F. sycomorus subsp. gnaphalocarpa are reportedly used against sore 
throats and coughs (Burrows and Burrows, 2003; Neuwinger, 2000). In Senegal, the 
maceration of the leaves of Ficus dekdekena are used to treat tuberculosis, while in 
Cameroon the 1:1 decoction of Ficus chlamydocarpa and Ficus cordata is also used 
traditionally and indiscriminately used in the treatment of filaris, diarrhoeal infections 
and tuberculosis (Kuete et al., 2008). In view of the ayurvedic system of medicine the 
bark decoction of F. virgata Reinw. ex Blume and F. racemosa L. is gargled to cure 
mouth ulcers (Abdul et al., 2008; Mahota and Chaudhary 2005). The stem bark of F. 
ingens, F. lutea, F. polyphlebia, F. virgata, F. sycomorus, F. thonningii, F. sur, and F. 
umbellata have been used for stomach troubles; diarrhea, dysentery, colds and as an 
astringent (Al-Musayeib et al., 2012; Teklehaymanot and Giday, 2007; Burrows and 
Burrows, 2003).  
Some non-communicable diseases such as diabetes have also been managed by 
traditional medicines obtained from the genus Ficus (Aref et al., 2010). For instance 
decoctions of the bark and fruits of F. virgata and F. glumosa Delile are well known to be 
useful in diabetes (Abdul et al., 2008; Neuwinger, 2000). Abdul et al., (2008) also reports 
how the bark of F. virgata is antiseptic, antipyretic and vermicidal hypoglycemic. The 
use of leaves, stem bark and root bark of some species like F. sycomorus have been 
extended to treat conditions such as mental illnesses, liver problems, hepatitis and sickle-
cell anemia symptoms (Hubert et al., 2011). Koné et al., 2004 reports the use of the 
leaves of F. thonningii for rheumatism and the stem bark of F.  vallis-choudae Delile to 
treat heart problems in Cˆote-d’Ivoire. The aerial and root parts of F. natalensis (mixed 
with Sporobolus indicus (L.) Br.), F. sycomorus (mixed with Bridelia micrantha Hochst.) 
and F. sur are reported to be used for jaundice and as snake bite antidote (Mpiana et al., 
2008; Burrows and Burrows, 2003; Neuwinger, 2000). The paste of the bark of F. 
racemosa and fresh leaves of F. trichopoda has been used to cure swellings of foot and 
hands (Mahota and Chaudhary 2005; Neuwinger, 2000). The leaf decoction of F. vallis-
choudae (mixed with Ipomoea argentaurata Hallier f.) is reportedly used against 
hyperthermia (Neuwinger, 2000). 
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For maternal health, F. natalensis has been reportedly used as an ecbolic (an agent that 
induces contractions of the uterus) during labour and also to induce lactation. While the 
fruit of F. sycomorus subsp. gnaphalocarpa mixed with Cordyla pinnata (Lepr.) Milne-
Redh. bark are used for oxytocic activity during child birth (Neuwinger 2000). 
Meanwhile in Nigeria, the leaves of F. exasperata Vahl are also used for oxytocic 
activity, and in vitro uterine stimulatory effect was investigated (Bafor et al., 2010).  
 
In Zambia, some members of the genus Ficus have also been used for different illnesses 
as summarized in (Table 1). However, the identification of most of these Ficus plants in 
folklore use does not go up to species level. This has been observed by Fowler (2007) 
that a great number of plant concoctions are prescribed for the same disease. In addition 
the same vernacular name is applied to more than one species, calling for caution in their 
use and one of the reasons this study was undertaken. 
Table 1: Summary of the traditional medicinal uses of Ficus species in Zambia as 
documented by Fowler (2007). 
Species Traditional medicinal use 
F. burkei Bleeding, constipation, colds, cuts and wounds, eye infections, varicose veins, 
tonsillitis and sore throat 
F. sycomorus Chest complaints, coughs, dysentery, diarrhoea, swollen glands, inflammation, 
tonsillitis and sore throat, sores and skin rashes, ulcers, TB (lymph  nodes), to 
stimulate lactation 
F. natalensis Colic, influenza, syphilis, skin rashes, midwifery,  to induce lactation 
F. sur coughs, eye infections, gonorrhoea, gynaecological ailments, infertility, impotence, 
TB, tonsillitis and sore throat, pneumonia, nausea and anti-emetic, tongue and 
mouth, bladder and kidney 
F. glumosa Eye infections, induce lactation 
F. exasperata Eye infections, tonsillitis and sore throat, tongue and mouth, tonic, stimulant, worms 
F. dekdekana Stomach ailments 
F. vallis-choudae Leprosy 
F. ingens Anaemia 
F. capensis Antipyretic 
 
F. gurkei To increase lactation 
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With all the acclaimed traditional uses of the genus Ficus, there has also been a number 
of scientific works done to validate and document the pharmacological properties that the 
plants exhibit. The genus has been well documented for its biological activities like 
antioxidant (Li et al., 2004), anticancer (Mradu et al., 2012), antidiarrhoeal (F. lutea, F. 
cordata Thunb. subsp. salicifolia (Vahl) C.C. Berg. (syn: F. religiosa Forssk.) F. 
sycomorus), antibacterial (F. ingens), antifungal (Kuete et al., 2009), antiplasmodial (F. 
sycomorus, F. polita), antiulcer, gastroprotective and wound healing activity in 
experimental animals (Thakare et al., 2010; Kuete et al., 2009; Lansky et al., 2008).  
 
1.6 THE FICUS SPECIES SELECTED FOR THIS STUDY 
1.6.1 Ficus ingens (Miq.) Miq. 
Ficus ingens (Figure 16) is commonly known as the red-leaved fig, while in Zambia it is 
locally known by different names such as Mupata (Bemba), chilembalemba (Kaonde), 
mutate (Lozi) or as muteba. In Zambia, it has a continuous distribution in four provinces 
namely; The Copperbelt, Northern, Eastern and Southern provinces. 
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Figure 16: Ficus ingens leaves and fruit (http://www.figweb.org/Figs_and_fig_wasps/index.htm 
and www. Plantzafrica.com). 
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1.6.2 Ficus lutea Vahl (Giant-leaved fig) 
Ficus lutea (Figure 17) also known as the giant-leaved fig is a large tree measuring up to 
20 m tall. The distribution in Zambia covers Copperbelt, Eastern, Northern and Southern 
provinces. 
 
 
Figure 17: Ficus lutea leaves and fruit (http://www.figweb.org/Figs_and_fig_wasps/index.htm 
and www. Plantzafrica.com). 
Introduction 
61 
1.6.3 Ficus natalensis Hochst. subsp. natalensis 
Ficus natalensis (Figure 18) is also known as the natal fig, while in Zambia it is locally 
called Kanyanguni and Mutaba (Bemba) and then called kachele (Chewa). In Zambia, it 
is distributed throughout the Copperbelt, Luapula and North-Western provinces. This 
species is a small to large tree, up to 20 m tall and 30 m wide, epiphytic or a rock splitter, 
eventually a free-standing tree, evergreen or deciduous, with a few abundant aerial roots 
(Burrows and Burrows, 2003). 
 
 
Figure 18: Ficus natalensis subsp. natalensis leaves and fruit 
(http://www.figweb.org/Figs_and_fig_wasps/index.htm and www. Plantzafrica.com) 
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1.6.4 Ficus ovata Vahl. 
Ficus ovata shown in Figure 19, also known as the rough-barked fig is locally called 
chilemba (Bisa, Kunda). In Zambia it occurs in the Copperbelt, Luapula and Northern 
provinces. It is a small to medium evergreen tree, upto about 25 m with a spread of 
approximately 15 m, terrestrial. Initially it occasionally grows as a hemi-epiphyte and 
lacking aerial roots. 
  
Figure 19: Ficus ovata leaves and fruits (http://www.figweb.org/Figs_and_fig_wasps/index.htm 
and www. Plantzafrica.com). 
Introduction 
63 
1.6.5 Ficus sansibarica Warb. subsp. macrosperma (Mildbr. and Burret) C.C. Berg 
Common names of Ficus sansibarica include Zanzibar fig, Angola fig and knobbly fig 
(Figure 20). In Zambia, with the tribes in brackets, it is called chitabataba (Kaonde), 
musoko (Tabwa), mutaba (Bemba) and its distribution in Zambia covers the Copperbelt, 
Lusaka, North-Western and Southern provinces. 
It is a large tree with a wide-spreading crown, normally up to 20 m tall and 30 m wide but 
occasionally larger, hemi-epiphytic, becoming terrestrial, commonly unbutressed and 
with a few small aerial roots, but usually without (Burrows and Burrows, 2003). 
 
 
Figure 20: Ficus sansibarica leaves and fruits 
(http://www.figweb.org/Figs_and_fig_wasps/index.htm and www. Plantzafrica.com) 
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1.6.6 Ficus sycomorus L. subsp. sycomorus 
Ficus sycomorus subspecies sycomorus is commonly known as the sycamore fig or 
mulberry fig ( 
Figure 21). In Zambia, the species is known by local names; Mukunyu (Bemba, Bisa), 
Chikujumba (Chewa), Chikunyu (Bisa, Kunda), Katema (Kaonde, Lozi, Lunda, Tonga), 
Musuera (Luvale), Nkuyu (Tumbuka). It is widespread in Zambia. 
It is a large, spreading tree up to about 30 m tall and 30 m wide (canopy covering), 
deciduous or evergreen; with a typically short, thick trunk extending to 3.5 m in diameter, 
old tree developing buttresses but lacking root sucker, branches wide-spreading, not 
developing aerial roots. 
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Figure 21: Ficus sycomorus  subsp. sycomorus  leaves and fruit 
(http://www.figweb.org/Figs_and_fig_wasps/index.htm and www. Plantzafrica.com). 
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1.6.7 Ficus sycomorus subsp. gnaphalocarpa (Miq) C.C. Berg 
Ficus sycomorus subsp. gnaphalocarpa is the large-fruited sycamore fig (Figure 22). It is 
commonly known as the sycamore fig just like the subspecies sycomorus. It is also 
known by the same local names in Zambia. It is widespread in Zambia. 
 
 
Figure 22: Ficus sycomorus subsp. gnaphalocarpa leaves and fruits 
(http://www.figweb.org/Figs_and_fig_wasps/index.htm and www. Plantzafrica.com). 
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1.6.8 Ficus wakefieldii Hutch 
Ficus wakefieldii is commonly known as Wakefield’s fig (Figure 23). In Zambia, it has 
different names according to the region. It is called Chikolo or Chitabataba (Lamba), 
Chilemba (Bemba), Ituntu, mukunyu, mupulampako (Bemba, Kaonde), mutawa (Chewa). 
Distribution in Zambia covers the Central, Copperbelt and Luapula provinces, being 
confined to high rainfall area zone. 
 
 
Figure 23: Ficus wakefieldii leaves of a young branch 
(http://www.figweb.org/Figs_and_fig_wasps/index.htm and www.Plantzafrica.com).  
(http://www.zambiaflora.com/speciesdata/image -display.php).
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1.7 CHEMICAL CONSTITUENTS IN THE GENUS FICUS 
The chemical composition of some of the members of genus Ficus has been widely 
studied. Most members have been investigated pharmacologically and phytochemically 
because of their chemical constituents which, are used medicinally. A phytochemical 
review (see Appendix) shows that plants from this genus are rich sources of characteristic 
classes of secondary metabolites such as prenylated flavonoids and isoflavonoids, 
lignans, terpenoids (Figure 24d), alkaloids, coumarins, chromones, phenylpropanoids  
and tannins (Chen, et al., 2010; Kuete, et al., 2008). Other classes reported include 
steroids, triterpenoids, fatty acids, saponins and anthocyanins (Chawla et al., 2012). 
Sugars such as sucrose and lactose have also been isolated from Ficus species. Some of 
these classes will be discussed in the text. The chemical composition of latex is very 
complex as it is composed of proteins, alkaloids, starches, sugars, oils, tannins, resins, 
gums and other minor constituents (Richardo et al., 2004). 
1.7.1 Phenolic compounds 
Phenolic compounds are ubiquitous in the plant kingdom and are thus the most studied, 
even though not exhaustively, phytochemicals in plant research (Mradu et al., 2012). 
They are chemically diverse secondary metabolites, which are characterized by aromatic 
rings with one or more hydroxyl functional groups. Phenolic compounds can be classified 
into different groups such as flavonoids, flavonones, flavones, anthraquinones and 
tannins (Figure 24). 
Flavonoids such as catechins, epicatechins and epiafzelechins isolated from F. ovata are 
common to the genus (Kuete et al., 2009). Furthermore, isoflavones such as genistein, 
prunetin, and (2S)-naringenin were indentified in F. polita. The antimycobacterial 
activities of these three compounds have been shown against Mycobacterium tuberculosis 
H37RV in vitro and  the determined MIC values were 35 µg/ml, 30 µg/ml and ≤ 2.8 
µg/ml, respectively (Chen et al., 2010). 
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a)      b)  
c) d)  e)  
 
Figure 24: Some common constituents of Ficus species 
a) prenylated flavonoid (7-γ,γ-dimethylallyloxy-5-hydroxy-4’-methoxyisoflavone) isolated from Ficus 
sycomorus; b) β-sitosterol isolated from F. glomerata; c) catechin isolated from F. ovata and sycomorus. d) 
Flavone; e) Tannin 
 
1.7.2 Terpenoids 
Terpenoids such as taraxeryl acetate and betulinic acid are common bioactive compounds 
that have been isolated from the genus, and these are known to have antiprotozoal 
properties (Hubert et al., 2011). In most of the Ficus species, some compounds have been 
identified as marker compounds, these include bergapten, fumaric acid, 1,4-dimethyl-7-
isopropylazulene (guaiazulene), lupeol, oleanolic acid, psoralen, rutin, scopoletin 
(Flavonoids), α-terpineol, umbelliferone and xanthotoxin (Phytolab, 2010/2011). 
1.7.3 Steroids 
Another interesting class of bioactive compounds found in the genus Ficus are steroids. 
These include ß-sitosterol (Figure 24b) isolated from F. polita and ß-sitosterol-D-
glucoside isolated from F. glomerata and F. cordata stem bark. Potent hypoglycaemic 
and antibacterial properties of ß-sitosterol-D-glucoside have been reported 
(Channabasavaraj et al., 2008). Of the eight Ficus species under study, F. sycomorus is 
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the most widely studied, and as such many compounds have been isolated and identified 
from this species.  
Amongst other groups of compounds that have been isolated from F. sycomorus root bark 
include tannins, alkaloids, sugars, saponins and anthracenosides which have been 
reported to exhibit antimicrobial activity (Zaku et al., 2009). Below is Table 2 of the 
secondary metabolites that have been isolated and identified within the eight selected 
Ficus species under study. The chemical structures are presented in the appendix (6.1). 
Table 2: Chemical constituents that have been isolated from the eight Ficus species under 
study. 
Chemical compound Species Area of plant 
collection 
p
a
r
ts 
References 
Flavonoids   
 
 
Rutin  (quercetin-3-0-α-L-
rhamnopyronosyl (1→6)β-D-
glucopyranoside 
F. sycomorus El-Qualubia 
Governorate 
L El-Sayed et al., 2010 
Isoquercitrin (quercetin-3-0-β-D-
glucopyranoside) 
F. sycomorus El-Qualubia 
Governorate 
L El-Sayed et al., 2010 
Quercetin 3,7-0-α-L-dirhamnoside F. sycomorus El-Qualubia 
Governorate 
L El-Sayed et al., 2010 
Quercetin-3-0-β-D-galactopyronosyl 
(1→6) glucopyranoside 
F. sycomorus El-Qualubia 
Governorate 
L El-Sayed et al., 2010 
3-methoxyquercetin –catechin F.  gnaphalocarpa N.I B Hubert et al., 2011 
Epicatechin F.  gnaphalocarpa N.I B Hubert et al., 2011 
Quercetin F.  gnaphalocarpa 
F. sycomorus 
N.I 
El-Qualubia 
Governorate 
B 
L 
Hubert et al., 2011 
El-Sayed et al., 2010 
Quercitrin F.  gnaphalocarpa  B Hubert et al., 2011 
Cajanin F. ovata  B Kuete et al., 2009 
Terpenoids 
3-friedelanone F.  ovata Mt. Kala, Cameroon, 
2004 
B Kuete et al., 2009 
Taraxeryl acetate F.  ovata Mt. Kala, Cameroon, 
2004 
B Kuete et al., 2009 
Betulinic acid F.  ovata 
F. gnaphalocarpa 
Mt. Kala, Cameroon, 
2004 
N.I 
B 
B 
Kuete et al., 2009 
Kamga et al., 2010 
Α-amyrin F. sycomorus  La Lansky and Paavilainen, 2011 
Bergapten F. sycomorus  La Lansky and Paavilainen, 2011 
Imperatorin F. sycomorus  La Lansky and Paavilainen, 2011 
Xanthotoxin F. sycomorus  La Lansky and Paavilainen, 2011 
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Oleanoic acid F. ovata Mt.  Kala, Cameroon, 
2004 
B Kuete et al., 2009 
Steroids 
Gallic acid (3,4,5-trihydtxybenzoic acid) F. sycomorus El-Qualubia 
Governorate 
L El-Sayed et al., 2010 
ß-sitosterol-3-0-β-D-glucopyranoside F. sycomorus El-Qualubia 
Governorate 
L El-Sayed et al., 2010 
 
Chemical compound Species Area of plant 
collection 
parts References 
Essential oils 
2-Hexen-1-ol benzoate F. ovata Nigeria L Sonibare et al.,  2009 
Еphytol F. ovata Nigeria L Sonibare et al., 2009 
Benzyl tiglate F. ovata Nigeria L Sonibare et al., 2009 
Е-Menth-2-en-1-ol F. ovata Nigeria L Sonibare et al., 2009 
Z-Menth-2-en-1-ol F. ovata Nigeria L Sonibare et al., 2009 
β-Selinene F. ovata Nigeria L Sonibare et al., 2009 
1,2-Dimethoxy-4-ethylbenzene F. ovata Nigeria L Sonibare et al., 2009 
Geranyl acetone F. ovata Nigeria L Sonibare et al., 2009 
1-Octen-3-ol F. ovata Nigeria L Sonibare et al., 2009 
Caryophyllene oxide F. ovata Nigeria L Sonibare et al., 2009 
Octacosane F. ovata Nigeria L Sonibare et al., 2009 
Heptacosane F. ovata Nigeria L Sonibare et al., 2009 
Isophytol F. ovata Nigeria L Sonibare et al., 2009 
6,10,14-Trimethyl-2-pentadecanone F. ovata Nigeria L Sonibare et al., 2009 
α-Ionone F. ovata Nigeria L Sonibare et al., 2009 
n-Nonanal F. ovata Nigeria L Sonibare et al., 2009 
Limonene F. ovata Nigeria L Sonibare et al., 2009 
Benzyl benzoate F. ovata Nigeria L Sonibare et al., 2009 
Oleic acid F. ovata Nigeria L Sonibare et al., 2009 
6-Methyl-5-hepten-2-one F. ovata Nigeria L Sonibare et al., 2009 
Benzaldehyde F. ovata Nigeria L Sonibare et al., 2009 
Neral F. ovata Nigeria L Sonibare et al., 2009 
Linalool F. ovata Nigeria L Sonibare et al., 2009 
β-Ionone F. ovata Nigeria L Sonibare et al., 2009 
α-Pinene F. ovata Nigeria L Sonibare et al., 2009 
β-Caryophyllene F. ovata Nigeria L Sonibare et al., 2009 
3,4-Dimethyltoluene F. ovata Nigeria L Sonibare et al. , 2009 
Octadecanoic acid F. ovata Nigeria L Sonibare et al., 2009 
 
N.I- Place and year of collection not indicated; B- stem bark; L- leaves; La- latex; R- roots. 
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1.8 AIM 
The main aim of this thesis was to evaluate the medicinal potential of members of the 
genus Ficus growing in Zambia. The Ficus species are used indiscriminately against 
infectious diseases including microbial and parasitic infections as well as a few non 
communicable diseases like gynaecological conditions, diabetes and high blood pressure. 
To achieve this global picture, this project will collect, extract and fractionate eight  Ficus 
species that occur in high rainfall areas in Zambia , namely F. ingens, F. lutea, F. 
natalensis, F. ovata, F. sansibarica subsp. macrosperma, F. sycomorus subsp. 
gnaphalocarpa, F. sycomorus subsp. sycomorus and F. wakefieldii. Information on their 
ethnobotanical use will be gathered from the users. The resulting extracts and subextracts 
of different plant parts will then be: 
 phytochemically profiled using chromatographic methods such as thin layer 
chromatography (TLC), proton Nuclear Magnetic Resonance (
1
H NMR) and high 
performance liquid chromatography (HPLC) fingerprinting; 
 screened in vitro against a panel of fungi and bacteria, as well as Mycobacterium 
tuberculosis, Schistosoma mansoni, Leishmania donovani, Trypanosoma brucei 
gambiense, Trypanosoma cruzi and Plasmodium falciparum; 
 screened in vitro against recombinant FAS-II elongation enzymes, FabG, FabI and 
FabZ as potential targets in liver stage malaria parasites. Hence, a bioactivity guided 
isolation of the active principles will be attempted. 
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2. MATERIALS AND METHODS 
2.1 HEALTH AND SAFETY 
All the procedures and experiments in this thesis were performed in level two (2) 
laboratories and were carried out in accordance with the provisions of the Health and 
Safety Act, of the University College London - School of Pharmacy. Risk assessment was 
carried out for which Control of substances hazardous to health regulations (CoSHH) 
forms were completed and the outcome was favourable to enable us work in reasonably 
practicable and safe working environment conditions. 
2.2 PLANT MATERIALS 
2.2.1 Plant collection 
The plant materials were collected in Zambia, during the month of December 2009. This 
is the fruiting period for all but one selected Ficus species. The aerial plant parts and 
roots were air dried for several days and stored at room temperature in a dark cupboard 
until required for extractions. 
Different plant species of Ficus were collected from the high rainfall and riverine areas of 
Zambia. These include plants that are native to the north of the Zambezi River, namely F. 
ovata Vahl. and F. wakefieldii Hutch. The other Ficus species collected are widely spread 
throughout the country, such as F. natalensis Hochst. subsp. natalensis, F. sansibarica 
Warb. subsp. macrosperma (Mildbr. and Burret) C.C. Berg, F. lutea Vahl, F. ingens 
(Miq.) Miq., F. sycomorus subsp. gnaphalocarpa (Miq) C.C. Berg and F. sycomorus L. 
subsp. sycomorus. The plants were identified by a taxonomist, Professor Patrick Phiri of 
the Copperbelt University, Zambia. Voucher specimens have been deposited at the 
University of Zambia herbarium (UZL) under accession numbers ranging between 20904 
and 20911 (Table 3). 
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Table 3: Localities, date of collection and plant parts of eight Ficus species. 
Plant  species 
 
Date of 
collection 
Ecology of Place of 
collection 
GPS reading 
Voucher 
number 
F. ingens 17/12/2009 Juvenile plant as an 
epiphyte 
Lat:12050.7’ S, Log:28021.6’E 
Alt: 1049m 
20909 
F. lutea 17/12/2009 Juvenile plant as an 
epiphyte 
Lat:12050.7’ S, Log:28021.6’E 
Alt: 1049m 
20908 
F. natalensis 17/12/2009 tree on termite mounds 
 
Lat:12048.05’S, 
Log:28014.28’E 
Alt: 1050m 
20910 
F. ovata 16/12/2009 Tree on dambo soil Lat:12050.9’ S, Log:28021.6’E 
Alt: 1050m 
20906 
F. sansibarica 16/12/2009 Mesic miombo 
woodland on termite 
mounds 
 
Lat:12050.9’ S, Log:28021.6’E 
Alt: 1050m 
20905 
F. sycomorus 
subsp. 
gnaphalocarpa 
26/12/2009 Tree in acacia-
combretum woodland 
 
Not taken 20904 
F. sycomorus 
subsp. sycomorus 
16/12/2009 Not specific Lat:12050.9’ S, Log:28021.6’E 
Alt: 1050m 
20911 
F.  wakefieldii 16/12/2009 mesic miombo 
woodland on termite 
mounds 
Lat:12050.9’ S, Log:28021.6’E 
Alt: 1050m 
20907 
     
2.2.2 Plant Extraction and partitioning 
There are several methods of extracting plant constituents. In this study, cold continuous 
maceration on a magnetic stirrer was used throughout the project. This method allows for 
chemical constituents to be extracted from plant material by continuously stirring ground 
material in a solvent. The major advantage of this method is that it is exhaustive, 
especially when you use a solvent such as an alcohol, methanol being the most common, 
which is a good all-purpose solvent for preliminary extractions (Waksmundzka-Hajnos et 
al., 2008; Heinrich et al., 2004; Harbone, 1998). Almost all constituents get extracted. 
However, some may not as they maybe insoluble in cold solvent, in which case a little 
heating can be applied. An additional advantage is the low cost of equipment and solvents 
required. Thus, for an exhaustive extraction, solvents in which both nonpolar and polar 
constituents could dissolve were used in this study, plus the technique of continuous 
maceration. 
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The experimental procedure was as follows: twenty grams (small scale) and about 320 g 
(large scale) of the dried plant materials (leaves, stem barks and roots) were ground to a 
fine powder. This was done to increase the surface area of the plant materials in order to 
reduce the time of extraction. The ground plant materials were then extracted with 200 ml 
methanol (MeOH) (Fisher, HPLC grade) for small scale and twice with 800 ml for large 
scale by continuous maceration on a magnetic stirrer for 24 hrs and 48 hrs (for each run) 
respectively at room temperature. The total extraction time for large scale, thus lasted 96 
hrs, with a total volume of solvent used coming up to 3.2 liters. The extract was then 
filtered by vacuum using a Buchner funnel lined with Whatmann No.1 filter paper, and 
the filtrate evaporated to dryness using a rotary evaporator (Heidolf – Laborota 4003) at 
32
o
C. This is what will be referred to as the crude methanol extract (CR-MeOH). The 
samples were stored at -21
o
C, until screened for biological activity. 
The CR-MeOH extracts were further partitioned to provide a coarse separation of 
subextracts according to polarity. Thus a solvent-solvent partition extraction was 
performed according to Searle and Molinski (1994). Three (nonpolar, mid-polar and 
polar) subextracts were obtained from this process (Figure 25). The CR-MeOH extract 
was dissolved in 100 ml of 90% methanol and then partitioned three times against 100 ml 
n-hexane (Fisher, HPLC grade). The resulting n-hexane subextracts were combined and 
evaporated to dryness. The aqueous-methanolic layer was then diluted to 70% MeOH to 
create distinct layers of two immiscible solvents (Figure 26). It was further partitioned 
three times with 100 ml chloroform (Fisher, HPLC grade). For large scale partitioning, 
62.83g dried CR-MeOH extract of F. sansibarica was dissolved in 1.5L of 90% MeOH. 
It was partitioned three times against 1.5L n-hexane. The residue was then diluted to 70% 
MeOH and further partitioned three times with 1.5L CHCl3. The CHCl3 subextracts were 
combined and evaporated to dryness, while the aqueous-methanolic fraction was freeze 
dried. All subextracts were stored at -21
o
C until work-up. 
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Figure 25:Liquid-liquid partitioning (Modified Kupchan extraction) scheme 
 
 
 
Figure 26: The liquid-liquid partitioning (modified Kupchan method). 
 
Chloroform subextract-3 
90% Methanol  
Crude methanol extract-1 
Aqueous MeOH subextract-4 
Hexane subextract-2  
100 ml X 3  
Hexane 
70% 
Methanol/wate
r fraction 
100 ml X 3 
Chloroform 
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2.3 PHYTOCHEMICAL METHODS 
Phytochemical methods were employed for the extraction, isolation, purification and 
characterization of the plant extracts. Most of the techniques used were chromatographic 
and spectroscopic techniques. In addition to the aboce procedures, chemical profilling by 
TLC, 
1
H NMR and HPLC was performed. The biological assays together with the 
chemical profilling were applied to create a phytopharmacological profile of the selected 
Ficus species. 
2.3.1 Chromatographic techniques 
Chromatography is a technique used for the separation of mixtures. It works on the 
principle of the different affinity towards the stationary phase and the mobile phase that 
the various constituents in the mixture have. Thus, the various constituents travel at 
different speeds along the stationary phase, causing a separation based on differential 
partitioning between the mobile and stationary phases. There exist several 
chromatographic techniques that can be used to isolate and purify chemical constituents 
of interest from crude extracts. However, compounds are isolated and purified largely on 
the basis of polarity, size, charge and specific affinity to the stationary phase. The 
techniques used in this project include; size exclusion gel chromatography, thin layer 
chromatography (TLC), vacuum liquid chromatography (VLC), gravity based open 
column chromatography (OCC), solid phase extraction (SPE) and high performance 
liquid chromatography (HPLC). 
2.3.1.1 Thin Layer Chromatography (TLC) 
Thin layer chromatography (TLC) is a technique that can be used to analyze and separate 
plant extracts qualitatively and quantitatively. It is often used to provide the first 
characteristic fingerprints of an extract as it shows the different constituents of a crude 
mixture and also the purity of an isolated compound (Waksmundzka-Hajnos et al., 2008). 
It operates on the principle of different migration properties of compounds in different 
solvent systems.  It is also defined as the partitioning of a substance between two 
immiscible phases (Evans, 2009). The stationary phase is a thin layer of adsorbent 
material, mostly silica gel, which is immobilised on an aluminium plate. On it as well, a 
fluorescent coating (F254) which allows visualization of UV active compounds when 
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viewed under long- and short-wave UV light (254 nm and 366 nm) is placed. For the 
visualization of colourless compounds, staining reagents are used. The mobile phase is a 
mixture of solvents into which one end of the plate is dipped. Because of capillary action 
the solvent mixture migrates to the top of the plate carrying with it different components 
of the extract migrating at different paces. The type of compounds that will travel the 
fastest to the top of the plate depends on the strength of the solvent mixture. For a 
mixture dominated with polar compounds, the solvent mixture would need to have polar 
properties and vice versa. The migration of the compounds in a mixture can be described 
by their Rf  values defined by the equation below. 
Rf  =  
In this research, TLC was performed on the plant extracts and subextracts (CR-MeOH, 
hexane, CHCl3 and aq.MeOH) of Ficus as follows; 
One milligram (1 mg) of the dry sample was dissolved in 50 µl of appropriate solvent. 
Then 5 µl of the 20 mg/ml sample was applied 2 cm from the bottom on silica gel 60F254 
pre-coated TLC plate (Merck 105554.0001). It was then placed in a tank saturated with 
an appropriate mobile phase as shown in and quaternary amine compounds. 
Table 4. After the separation was completed, the plate was air dried and viewed under 
short wavelength UV254 nm and long wavelength UV366 nm (UV cabinet, Camag) to 
determine absorbance and fluorescence properties of the compounds in the extracts. 
Substances that quench fluorescence appeared as dark spots in short wavelength UV254 
nm and they were pencil marked on the left ([). The substances that fluoresce in long 
wavelength UV366 nm appeared as bright spots and were marked on the right side (]). 
The plates were sprayed with different detection reagents to visualize the characteristic 
compounds. The main reagent spray used was 4 % (W/V) vanillin (Sigma-Aldrich, V110-
4, UK) in sulphuric acid (Sigma-Aldrich 32,050-1, UK) (VS), and thereafter heated 
(Hotplate, VWR) for about two minutes at 110 
o
C. VS reagent is a universal spray 
reagent which detects many natural products like components of essential oils such as 
terpenoids, phenylpropanes derivatives and phenols. Other natural products that can be 
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detected are some phenolic compounds and non polar compounds. The other reagent 
sprays used included natural product (NP) spray composed of 1% (W/V) methanolic 
diphenylborinic acid 2-aminoethyl ester (Acros Organics, 155400500) followed by 5 % 
(W/V) ethanolic polyethylene glycol (PEG) 4000 grade (Fisher, P/3680/53) to visualize 
flavonoids and related polyphenols under UV 366 nm wavelength. Dragendorff’s reagent 
(DRG) which consisted of a 1:1 mixture of 0.85g bismuth nitrate dissolved in 10 ml 
acetic acid and 40 ml water and 8 g potassium iodide dissolved in 20 ml water was used 
to visualize alkaloid, heterocyclic nitrogen and quaternary amine compounds. 
Table 4: TLC plate development conditions. 
Plant extract Solvent extract 
dissolved in 
Mobile phase Detection spray reagent 
Crude MeOH Methanol EtOAc : MeOH: H2O 
(40.5 : 5.5 : 4) 
4 % Vanillin/Sulphuric acid 
Hexane Chloroform Hex : EtOAc (8 : 2) 4 % Vanillin/Sulphuric acid 
Chloroform Chloroform CHCl3 : EtOAc (6 : 
4) 
4 % Vanillin/Sulphuric acid 
Natural product spray * 
Aqueous MeOH Methanol EtOAc : MeOH: H2O 
(40.5 : 5.5 : 4) 
4 % Vanillin/Sulphuric acid 
*NP/PEG 
2.3.1.2 Solid-Phase Extraction (SPE) 
Solid-phase extraction (SPE) is another technique that was greatly used in the isolation of 
chemical constituents. It is mostly used for small amounts of extracts which have fairly 
few chemical components. SPE is an alternative technique to liquid-liquid extraction 
which operates on the principle of liquid-solid extraction. It is effective for small samples 
because it exhibits high selectivity and faster elution profile and minimization of solvent 
consumption (Waksmundzka-Hajnos et al., 2008; Hostettmann et al., 1998). The sample 
is usually dissolved in an appropriate solvent and passed through a small bed of adsorbent 
(solid phase) of very consistent particle size and shape to maximise separation efficiency. 
The compounds are eluted with stepped changes of small volumes of solvent depending 
on the stationary phase (Hostettmann et al., 1998). For normal phase, less polar to 
increasing polar eluents such as pentane, hexane, dichloromethane to chloroform can be 
used to extract non polar constituents. Meanwhile, hydrophobic and polar constituents are 
extracted from the aqueous solutions in reversed-phase SPE, in which more polar eluents 
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to decreasing polarity in the order of water, methanol and acetonitrile are used to achieve 
fractions enriched in specific chemical classes. Elution occurs upon the addition of an 
organic solvent that effectively disrupts the interactions between the adsorbent and the 
target constituents. Prior to the isolation, the column is activated by conditioning and 
equilibrating it with the solvent which will be used first to elute the sample. In reversed-
phase, a polar organic solvent such as methanol is used to condition the sorbent, and then 
in a gradient equilibrate with water. While in normal phase, a polar organic solvent is 
used for conditioning, followed by equilibration with a less polar solvent like hexane or 
chloroform depending on what you are eluting. 
In this thesis, the extract was dissolved in minimal solvent before it was applied evenly 
on top of the column under vacuum. For reversed-phase SPE, the Strata C18-E (55µm, 
70A) 10g/60 ml Giga tubes by Phenomenex were used. The Strata SI-1 silica (55µm, 
70A) 10g/60 ml Giga tubes were used for normal phase SPE. Fifty milliliters of 
increasingly polar (10 % gradient) mobile phase (100 % hexane to 100 % ethyl acetate) 
were eluted for normal phase SPE. Methanol (100 %) was used as the final wash. RP-
SPE used a stepped up gradient from 100 % water to 100 % MeOH in 10 % increments. 
The collected fractions were subjected to TLC in which the similar fractions by TLC 
analysis were pooled, and then dried using a rotary evaporator at 34
o
C. Aqueous fractions 
were frozen overnight before being freeze dried. 
2.3.1.3 Vacuum-liquid chromatography (VLC) 
Vacuum liquid chromatography (Figure 27A) is a quick and inexpensive technique used 
to fractionate large amounts of plant extracts. It works with the same principle as that of 
SPE, in which the chemical components are fractionated based on an elution polarity 
gradient. There are two types of VLC depending on the polarity of the constituents of 
interest in the crude mixture and the stationary phase chosen. These are normal-phase 
silica VLC and reversed-phase C18 VLC. In this thesis we used reversed-phase C18 
because the chemical constituents of interest were mostly polar compounds. 
The reversed-phase C18 stationary phase was firmly packed in a column which was then 
equilibrated with stepped up gradient solvent from 100 % methanol to 100 % water. The 
plant extract was dissolved in minimal methanol and then loaded onto the column. 
Materials and methods 
81 
Aliquots of the mobile phase were added to the column to elute the fractions in a stepped 
up gradient from 100 % water to 100 % methanol in 10 % increment of the methanol. 
The collected fractions that were similar in Rf values and colour spot by TLC analysis 
were pooled and dried on a rotary evaporator. 
2.3.1.4 Size Exclusion Chromatography 
Size exclusion or gel filtration chromatography is a useful technique for preliminary or 
final step in the isolation process of natural products (Hostettmann et al., 1998). It is 
commonly performed as open column chromatography (OCC) on solid phase supports 
such as sephadex (Figure 27B). The most commonly used is Sephadex LH-20, a 
hydrophilic beaded dextran that is cross-linked by glycerin-ether bonds. It is 
hydroxypropylated and therefore exhibits both hydrophilic and lipophilic characteristics 
which allow separation of non-polar and polar compounds in the same run, as well as the 
separation of compounds according to their molecular weights. It is therefore, ideal for 
the separation of large polymeric molecules. 
In our experiments, a weighed amount of sephadex LH-20 (GE Healthcare, 17-0090, UK) 
was soaked in methanol overnight to allow the gel to swell before packing the column. 
The sephadex slurry was then carefully poured into the column in a continuous flow to 
avoid bubbles and uneven settling. Meanwhile, the extract was dissolved in minimal 
solvent, usually in the packing solvent, and then applied gently on top of the column. 
Cotton wool was placed on top of the column in order to secure the surface so that the 
eluting solvent does not disturb the surface of the column when being poured onto it. The 
column was run isocratically using MeOH, at a flow rate of about 1 ml/min at the 
beginning of the run, and when there were distinct bands showing in the column, the flow 
rate was increased to about 5 ml/min. Fractions were collected in amounts between 10-50 
ml. The fractions were then subjected to TLC analysis, and the similar ones were pooled, 
dried and stored at -20
o
C until workup. 
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Figure 27: Chromatography apparatus and set up 
2.3.1.5 High Performance Liquid Chromatography (HPLC) 
HPLC is a high-resolution technique, with efficient and fast separation (Waksmundzka-
Hajnos et al., 2008; Heinrich et al., 2004). It is the most widely used technique for the 
analysis of classes of compounds which are non-volatile such as phenolics, higher 
terpenoids, alkaloids, lipids and sugars which are soluble in organic solvents (Kalili and 
de Villiers, 2011; Qiao et al., 2011; Harbone, 1998). It can also be used for fingerprinting 
of biologically active extracts, or monitoring chemical reactions of some metabolites in 
organic synthesis of pharmaceutically potent compounds. The most widely used 
stationary phase in HPLC is C18 (reversed-phase), generally using water/methanol or 
water/acetonitrile mixtures as the mobile phase. The mobile phases can be run in gradient 
elution mode, in which the concentration of a particular solvent is increased sequentially 
over a period of time, starting, for example, with 100% water and increasing to 100% 
acetonitrile over a set time. Another mode is the isocratic elution mode, in which a 
constant composition of solvent is maintained for a set period of time throughout the 
experiment (Heinrich et al., 2004). There are two types of HPLC analyses that can be 
performed depending on the required results. These include analytical HPLC for the 
qualitative and quantitative determination of compounds, and preparative HPLC which is 
mainly used for the isolation and purification of targeted compounds (Waksmundzka-
Hajnos et al., 2008). The advantages of HPLC are the excellent resolution, speed and 
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reproducibility. The major disadvantage is the expense, especially of the preparative 
column. 
The HPLC fingerprint of the phenolic composition of the crude methanol and aq. 
methanol subextracts of eight Ficus species was performed to identify the phenolic 
compounds that characterize the selected species. HPLC was determined using the 
Agilent 1200 series system equipped with a UV/Vis diode array detector (G1315D), 
quaternary pump (G1311A), autosampler (G1329A), fraction collector/autosampler 
thermostat (G1330B), thermostated column compartment (G1316A), refractive index 
detector (G1362A) and analytical fraction collector (G1364C). Samples were prepared at 
a concentration of 1 mg/ml in MeOH, and filtered through syringe filters with pore size Ø 
0.45 µm before injection. The stationary phase used was a phenomenex 
(R) 
synergy polar-
RP80A column (250 mm X 4.6 mm, I.D. 4 μm) protected with a Nova –pak (R) C18 guard 
column. The detector was set to scan from 190 to 400 nm at 40
o
C. The binary mobile 
phase consisted of solvent A (0.2 % glacial acetic acid in water) and solvent B (methanol 
Fisher HPLC grade with 0.2 % glacial acetic acid). The solvents were acidified to 
maintain the pH of the crude sample inorder to enhance separation and to reduce peak 
tailing and prevent the deprotonation of the phenolic hydroxyl groups. 
The conditions were set according to Giner et al. (1993). The gradient elution was set at 
10-20 % B (0-5 mins), 20-50% B (5-65 mins), 80-100% B (75-80 mins) at a flow rate of 
0.8 ml/min. The injection volume of each sample was 10 μl and the peaks were 
monitored at a short wavelength of 254 nm. A cocktail of 12 phenolic compounds were 
used as standards (50 μl of each compound at about 10 mg/ml was combined and used as 
a standard). The 12 phenolic standards that composed the cocktail included; (-) 
Epicatechin 90% (Aldrich 525952), Catechin hydrate (unhydrous), Quercetin (Li light 
and Co ltd, Colnbrook Bucks England), Rutin hydrate (Sigma 14 Ho5521), Gallic acid 
(Sigma G7384-100G), Quercitrin (Glucoside + rhamnoside),  Kaempferol, Luteolin 
(Extrasynthese 69730 Genay France), Caffeic acid (Sigma C0625-29), Genistein (Genay 
Francs 69730), Apigenin-7-glucoside, and Epi-gallocatechin gallate (EGCG). The 
experiment was run and analysed by application of the Chemstation (Agilent) software. 
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2.3.2 Structure elucidation techniques 
2.3.2.1 Nuclear Magnetic Resonance (NMR) Spectroscopy 
2.3.2.1.1 Proton Nuclear Magnetic Resonance (1H NMR) 
Proton nuclear magnetic resonance (
1
H NMR) is a spectroscopic technique mainly used 
for the identification of the hydrogen and carbon frameworks of organic compounds 
when applied to crude extracts of natural origin. This is all to aid in the structure 
elucidation of the organic compounds therein after a series of isolations. In this case 
certain chemical functional groups and classes such as, double bonds, aldehydes, 
aromatic structures, carboxylic acids, fatty acids, sugars and steroids can be determined. 
However, other spectroscopic techniques are applied to distinguish between chemical 
classes that are closely related and appear in the same region on the spectra. 
NMR spectroscopy detects nuclei that have an overall net spin, I. The most useful 
nucleus for observation in NMR is that of the major isotope of hydrogen (
1
H), which has 
two different possible states, a higher energy level and a lower energy level. The nuclei in 
a lower energy state can be brought to a higher state with electromagnetic radiation, this 
is said to be the nuclear magnetic resonance. The energy absorption gets detected as a 
signal plotted against the chemical shift (δ). The amount of energy that is necessary is 
related to the chemical binding properties of the atom.  
In this study, 
1
H NMR was used to get an overview of the chemical profile of the CR-
MeOH extracts and the liquid-liquid partitioning subextracts (n-hexane, CHCl3 and 
aq.MeOH) of the Ficus species. Thus, 20 mg of the dry plant extracts were dissolved in 
500 µl of appropriate solvent according to the polarity and solubility of the extracts as 
shown in Table 5. The samples were transferred into NMR tubes and run on a Brüker 400 
MHz equipment (128 scans at room temperature), and also at 500 MHz for purer 
compounds. 
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Table 5: Deuterated solvents used extracts and subextracts 
Extract               Solvent 
Crude methanol   deuterated methanol (CD3OD) 
Hexane    deuterated chloroform (CDCl3) 
Chloroform    deuterated chloroform (CDCl3) 
Aqueous methanol   deuterated methanol (CD3OD) 
 
2.3.2.1.2 Carbon Magnetic Resonance (13C NMR) 
Carbon magnetic resonance (
13
C NMR) is complementary to 
1
H NMR as it gives further 
information on the environment of the different functional groups and the number of 
carbons present and how these carbon are correlated to the hydrogens. In addition, 
13
C 
NMR is used in the analysis of glycosides, one of which is showing the kind of bonds 
that link the sugar moieties and their configurations. These two techniques are said to be 
one-dimensional experiments as they detect more of the organic frame of the compounds, 
thus providing a very powerful means of structural elucidation. Another complimentary 
one-dimensional experiment is the Distortionless enhancement by polarization transfer 
(DEPT-35) which help to confirm the carbons that have protons attached to them, and the 
carbons that are quarternary (without any hydrogens attached to them). 
2.3.2.1.3 Two-dimensional NMR experiments 
Two-dimensional NMR experiments include; Correlation spectroscopy (COSY), 
Heteronuclear Multiple Quantum Coherence (HMQC) spectroscopy and Heteronuclear 
Multiple Bond Coherence (HMBC) spectroscopy. 
COSY detects spin-spin couplings between protons that are close to each other (up to two 
germinal coupling, 
2Ј or three vicinal coupling, 3Ј bond distances). It also detects 
interactions between two different nuclei like that of 
1
H and 
13
C. HMQC reveals one 
bond coupling between a carbon and proton (1-bond H-C), while HMBC shows 
correlations between protons and the carbon atoms that are two and three bonds away 
from each other; these couplings are referred to as 
2
J and
 3
J, respectively. HMBC spectra 
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are very informative and allow partial structure fragments to be constructed which can 
enable the full structure elucidation of the compounds. 
In this thesis, the analysis of the extracts and subextracts was performed on an AVANCE 
400 MHz spectrometer (Brüker) by 
1
H NMR experiments with 128 scans. About 50 mg 
of sample (or the whole sample, if smaller amounts were isolated), were dissolved in 500 
μl chloroform-d (CDCl3) (Cambridge Isotopes Laboratories, DLM-7-100) or in 500 μl 
methanol-d4 (MeOD) (Cambridge Isotopes Laboratories, DLM-24-10) and transferred 
into an NMR tube with 5 mm diameter and 17.8 cm length (Aldrich, Z27678). The 
Brüker Software Topsin 1.3 was used for spectra acquisition and processing. The spectra 
calibration was carried out on the residual solvent peak (MeOD: δ 3.31, δ 4.8 (residual 
water peak), CDCl3: δ 7.27). 
For isolated metabolites, the structure elucidation was performed using a variety of one-
dimensional (
1
H NMR, 
13
C NMR, DEPT) and two-dimensional (HMQC, HMBC, COSY 
and NOESY) experiments which were performed on an AVANCE 500 MHz 
spectrometer (Bruker). Analysis of pure compounds by 
1
H NMR was performed with 512 
scans, for 
13
C NMR with 2 000 scans with a resonance frequency of 125 MHz and for 
DEPT-35 with 2 000 scans as well. HMQC and HMBC were both measured with 16 
scans, while NOESY with 32 scans and 400 ms mixing. The Brüker Software Topsin 1.3 
was used for spectra acquisition and processing. The spectra calibration was carried out 
on the residual solvent peak, as follows; MeOD: 
1
H = δ 3.31, δ 4.8 (residual water peak), 
13C = δ 40; CDCl3: 
1H = δ 7.27, 13C = δ 77; pyridine-d5: 
1H = δ 8.74, δ 7.58, δ7.22, 13C = 
δ150.35, δ135.91, δ123.87; and for deuterium oxide (D2O): 
1
H = δ4.80. 
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2.3.3 Mass Spectrometry (MS) 
Mass spectrometry (MS) is a technique that measures the molecular weight of a 
compound. It works by fragmenting small amounts of the organic compound and then 
recording the fragments according to their mass. Firstly, the compound is ionized to 
positive mode, then accelerated and deflected according to their mass to charge ratio 
(m/z) and finally detected. The lighter and the charged the fragmented particles are, the 
more they are deflected. Detection depends on the number of charges on the ions such 
that the resultant spectrum shows relative abundance of the separated ions according to 
their mass to charge ratio. In this study, a softer ionization technique, called the 
electrospray ionization (ESI) was used. This technique produces less fragmentation 
information for structure elucidation. 
Mass spectra were acquired using an LCQ Mass spectrometer (Finnigan MAT) equipped 
with an electrospray ionization source (ESI). The operating parameters were as follows; 
the spray needle voltage was set at 4.5 kV and the spray was stabilized with a nitrogen 
sheath gas (700lb/in.
2
). ES capillary voltage was 30V, helium was used as auxiliary gas 
(15lb/in.
2
), and capillary temp was 200
o
C, collision energy 45% of 5V for MS/MS. A 
syringe pump delivering 3 µl/min was used for the direct loop injections of pure 
standards dissolved in MeOH (about 0.3 µg/l). MS experiments were performed in 
negative mode. The negative MS
2
 spectra were obtained with a CE-nano-ESI-(MS)
2
 with 
35 collision-induced dissociation (CID). The ESI (low resolution) and accurate mass 
(high resolution) experiments were applied to isolated compounds. High resolution 
accurate mass spectra were acquired using a micromass Q-TOF Ultima Global Tandem 
Mass spectrometer (Micromass). Samples were measured under electrospray ionization 
mode using 50% acetontrile (ACN) in water and 0.1% formic acid as solvent. 
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2.4 BIOLOGICAL ACTIVITY ASSAYS 
All the extracts and subextracts obtained from the initial extractions were subjected to 
activity screenings which included both in vitro biochemical and biological assays. 
2.4.1 Antimicrobial activities 
There are several methods that can be employed for antimicrobial assays. The most 
common types for susceptibility testing include broth dilution and agar-based methods. 
Of the latter type, the agar disc diffusion method is the most common. It involves the 
application of the extract onto a filter paper disc, which is then placed onto solid medium 
seeded with the test microorganism. It is a simple, reliable, inexpensive and easily 
adaptable assay (Singh et al., 2007). Another of this type is the agar well diffusion which 
involves the puncturing of a well into solid agar, and the test sample is poured into the 
well. 
The other common assay is the broth dilution method which, is commonly used for the 
establishment of the minimum inhibitory concentration (MICs). This parameter is 
important for assessing the antimicrobial potential of analytes. It involves the dilution 
with broth (in most cases Mueller-Hinton broth) of extract dissolved in a solvent. Then 
subcultured inoculums on agar slants is prepared in normal saline and compared with a 
0.5 McFarland turbidity standard, and then diluted according to the desired inoculums 
density. In this thesis, we will look at in vitro antifungal and antibacterial activity assays 
using agar disc diffusion and broth dilution methods. 
2.4.2 Antifungal activity 
The method used to screen the crude methanol extracts was the agar disc diffusion 
method. Four test organisms were selected for this assay. Two clinical cultures of 
dermatophytes which included Trichophyton tonsurans Z6786 and Trichophyton 
interdigitale were selected on the basis that they are the most common tinea fungi 
isolated from patients of African origin who suffer from ringworms. Two additional 
fungi, the yeast; Candida albicans (NCPF 3153) and a mould; Aspergillus fumigatus 
were used as they cause common ailments. 
Materials and methods 
89 
Approximately 200 ml of distilled water was poured onto overgrown spores of fungi. The 
spores were lightly scrapped and 200 ml transferred into another bottle. The 
concentration and density of the suspension was determined and adjusted to 3 x 10
6 
CFU 
MacFarland standard. Then 200 μl of the spore suspension was applied onto Sabouraud 
dextrose agar plate (Oxoid), spread evenly and dried; 6 mm diameter sterile discs loaded 
with 100 µg extract/disc and 50µg extract/disc were placed on the seeded agar. Ten 
microgram per milliliter miconazole (1-[2, 4-dichloro-β- [2, 4 dichlorobenzyl]-oxy) 
phenethyl] imidazole) nitrate salt) from Sigma and methanol (Fisher) were used as the 
positive and negative controls, respectively. The plates were incubated for 5-7 days for T. 
tonsurans and T. interdigitale and for 18 hrs for C. albicans and A. fumigatus. Disc 
diffusion assay was performed according to NCCLS guidelines. Each extract was tested 
in triplicates. 
2.4.2.1 Antibacterial activity 
2.4.2.1.1 Broth dilution method 
Six clinically important test organisms were selected for the screening of crude methanol 
extracts from the 8 Ficus species under study. They were selected on the basis of the 
diseases they cause, in correlation with the traditional uses of the Ficus species in 
Zambia.  Thus, three gram-positive bacteria; Staphylococcus aureus (NCTC 12695), 
Enterococcus faecalis 13379 (ISA) and Streptococcus pneumoniae (NCTC 12695) and 
three gram-negative bacteria included Pseudomonas aeruginosa (NCTC 10662), 
Acinetobacter baumanii (ATCC 19606) and Escherichia coli (NCTC 10418) were tested. 
The stock concentration of the crude extracts was prepared (40 mg/ml) by dissolving 20 
mg dry extract into 500 µl 100% dimethylsulfoxide DMSO (Sigma, D8418). This 
solution was further diluted by transferring 5 µl of the stock solution into 995 µl Muller-
Hinton broth (MHB) (CM 0473, Iso-sensitest, Oxoid) inoculated with 1 x 10
5
 CFU/ml 
bacterial suspension, to give a final concentration of 200 µg/ml of the extract. The 
prepared microtiter plates were then incubated for 18 hrs at 37
o
C. The complete absence 
of bacterial growth was regarded as susceptible to the extracts. The results obtained were 
means of at least three independent assays. 
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2.4.2.1.2 The disc diffusion method 
Four test organisms were selected for the screening of all the plant extracts of the 8 Ficus 
species under study. Three gram-positive bacteria; S. aureus (NCTC 12695), E. faecalis 
13379 (ISA) and methicillin resistant S. aureus (MRSA 1199 B NorA) and one gram-
negative bacteria; E. coli (NCTC 10418) were tested. Preparation of the agar (CM 0471, 
Iso-sensitest, Oxoid) and MHB broth was done according to the manufacturer’s 
instructions. MRSA is a type of S. aureus that has become resistant to many antibiotics, 
including methicillin, penicillin, amoxicillin, and cephalosporins. 
The method was performed according to BSAC (2005) standards. Approximately, 4-5 
colonies of inoculum were touched with a sterile swab and suspended in 3 ml broth to 
give just visible turbidity. The suspension was standardized by measuring the wavelength 
(Heλios α, Thermo Scientific spectrophotometer) of the bacterial suspension at 500 nm. 
Depending on the reading of the absorbance (Table 6) of different organisms, an 
appropriate amount of inoculum was transferred into 5 ml sterile broth to give a further 
dilution. The adjusted suspension was now used to inoculate the plates before applying 
the discs loaded with plant extract at a concentration of 100 μg extract/disc. The seeded 
plates were incubated (Genlab) for 18 hrs at 37
o
C and inhibition was measured as the 
diameter in milimetres of the clear zone that had no bacterial growth. The assay was done 
in duplicates and the results recorded as means of the two experiments. The positive 
control was ciprofloxacin 1 µg/disc (CT 0623B, Oxoid) and 100 % methanol was the 
negative control. 
Table 6: Absorbance and dilution for inoculum suspension. 
Organisms Absorbance at 500 nm 
Volume (μl) to transfer to 
5 ml sterile broth 
E.  faecalis 0.05 125 
S.  aureus 0.5 20 
MRSA 0.496 25 
E.  coli 0.01 250 
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2.4.2.2 Anti-mycobacterial activity 
The anti-mycobacterial activity was assessed by an MTT (3-4, 5-dimethylthiazol-2-yl-2, 
5-diphenyl tetrazolium bromide) assay based on the method detailed by Montoro et al. 
(2005). The assay assessed the ability of viable mycobacterial cells to reduce the MTT 
tetrazolium salt by actively growing cells to produce a blue formazan product. Thus, 100 
μl of Middlebrook 7H9 media supplemented with 10% oleic acid-albumin-dextrose-
catalase, 0.5% glycerol and 0.05% tween 80 were added to each sterile well of a 96-well 
flat bottom plate. In each well was also added 100 µl of approximately 2.5 x 10
7
 M. 
tuberculosis strain H37Rv. Then serial dilutions of the extracts were prepared on the 
plates by adding 100 µl of the stock solution to the wells to achieve the final 
concentrations ranging from 256 μg/ml to 1 μg/ml. The plates were sealed then incubated 
with gentle rocking (30 rocks per min.) for 7 days at 37°C.  MTT dye (10 µl filter-
sterilized at 5 mg/ml in dH2O) was added to each well and the plates were re-incubated 
for another 24 hrs. MICs were recorded as the lowest concentration at which a purple 
precipitate of formazan did not appear in the wells. Streptomycin (Sigma) was used as the 
positive control. 
2.4.3 Antischistosomal activity 
This assay was performed by using CD1 mice supplied by Charles River, UK which were 
maintained at St Mary’s Hospital, Imperial College London. All experimentation was 
undertaken with the guidelines of the United Kingdom Animal’s scientific procedures 
Act 1986 and approved by the London School of Hygiene and Tropical Medicine ethics 
committee. 
2.4.3.1 Production of schistosomula 
A Puerto Rican strain of Schistosoma mansoni was maintained by routine passage 
through Biomphalaria glabrata snails and CD1 mice. Schistosomula were prepared as 
described by Mansour and Bickle (2010). Here, cercariae of the Puerto Rican strain of 
Schistosoma mansoni (Doenhoff, et al., 1978) were shed in clean tap water from infected 
Biomphalaria glabrata snails exposed to direct illumination for 1 hr. The cercariae were 
then concentrated to 20 ml using an 8 µM filter (Sartorius CN, Scientific Laboratory 
Supplies, Ltd) on a concentration apparatus (Millipore) and cooled on ice for 1 hr. The 
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water was removed from the pelleted cercariae and replaced by cold serum free medium 
169 (Basch, 1981) (M169) which was supplemented with 300 U/ml Penicillin (Gibco, 
UK), 300 µg/ml Streptomycin (Gibco, UK), and 160 µg/mL Gentamicin (Sigma-Aldrich, 
UK) (Incomplete M169). Under sterile conditions, cercariae were mechanically 
transformed into schistosomula using the ‘Syringe Method’ (James and Taylor, 1976). 
The cercarial head and tail suspension was layered onto a sterile gradient of 50% and 
70% Percoll (Sigma-Aldrich, UK) in M169 in 15 ml polystyrene tubes (Lazdins, et al., 
1982). These tubes were centrifuged for 10 min at 350 x g at 4 ºC, after which the 
supernatant layers were decanted and the cercarial heads (schistosomula) recovered from 
the 70% layer. They were washed 3 times in 10 ml of Incomplete M169 by centrifuging 
again at 400 x g and 4 ºC for 2 min. The schistosomula were then washed once more in 
M169 supplemented with 100 U/ml Penicillin, 100µg/ml Streptomycin and 5% foetal calf 
serum (Sigma-Aldrich, UK) (Complete M169 or cM169). The schistosomula were then 
transferred into 6-well plates (Nunc, UK) and incubated overnight at 37 ºC and 5 % CO2.  
2.4.3.2 Schistosomula Drug sensitivity assay 
This is the primary larval assay in which 20 mg/ml stock solutions of extracts were 
prepared in 100% DMSO (Sigma-Aldrich, UK) immediately before use. Then 1 µl of test 
extracts were added to 100 µl of cM169 in each culture well of 96-well plates (Nunc, 
UK) and mixed well. The wells were topped up with another 100 µl of cM169 containing 
100 schistosomula to give final concentrations of 100 µg/ml of extract in each well. 
Negative control wells contained larvae cultured in cM169 alone or cM169 with 0.5% 
DMSO. Positive control wells contained larvae cultured in Praziquantel (Sigma-Aldrich, 
UK) at 10 µg/ml (32 µM). After 3 days of culture the viability of schistosomula was 
assessed using an inverted microscope (Leitz Diavert Wetzlar, Germany) and any extracts 
which caused death (immotile, often showing a characteristic uniform shape and granular 
appearance) and/or morphological damage (showing a range of altered shapes, 
granularity and/or blebbing but still with some motility) of ≥ 70% was considered a hit. 
These hits were tested for IC50 in a secondary larval screen run at four serial 1 to 3 extract 
dilutions from 100 to 3.7 µg/ml or lower if necessary. The IC50 values (and IC70 values 
for certain extracts) were calculated using Microsoft XLfit version 5.1.0.0 (2006-2008 ID 
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Business Solutions Ltd). The average IC50 value for Praziquantel in the larval assay was 
0.25 µg/ml (0.8µM).  Larval hits in the primary larval screen were taken forward to be 
tested in the adult ex-vivo primary screen. 
2.4.3.3 Adult worm culture conditions 
Adult worm ex-vivo drug testing was performed as previously described by Ramirez, et 
al., (2007). The CD1 strain mice were infected by subcutaneous injection with 500 
cercariae, freshly shed from infected Biomphalaria glabrata snails to obtain Schistosoma 
mansoni (Puerto Rican) adult worms. The worms were harvested, using sterile 
techniques, by portal perfusion 6 weeks post-infection using warm perfusion medium 
(Dulbecco’s Modified Eagle’s Medium [DMEM]), 2 mM l-glutamine, 100 U/ml 
penicillin, 100µg/ml streptomycin, 20 mM Hepes, 10 U/ml Heparin [Sigma-Aldrich, 
UK]).  Under sterile conditions, the worms were washed 4 X, from host red blood cells 
by sedimentation in perfusion medium. The perfusion medium was then replaced with 
complete medium (cDMEM i.e., DMEM containing 10% foetal calf serum, 2 mM L-
glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin) and the worms were poured into 
6-well plates, after which they were then distributed in test wells of 24-well plates (Nunc, 
UK) containing 1 ml complete medium to give at least five males and five females per 
well. The volume in the wells was then topped up to 2 ml of complete medium. Cultures 
and assays were incubated at 37 ºC and 5% CO2. The effect of the extracts was recorded 
as evidenced by worm motility disturbances (e.g sluggishness or paralysis) and 
morphological changes like relaxation, shrinkage, curling, tegumental disruption and 
worm disintegration. 
2.4.3.4 Adult wormd drug sensitivity assay 
For the adult worm screening; 100 mg/ml stock solutions of extract were prepared in 
100% DMSO immediately before use. 2 µl of test extracts were added to each culture 
well to give 100 µg/ml final concentrations. Negative control wells contained worms 
cultured in cDMEM alone or cDMEM with 0.1% DMSO. Positive control wells 
contained worms cultured in 10 µg/ml Praziquantel (Sigma-Aldrich, UK). The effect of 
the extracts was determined on the fifth day of culture using an inverted microscope 
(Leitz Diavert Wetzlar, Germany). Any extract that produced ≥ 70% worm motility 
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inhibition ± tegumental damage was recorded a hit in the primary screen. These active 
extracts were then tested for IC50 in a secondary screen run at four serial 1 to 3 dilutions 
of the extract starting with the concentration used in the primary screening i.e., 100 to 3.7 
µg/ml or lower if necessary. The IC50 values were calculated using Microsoft XLfit 
version 5.1.0.0 (2006-2008 ID Business Solutions Ltd). The average IC50 value for 
Praziquantel, the positive reference was 0.36 µg/ml (1.15 µM). 
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2.4.4 Antiprotozoal activity 
The plant extracts were screened for their in-vitro activity against four parasitic protozoa, 
which included; Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania 
donovani and Plasmodium falciparum. These parasites cause diseases that are prevalent 
to tropical regions of the world, of which P. falciparum causes the deadly malaria. 
2.4.4.1 Trypanocidal activity against Trypanosoma brucei rhodesiense 
The stock of Trypanosoma brucei rhodesiense, STIB 900 strain was isolated in 1982 
from a human patient in Tanzania (Witschel et al., 2012). After several mouse passages, 
the strain was cloned and adapted to axenic culture conditions (Baltz et al., 1985; Thuita 
et al., 2008). Minimum Essential Medium (MEM) (50 µl) supplemented with 25 mM 
HEPES, 1 g/L additional glucose, 1% MEM non-essential amino acids (100x), 0.2 mM 2-
mercaptoethanol, 1mM Na-pyruvate and 15% heat inactivated horse serum was added to 
each well of a 96-well microtiter plate. Serial drug dilutions of seven 3-fold dilution steps 
covering a range from 90 to 0.123 μg/ml were prepared. Then 104 blood-stream forms of 
T. brucei rhodesiense STIB 900 in 50 µl were added to each well and the plate was 
incubated at 37°C under a 5% CO2 atmosphere for 72 hrs. 10 µl of a resazurin (Sigma), 
solution (12.5 mg resazurin dissolved in 100 ml double-distilled water) was then added to 
each well and incubation continued for a further 3 hrs (Räz et al., 1997). The plates were 
read with a Spectramax Gemini XS microplate fluorometer (Molecular Devices 
Cooperation, Sunnyvale, CA, USA) using an excitation wavelength of 536 nm and an 
emission wavelength of 588 nm. Melarsoprol (Arsobal
®
, Sanofi-Aventis, provided by 
WHO) was used as a reference drug. Data was analyzed and IC50 values were determined 
using the microplate reader software Softmax Pro (Molecular Devices Cooperation, 
Sunnyvale, CA, USA). 
2.4.4.2 Trypanocidal activity against Trypanosoma cruzi 
For the in-vitro assay of Trypanosoma cruzi, rat skeletal myoblasts (L-6 cells) (ATCC) 
were used. These were seeded in 96-well microtitre plates at 2000 cells/well in 100 μL 
RPMI 1640 medium with 10% fetal bovine serum (FBS) and 2 mM L-glutamine. After 
24 hrs the medium was removed and replaced by 100 μl per well containing 5000 
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trypomastigote forms of T. cruzi Tulahuen strain C2C4 containing the β-galactosidase 
(lac Z) gene (Buckner et al., 1996). After 48 hrs, the medium was removed from the 
wells and replaced by 100 μl fresh medium with or without a serial drug dilution of seven 
3-fold dilution steps covering a range from 90 to 0.123 μg/ml. After 96 hrs of incubation, 
the plates were inspected under an inverted microscope to assure growth of the controls 
and sterility. Then 50 μl of the substrate CPRG/Nonidet (CPRG: Roche Diagnostic; 
Nonidet: Calbiochem) was added to all the wells. A color reaction which could be read 
photometrically at 540 nm developed within 2-6. The data was then transferred into a 
graphic programme Softmax Pro (Molecular Devices), to calculate IC50 values. 
Benznidazole (Hoffmann-La Roche, provided by WHO) was the standard drug used. 
2.4.4.3 Leishmanicidal activity against Leishmania donovani. 
In this assay, amastigotes of L. donovani strain MHOM/ET/67/L82 (LSHTM) were 
grown in axenic culture at 37°C in SM medium at pH 5.4 supplemented with 10% heat-
inactivated fetal bovine serum (FBS) under an atmosphere of 5% CO2 in air. One hundred 
microlitres of culture medium with 10
5
 amastigotes from axenic culture were seeded in 
96-well microtitre plates. Serial dilutions of the plant extracts covering a concentration 
range from 90 to 0.123 μg/ml were prepared. Meanwhile, the seeded plates were 
inspected under an inverted microscope to assure growth of the controls and sterility of 
conditions after 72 hrs of incubation. Then 10 μl of resazurin solution (0.125 mg/ml 
resazurin in distilled water) (Mikus and Steverding, 2000) was added to each well and the 
plates incubated for another 2 hours. The plates were read with a Spectramax Gemini XS 
microplate fluorometer using an excitation wavelength of 536 nm and an emission 
wavelength of 588 nm. Data were analyzed using the software Softmax Pro (Molecular 
Devices Cooperation, Sunnyvale, CA, USA). Decrease of fluorescence (interpreted as 
inhibition) was expressed as percentage of the fluorescence of control cultures and 
plotted against the drug concentrations. From the sigmoidal inhibition curves the IC50 
values were calculated. Miltefosine (Sigma) was used as a reference drug. 
2.4.4.4 Antiplasmodial activity against blood stage Plasmodium falciparum. 
The in vitro activity against erythrocytic stages of P. falciparum was determined by a 
modified [
3
H]-hypoxanthine incorporation assay (Matile and Pink, 1990), using the 
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chloroquine- and pyrimethamine-resistant K1 strain and the standard drug chloroquine 
(Sigma). Since resistance development is the challenging factor hampering effective 
malaria treatment, the multidrug K1 strain was chosen for the assay. It was however, not 
possible to screen the extracts against the chloroquine sensitive strain as has been 
suggested by Wright (2010), because of time constraints. 
In this method, [
3
H]-hypoxanthine was used to determine the level of in vitro growth 
inhibition of P. falciparum in human erythrocytes (Calderon et al., 2012). Thus, a serial 
dilution technique which measures the ability of the plant extracts to inhibit the 
incorporation of [
3
H]-hypozanthine into the malaria parasite was performed. The parasite 
cultures were incubated in RPMI 1640 medium with 5% Albumax (without 
hypoxanthine) and they were then exposed to serial drug dilutions in 96-well microtiter 
plates. After 48 hrs of incubation at 37°C in a reduced oxygen atmosphere, 0.5 μCi [3H]-
hypoxanthine was added to each well. Cultures were incubated for a further 24 hrs before 
they were harvested onto glass-fiber filters and washed with distilled water. Radioactivity 
was measured using a Betaplate
TM
 liquid scintillation counter (Wallac, Zurich, 
Switzerland) and the results recorded as counts per minute (CPM) per well at each plant 
extract concentration and expressed as percentage of the untreated controls. IC50 values 
were calculated from graphically plotted dose-response curves. 
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2.4.5 Cytotoxic activity in the mammalian rat skeletal myoblast primary cell line 
L6 
The cytotoxic activity assay was the same as that performed for Trypanosoma brucei 
rhodesiense above. The cytotoxity of the crude methanol extracts and subextracts was 
performed using L6 cells, which are a primary cell line derived from mammalian rat 
skeletal myoblast, in order to determine their selectivity. Briefly, the L6-cells (4 x 10
4
) 
were maintained in 100 µl of RPMI 1640 medium supplemented with 1% L-glutamine 
(200 mM) and 10% FBS. Plant extract of seven 3-fold dilutions ranging from 90 to 0.123 
μg/ml were added to the cultured L6 cells and incubated for 72 hrs. To the plates, 10 μl of 
0.125 mg/ml resazurin solution was added as a viability indicator and they were 
incubated for another 2 hrs. Results were recorded by reading plates with a Spectramax 
Gemini XS microplate fluorometer using an excitation wavelength of 536 nm and an 
emission wavelength of 588 nm. Data were analysed using the microplate reader software 
Softmax Pro. Podophyllotoxin (Sigma) was the standard drug used. 
2.4.6 In vitro FAS-II inhibition assay 
There were three steps that characterized the FAS- II inhibition assay. Prior to performing 
the inhibition assay, the FAS enzymes were first expressed in E. coli BL21 (DE3)-
CodonPlus-RIL cells (Stratagene) and then purified. Below are detailed outlines of the 
methods. 
2.4.6.1 Protein Expression in E. coli BL21-CodonPlus (DE3)-RIL 
BL21 and its derivatives are popular strains obtained from E.coli mammalian gut for 
recombinant protein expression. These systems offer the best characterized systems for 
overexpression of recombinant proteins as genes of interest can be introduced.  Thus 
IPTG inducible protein expression can be performed because they contain T7 RNA 
polymerase under the control of the lacUV5 promoter. In this work the strain BL21-
CodonPlus (DE3)-RIL (Stratagene) cells was used. This strain contains extra copies of 
the argU, ileY, and leuW tRNA genes which are rarely expressed in E. coli, as well as a 
gene for chlorophenicolacetyltranferase enzyme which mediates chloramphenicol 
resistance. 
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In this expression glycerol stocks of cloned FAS enzymes FabI (NcoI, BamHI (Perrozo et 
al, 2002)), FabG (NcoI, EcoRI (Tasdemir et al., 2006)) and FabZ (Nde, EcoRI (Kostrewa 
et al., 2005) were grown in separate batches. Thus, they were expressed in 1 L terrific 
broth medium (Fluka, T0918) made by weighing out 47.6g Terrific Broth medium into 
three 1litre flasks plus  8ml glycerol filled to 1 L with deionized water. The medium was 
autoclaved 121
o
C for 45 minutes and then cooled, after which 1 mg chloramphenicol 
(Sigma, C0378) and 1 mg Kanamycin sulphate (Sigma, 60615) was added. The medium 
was then inoculated with frozen E. coli bacteria from a previously made glycerol stock 
stored at -80
o
C and incubated over night at 37°C and 160 rpm. The enzyme expression 
was induced after about 18 hrs by adding 1 mM isopropyl-β-D-thiogalactpyranoside 
(IPTG) (Calbiochem, 420322) and further incubated for 5 hrs at 37°C and 160 rpm. The 
bacterial cells were harvested by centrifugation at 4°C and 5000 rpm (Avanti J-E 
centrifuge, rotor 16.25, Beckmann Coulter) for 20 mins and the pellets (containing the 
enzymes) were immediately frozen and stored at -20°C until needed. 
2.4.6.2 Enzyme Purification 
The enzymes were purified using the Nickel-NTA-affinity chromatography as all FAS-II 
enzymes were cloned with polyhistidine residues (His-tag). This method is well 
established (Porath et al., 1975) as it uses the ability of 6 histidine amino acids at either 
the N or C terminus of a protein to bind nickel (Ni
2+
), which is also bound to an agarose 
bead by chelation using nitrilotriacetic acid (NTA) beads. When the lysed protein is 
poured onto the column, the His-tagged proteins bind to the NTA strongly while the low 
affinity proteins do not. Since imidazole has a greater affinity for Ni
2+
, it is used to elute 
the protein. Low imidazole (20 mM) buffer is used to elute low affinity bound proteins 
while the high affinity bound protein is eluted from the NTA-beads with 500 mM 
imidazole. The collected protein is then processed by gel filtration using equilibrated PD-
10 desalting column. This technique separates high molecular weight proteins from low 
molecular weight substances such as salts, free labels and impurities which maybe in the 
the protein. 
The procedure was as follows: The frozen E.coli protein pellet was thawed and re-
suspended in 35 ml cold lysis buffer which is made up of 20 mM TRIS (Aldrich, 
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154563), 500 mM Sodium chloride (NaCl; Acros organics, 2077900), 20 mM imidazole 
(Sigma-Aldrich, 56750), 1% glycerol (Sigma, 49767) at pH 8.0. To the suspension was 
added 1 mM PMSF (Sigma, 78830) in isopropanol and very minute amount of 
deoxyribonuclease I (DNase) from bovine pancrease (Sigma, DN25) for FabI and FabG 
only.  The suspension was then lysed by passing it through the French Press (Thermo) 
twice under a pressure of 1500 psi. The lysate was centrifuged at 9000 rpm for 40 
minutes at 4°C (Avanti J-E centrifuge, rotor 25.50, Beckmann Coulter) and the 
supernatant was filtered (Cellulose nitrate, Ø 0.45 μm). 
The supernatant was loaded onto an Econo-Pac chromatography column (Bio-Rad, 732-
1010), which was rinsed with distilled water and then washed with 20 ml cold lysis buffer 
and 10 ml cold  50 mM imidazole buffer B. This column, which is packed with 3 ml 
nickel-NTA agarose (Qiagen, 30210), and placed on top of the column, is a porous 30 μm 
polyethylene bed support. Before each use the column was washed with regeneration 
buffer containing 8 M (20 ml) Urea (Sigma U5378), 20 mM TRIS and pH 7.4, then 
followed by a wash with buffer containing 500 mM imidazole, 20 mM TRIS, 500 mM 
NaCl and 10% glycerol (V/V). It was finally equilibrated with ten times (20 ml) cold 
lysis buffer (20 mM imidazole). 
From the column, the enzymes were eluted in 1 ml steps with 500 mM imidazole. The 
eluted fractions were tested for protein content by adding 10 μl of each fraction into tube 
containing 790 μl H2O and 200 μl Bio-Rad protein assay dye reagent concentrate (Bio-
Rad, 500-0006), noting the colour change of the dye from brown to blue as in  
Figure 28 shows tubes 3, 4, 5 and 6 as containing the protein. Fractions containing 
protein were combined and then concentrated to 2.5 ml in an Amicon ultra-15 centrifugal 
filter unit with Ultracel-10 membrane (Millipore, UFC901024) by centrifugation at 4000 
g (Megafuge 1.0R, Heraeus) at room temperature. The enzyme was desalted using a PD-
10 desalting column (GE Healthcare, 17-0851-01) with a cold desalting buffer containing 
20 mM  4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) (Sigma, 54457), 
150 mM NaCl all at pH 7.4 to elute the protein. 
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Figure 28: Presence of protein in Bio-Rad protein assay dye reagent. 
(The blue colour change from brown indicates the presence of protein in vials 3, 4, 5 and 6). 
 
The enzyme concentration was determined spectrophometrically by measuring the 
absorption of 10 µl protein in 990 µl 20 mM HEPES buffer C using a semi-micro cuvette 
of quartz glass (45 mm H x 12.5 mm D x 12.5 mm W, column1400 μl, light path 10 mm) 
(Hellma, 104-QS) at 280 nm on a Lambda 25 UV/VIS spectrometer (Perkin Elmer). The 
following formula was used to determine the concentration: 
[c]= mean Aprotein × 100 ⁄ A1
0,1%
 
Where A1
0,1%  
with His-Tag values for the enzymes are 0.951 for FabI, 0.586 for FabG 
and 0.606 for FabZ. Enzyme concentrations below 4 mg/ml were futher concentrated in 
an Amicon ultra-4 centrifugal filter unit with Ultracel-10 membrane (Millipore, 
UFC801024). The protein was stored in 50% glycerol (Sigma-Aldrich, 49767) at -20°C 
to be used within 3 months under these conditions. 
2.4.6.3 Enzyme documentation by SDS-PAGE 
The enymes were documented by SDS Polyacrylamide Gel Electrophoresis (SDS-
PAGE), which is the most widely used method to determine the complexity and 
molecular mass of constituent polypeptides in a protein sample. It is simple and quick to 
use, and also polypeptide compositions of small amounts of proteins can be analyzed. 
The proteins are readily solubilized by sodium dodecyl sulphate (SDS), an ionic 
detergent, designed to dissociate all proteins into individual polypeptide subunits. It 
accumulates stoichiometrically at the protein (1 molecule SDS per 2-3 amino acids) so 
that the amount of amino acids and negative charge is proportional. The electrophoretical 
mobility of a protein is therefore proportional to the logarithm of its molecular weight. 
The tertiary and secondary structure of the protein is dissolved by breaking down 
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hydrogen bonds and straightening of the molecule. Dithiothreitol (DTT) or C-
mercaptoethanol in the SDS Sample buffer reduce intermolecular disulfide bonds 
between cysteins and disrupt the quaternary structure. 
Samples were collected from the total lysate (Tc) before centrifugation, the supernatant 
(S) and pellet (P) after centrifugation, the flow through after loading the column (FT), the 
flow through (W) after washing the column with 50 mM imidazole, from each fraction 
containing enzyme before combination (vial numbers 3,4 and 5 as in  
Figure 28) and from enzyme fractions after desalting (vial numbers 1, 2  and 3). All the 
samples were added up to 20 μl with sample buffer containing 166 mM TRIS pH 6.8, 
10% glycerol, 2% (W/V) Sodium Dodecyl Sulphate (SDS) (Sigma-Aldrich, L6026), 
3.5% 2-mercaptoethanol (Sigma, M7522), 17% bromphenol blue xylene cyanole dye 
solution (Sigma, B3269) and heated for 5 minutes at 95°C. The purpose was to denature 
the protein so that most of the polypeptides could bind to SDS in a constant weight ratio 
allowing the SDS-polyacrylamide complexes have an identical charge density and 
migrate in the polyacrylamide gels of the correct porosity strictly according to 
polypeptide size. Because of an alkaline pH-value used during electrophoresis and the 
interaction with SDS the proteins move towards the anode, a low range SDS-PAGE 
standard (Bio-Rad, 161-0304) was used as a marker. 
The samples were thus loaded into the 15% polyacrylamide stacking gel which was 
prepared with tetramethylethylenediamine (TEMED) (Sigma, T9281) and 10% (W/V) 
ammonium persulphate (APS) (Sigma-Aldrich, 248614), 0.5 M TRIS pH 6.8, 30% 
acrylamide, 10% SDS and deionized water. The separating gel was composed of 
TEMED, 10% APS, 30% acrylamide, 1.5 M TRIS pH 8.8, 10% SDS and deionized 
water. Electrophoresis was then run on 200 V (constant) and a maximum of 400 mA for 
50 minutes using a running buffer containing 25 mM TRIS, 192 mM glycine (Sigma, 
50046) and 0.1% (W/V) SDS. After electrophoresis, the gel was transferred into a 
staining solution composed of 0.1% (W/V) brilliant blue G (Sigma, 27815), 50% 
methanol and 6% glacial acetic acid (VWR, analytical grade) for 30 seconds in a 
microwave set at the maximum power setting (Cookworks, 650 W). It was then destained 
for at least 12 hrs in 5% methanol and 7.5% glacial acetic acid. 
Materials and methods 
103 
2.4.6.4 Enzyme inhibition assay 
The activities of extracts against FabI, FabG and FabZ were determined 
spectrophometrically by determining IC50 values, in which the changes in the light 
absorbed by the sample reaction mixture was recorded. The enzymes under study were 
two reductases (FabI and FabG) and a dehydratase (FabZ).  In the enzyme inhibition 
assay as illustrated in Figure 29, Fab G (β-oxoacyl-ACP reductase) reduces the substrate 
acetoacetyl-CoA to β-hydroxyacyl-CoA in the presence of NADPH, in which NADPH 
gets oxidized to NADP
+
. The changes in the absorption of the cofactors at 340 nm in the 
absence of specific inhibitors (compound or extract) are measured and compared to the 
reduction measured with the inhibitor. In the same manner, FabI (Enoyl-ACP reductase) 
reduces the double bond of the substrate crotonyl-CoA to yield butyryl-CoA in the 
presence of cofactor NADH. The oxidation of NADH to NAD
+
 in the reaction is 
measured by observing the decrease in absorption at 340 nm. For the third enzyme, FabZ 
(β-hydroxyacyl-ACP dehydratase) the same principle applies, however, it oxidizes the 
reverse reaction of crotonoyl-CoA to β-hydroxyacyl-CoA and the change in absorbance is 
measured at 263 nm. At this wavelength the reduction measured is due to the elimination 
of the double bond in crotonoyl-CoA. If a compound or extract inhibits an enzyme, the 
decrease in the absorption will be prevented. By increasing and decreasing the compound 
or extract concentration, complete inhibition and no inhibition can be measured. DMSO 
was used as a positive control as it was the solvent in which the extracts were dissolved 
and it provided full enzyme activity at 0.1% in its final concentration in the assay. 
 
 
Figure 29: Illustration of FAS enzymes catalyzing the oxidation of NADH/NADPH to 
NAD
+
/ NADP
+
. 
 
Before the assay, one milligram of the standards and extracts were dissolved in 100% 
DMSO (Sigma, D8418) with stock concentration of 10 mg/ml (to achieve 0.1% final 
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concentration in reaction mixture). Depending on how many samples had to be tested, a 
specific amount of the enzyme was taken from the stock and diluted with the HEPES 
buffer C (20 mM HEPES, 150 mM NaCl, pH 7.4). The cofactor and the substrates were 
dissolved in deionized water at a concentration of 1 mg/ml. During the assay, they were 
ten-fold diluted to lower concentrations with 100% DMSO until full enzyme activity was 
detected. The highest concentration measured for the extracts was 50 μg/ml. For FabG 
inhibition, 100 μM of the cofactor NADPH (Fluka, 93220) was added to 1 μg enzyme 
and sample mixed well. The reaction was started by addition of acetoacetyl coenzyme A 
sodium salt hydrate (acetoacetyl-CoA) (Sigma, A1625) substrate. The mixture was then 
read for 1 min at 340 nm. The same was performed for FabI, however, using NADH 
(Sigma, 43420) as co-factor and 50 μM 2-butenoyl coenzyme A lithium salt (Crotonyl-
CoA) (Sigma, C6146, UK) as a substrate. Meanwhile, FabZ was measured at 263 nm for 
2 min in the presence of 25 μM crotonyl-CoA and 1 μg enzyme. The negative control 
was the measurement of the 0.1% DMSO activity in the absence of the enzyme. The 
components for the enzyme assay were added into a quartz cuvette (Hellma, 104-10-40) 
and then HEPES buffer C  was added up to 1 ml in the order as listed below; 
Volume Reagent 
996 μl Measuring buffer (20 mM HEPES and 150 mM HCl) 
1 μl Cofactor 
1 μl Enzyme/s 
1 μl DMSO 
1 μl Substrate/s 
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Determination of activity was done by calculating the mean slope of at least three 
measurements (absorption against time) of the negative control. To determine the activity 
of the enzyme in the presence of the compound or extract, the following formula was 
used:  
 
The activities of different extracts (У-values) were plotted against the extract 
concentrations (Х-values) (Figure 30). If the extract inhibited the enzyme, a decrease of 
the activity was seen descending as the extract concentrations increased. The IC50 value 
could then be read on the plot. Sample concentrations were decreased until 100% activity 
was achieved. The limitations of these measurements were either the absorption of the 
spectrophotometer or the solubility of the sample. When the extracts were more 
concentrated, they had high concentration of chromophores (colour intensity), hence all 
the light was absorbed leading to a positive slope. In our experiments, the highest 
concentration was pegged at 50 μg/ml. Hence to find out the enzyme percentage 
inhibition, the change in absorbance (in this caes change in activity) was calculated 
divided by the average change in absorbance for the negative controls. The sample 
concentration to start the assay was 10 µg/ml  and all the samples that recorded enzyme 
activity less than 50 % were next measured at 50 µg/ml, while those that gave enzyme 
activity more than 50 % were measured next at 1 µg/ml. However, prior to the 
measurement of samples, pure standard compounds were measured to ascertain the 
viability of the enzymes. Plots for change in absorbance for the positive controls is 
illustrated in Figure 30A. The standard substrates used for as posistive controls for FabI 
was triclosan (Sigma, 72779) and that of FabG and FabZ was epigallocatechin gallate 
(EGCG) (Fluka 50299). The concentration of the standards (triclosan and EGCG) which 
inhibited 50% of the enzyme activity (IC50) was calculated and a graph of activity against 
concentration was plotted as illustrated in Figure 30B. 
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Figure 30: A) Plots for change in absorbance for negative controls. B) Activity against 
concentration for triclosan, a standard substrate used for FabI. 
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3. RESULTS AND DISCUSSION 
3.1 PLANT EXTRACTION 
Finely ground plant materials of the eight Ficus species were extracted with 100% 
methanol by continuous maceration on a magnetic stirrer for over 24 hrs. Table 7 (below) 
shows the percentage yields from dry mass of the obtained crude extracts (CR-MeOH) 
which range from 3.96% (root extract of F. ingens) to 16.95% (leaf extract of F. lutea). 
However the % yield of the CR-MeOH of the large scale extraction of F. sansibarica was 
higher with 23% yield. There were only nine out of the 24 extracts that yielded over 10% 
of the dry mass. 
The CR-MeOH extracts were then subjected to liquid-liquid partitioning. The subextracts 
were partitioned according to polarity and the % yield was calculated from the yield of 
the CR-MeOH extract. The aq. MeOH subextracts had the highest yields which can be 
attributed to the presence of large amounts of sugars. The partitioning provided a coarse 
separation of the the metabolites into nonpolar (hexane), medium polar (CHCl3) and polar 
(aq.MeOH) compounds. 
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Table 7: The percentage (%) yield of the plant extractions 
Species 
Plant 
part 
% yield from dry 
mass 
% yield from CR-MeOH extract 
CR-MeOH Hexane Chloroform Aq-MeOH 
F. ingens 
L 8.45 9.26 10.62 34.8 
S 9.15 16.5 14.6 34.0 
R 3.96 14.9 15.0 33.5 
F. lutea 
L 16.95 5.2 6.6 33.7 
S 13.45 11.0 7.7 44.3 
R 11.80 10.4 23.1 49.5 
F. natalensis 
L 15.20 8.9 8.3 46.1 
S 8.80 8.8 8.5 63.4 
R 11.50 5.7 9.9 47.1 
F. ovata 
L 11.0 11.8 12.1 48.4 
S 9.60 14.2 11.9 35.9 
R 13.15 13.7 11.6 45.6 
F. sansibarica 
L 13.55 12.2 24.05 36.5 
S 9.75 5.12 3.14 36.2 
R 8.08 13.9 12.4 45.5 
F. sycomorus subsp. 
gnaphalocarpa 
L 9.10 16.7 12.7 39.7 
S 8.25 8.4 8.4 66.4 
R 12.45 6.4 11.2 60.3 
F. sycomorus subsp. 
sycomorus 
L 7.15 16.7 7.2 27.4 
S 5.41 12.8 6.0 50.5 
R 7.32 21.9 18.4 20.2 
F. wakefieldii 
L 9.55 14.1 21.1 45.8 
S 7.74 21.6 9.3 56.2 
R 9.22 12.4 12.0 36.8 
F. sansibarica  
(large scale extraction) 
L 23.5 7.35 16 53.66 
 
L- leaves, S- stem bark and R- root bark. 
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3.2 PHYTOCHEMICAL PROFILING 
The use of herbal medicines has been in existence for centuries and has never stopped 
since. Their worldwide use has even increased in the last decade and developing 
countries like Zambia is not an exception. As infectious diseases are predominant and 
other debilitating non-communicable illnesses are on the increase, the use of herbal 
medicines by consulting traditional healers is part of most households’ primary care 
system (Ndubani and Höjer, 1999). Regardless of the use of these traditional herbal 
medicines over many centuries, only a very small percentage of plant species have been 
scientifically validated in Zambia.  Even worse, the safety and efficacy of the extracts and 
active ingredients of these medicines are not documented.  
However, the World Health Organization (WHO) as the custodian of global health 
matters has encouraged the consistent use of traditional plant based medicines because of 
their accessibility and affordability to many communities burdened with diseases. As 
such, it has developed technical guidelines for quality control assessments (Springfield et 
al., 2005). To this effect, TLC and HPLC are the separation techniques in 
pharmacopoeial monographs most commonly reported. 
TLC has the advantage of requiring minimal infrastructure so it would be economical to 
use for phytochemical screenings.  However, HPLC provides enhanced resolutions and 
separation (Rewald et al., 1994). HPLC has been a technique of choice as a reference tool 
for the identification and quality assessment of herbal medicines (Liu et al., 2007; Ma et 
al., 2007; Springfield et al., 2005). Even more the coupling of HPLC to the Diode array 
detector (DAD) has increasing use for the screening of drugs, and also for natural 
products (Springfield et al., 2005). With the tool of analysis in metabolomics, on top of 
HPLC analysis, NMR is also increasingly being used.  
3.2.1 Thin Layer Chromatography (TLC) 
The crude extracts being a mixture of many different chemical constituents with different 
functional groups, of different polarities and in variable concentrations, an appropriate 
separation solvent system was selected after several trials. The selection was based on the 
solvent system’s ability to separate the chemical constituents distinctively with spots 
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appearing with Rf values that were between 0.1 and 0.9. Based on the results, the solvent 
system that separated the crude methanol extracts and aq. MeOH subextracts quite 
reasonably constituted ethyl acetate: methanol: water: acetic acid (41:5:4: 0.5). The best 
solvent system found for hexane subextracts was hexane: ethyl acetate: acetic acid 
(8:2:0.5), and that of chloroform subextracts contained chloroform: ethyl acetate: acetic 
acid (6:4:0.5). 
The developed TLC plates were visualized under UV light at 254 and 365 nm to detect 
UV active or absorbing plant constituents and were then sprayed with 4% vanillin in 
sulphuric acid reagent spray and heated to optimize colour development. Two other 
visualizing reagents were used. These are natural product spray and Dragendorff’s 
reagent used to visualize polyphenolic compounds and alkaloids, respectively. 
3.2.1.1 Crude MeOH extracts and aq. MeOH subextracts 
The chemical composition of the CR-MeOH extracts of the leaves was dominated by 
pink and yellow spots which, appeared at the bottom and middle of the plates (Figure 
31A). This implies that the extracts constituted medium polar to polar compounds. 
However, less prominent violet/purple spots also appear at the top of the plate indicating 
the presence of nonpolar components. The TLC of the aq. MeOH subextracts (Figure 
31B) of the leaves resembled that of the CR-MeOH profile, except for the violet/purple 
spots which were missing. Track 9 denoting the leaf extract of F. lutea leaves exhibited a 
different profile from the rest as it did not have distinct chemical components highlighted. 
As for the stem bark and the root bark, the CR-MeOH extract and the aq. MeOH 
subextracts were run on the same plate because of the similarities that were observed 
during the process of mobile phase selection. The chemical composition of the CR-
MeOH extracts of the stem bark and root bark extracts resembles that of the leaves 
(Figure 31A and B). The CR-MeOH extract was then subjected to liquid-liquid 
partitioning to yield the hexane, CHCl3 and aq. MeOH subextracts. 
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Figure 31: TLC profiles of leaf CR-MeOH extracts (A) and the aq. MeOH subextracts (B). 
1 - F. ingens; 5 - F. sycomorus subsp. gnaphalocarpa; 9 - F. Lutea; 13 - F. natalensis; 17 - F. ovata; 21 - F. 
sansibarica; 25 - F. sycomorus subsp. sycomorus; 29 - F. wakefieldii 
 
 
                             
Figure 32: TLC plates of the CR-MeOH extracts and aq. MeOH subextracts of the stem 
barks (Plate A) and the root bark (Plate B). 
Plate A – ethyl acetate: methanol: water (41:5:4) Plate B – ethyl acetate: methanol :water (40.5:5.5:4) 
5, 8 - F. sycomorus subsp. gnaphalocarpa; 1, 4 - F. ingens; 9, 12 - F. Lutea; 13, 16 - F. natalensis ; 17, 20 - 
F. ovata; 21, 24 - F. sansibarica; 25, 28 - F. sycomorus subsp. sycomorus; 29, 32 - F. wakefieldii 
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3.2.1.2 Hexane subextracts 
The hexane substracts were the first to be obtained dominated by the least polar 
constituents. The TLC analysis was run with a predominantly nonpolar mobile solvent to 
obtain a separation that was dominated by purple spots at the top of the plate (Figure 33). 
On the TLC plate (Figure 33A), tracks 2 (F. ingens) and 6 (F. lutea) did not exhibit an 
abundance of these metabolites. However, subextracts of the leaves (Plate A) show great 
similarity to the root extracts (Plate C), which are dominated with purple and blue spots 
around the middle of the plate. Plate D of the roots was sprayed with Dragendorff’s 
reagent to highlight the possible presence of alkaloids which appear as brown spots. 
Tracks 2, 6, 10 (F. ingens, F. sycomorus subsp. sycomorus, F.lutea and F.natalensis) 
exhibited a strong presence of brown spots which in this case could represent alkaloids. 
The stem barks exhibited quite a rich profile with orange, pink, purple and blue spots on 
plate B (Figure 33). 
Comparison between the plant species revealed that track 2 for F. ingens leaves and barks 
were as rich in different types of compounds as was tracks 6, 14 and 18 representing F. 
sycomorus subsp. gnaphalocarpa, F. natalensis and F. ovata. Meanwhile, tracks 22 for F. 
sansibarica, 26 (F. sycomorus subsp. sycomorus) and 30 (F. wakefieldii) of the leaves 
were very similar to the profile of the stems, while track 22 for F. sansibarica of the root 
extract was very different, with no nonpolar spots shown. 
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Figure 33: TLC for the hexane subextracts of the leaves (Plate A), stem barks (Plate B) 
and the root barks (Plates C and D). 
 
Plates A-C were sprayed with VS. Plate D was sprayed with Dragendorff’s reagent. The mobile phase was 
hexane: ethyl acetate (8 : 2) 
2 - F. ingens ; 6 - F. sycomorus subsp. gnaphalocarpa; 10 - F. lutea; 14 - F. Natalensis; 18 - F. ovata; 22 - 
F. sansibarica; 26 - F. sycomorus subsp. sycomorus; 30 - F. wakefieldii 
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3.2.1.3 Chloroform subextract 
The CHCl3 subextracts were dominated by the compounds of medium to high polarity 
and as such a medium to high polar mobile solvent was used in the analysis. Thus 
chloroform/ethyl acetate (6:4) was used as mobile phase. The TLC Plates A-C (Figure 
34) were sprayed with NP/PEG and observed under UV 366 nm to detect flavonoids and 
related polyphenolic compounds which are abundant across the genus Ficus. Figure 34 
(leaf extract) was dominated by red spots at the top end of the plate depicting the 
presence of chlorophyll. Nonetheless, track 11 (F. lutea) did not show chlorophyll spots 
and any other abundant flavonoids. This can be observed as well on plate D which was 
sprayed with VS. Different classes of flavonoids have been highlighted by different 
colours of spots; for instance orange spots could depict the presence of flavonol or 
flavone glycosides. The dark and light blue spots at the bottom of the plate could 
represent phenol carboxylic acids and/or coumarins. Apart from F. lutea, tracks 3 (F. 
ingens) and 23 (F. sansibarica) have a slightly different chemical profile. Most 
flavonoids also exhibit yellow to red colour because of conjugated chromophores present 
(Qiao et al., 2011). 
In Figure 34, Plates A - C were sprayed with NP/PEG, plate D with VS and Plate E with 
Dragendorff’s reagent. The plate for the CHCl3 of root extracts was characterized by deep 
orange, bright blue and fluorescent spots. Track 15 (F. natalensis) showed a unique 
composition of just dark blue spots. Track 3 (F. ingens) on the stem bark plate B has a 
pronounced bright blue fluorescent spot unlike other species, which on the leaf extract 
plate A appears as purple spots. Dragendorff’s reagent didn’t visualize the alkaloids 
present as evidenced by (Figure 34Error! Reference source not found.E). When 
comparing the leaf to the stem bark extracts, a significant difference is the absence of the 
spots presumably of chlorophyll which appear in red in the leaf extracts. In addition, the 
comparison of leaf extracts to root extracts reveals appearance of bright orange and green 
fluorescent spots under UV 366 nm in the roots. The apparent red spots in the roots are 
thus not an indication of chlorophyll, but compounds that have conjugated chromophores. 
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Figure 34: TLC plates of the CHCl3 subextracts of the leaves (Plates A and D), stem barks (B and E) and 
the root barks (Plate C). 
 
Plates A-C were sprayed with NP/PEG and viewed under wavelength 366 nm. Plate D was sprayed with 
VS and plate E was sprayed with Dragendorff’s reagent. 
The mobile phase used was Chloroform: ethyl acetate (6:4) 
3 - F. ingens; 7- F. sycomorus subsp. gnaphalocarpa; 11 - F. lutea; 15 - F. natalensis; 19 - F. ovata; 23 - F. 
sansibarica; 27 - F. sycomorus subsp. sycomorus; 31 - F. wakefieldii 
 
The TLC screenings were done for rapid detection of the different plant constituents; 
however, for complex crude extracts it offers lower accuracy and precision. 
Overall, the TLC plates for the crude, hexane, chloroform and aqueous methanol extracts 
and subextracts were dominated with purple, orange, red, yellow and blue spots. The 
TLC plates were viewed under 254 nm and 366 nm UV light to identify the type of 
chemical compounds that were constituted in the extracts. One group of compounds that 
were evident in the Ficus extracts are flavonoids which cause fluorescence quenching 
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under the UV light at 254 nm.  Meanwhile, under the 366 nm UV light, flavonoids show 
dark yellow, green, or blue fluorescence (Waksmundzka-Hajnos et al., 2008). The red 
colour of spots which were also prominent could denote flavonoids because of 
conjugated chromophores present in the molecules (Effendy et al., 2011; Qiao et al., 
2011). The resolution of the chemical constituents was not precise, as was observed from 
the broad spots (tailing) which is one of the signs indicating the presence of charged 
functional groups.  However, an attempt was made to reduce the tailing by acidifying the 
mobile phases with 0.1% acetic acid which is sufficient to reduce the dissociation of ions.  
With VS visualizing spray, red or purplish-red spots are normally produced by catechins 
and proanthocyanidins immediately after spraying and warming the plates, while 
flavanones and dihydroflavonols develop more slowly (Waksmundzka-Hajnos et al., 
2008). Much as the spots could not be quantified, in this thesis, we can only assume that 
the intensity and size of the spots indicate the abundance of the group of compound in the 
extract, or it maybe that it is the most dissolved group of compounds in the solvent used 
both for extraction and for the chromatographic analysis. To sum up these results, the 
CR-MeOH extracts of the leaves, stem barks and root barks of F. lutea and F. 
sansibarica displayed different TLC profiles. Notably as well, are the CHCl3 subextracts 
of the stem and roots of F. ingens. 
3.2.2 Proton Nuclear Magnetic Resonance (1H NMR) 
The CR-MeOH extracts and liquid-liquid partitioned subextracts of the Ficus species 
were subjected to 
1
H NMR analysis. The 
1
H NMR profiles of all the species were 
dominated by signals between δH0 - δH2, δH3 - δH5 and δH6 - δH7.5 indicating the 
presence of aliphatic groups, sugars and some aromatic compounds. The chemical shifts 
(δ) given in ppm for the solvents used to dissolve the samples appeared at δH7.27 for 
CDCl3 and δH3.31 for CD3OD. The crude methanol (CR-MeOH) extracts were measured 
in CD3OD, while the hexane subextracts containing nonpolar compounds were measured 
in CDCl3. The CHCl3 subextracts have medium and high polar compounds and were thus 
measured in both CDCl3 and CD3OD. The aq. MeOH subextract contained hydrophilic 
compounds and were measured in CD3OD. 
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3.2.2.1 CR-MeOH extracts 
The 
1
H NMR profiles for the CR-MeOH extracts did not show definite functional 
groupings because it is composed of all kinds of compounds with different chemical 
class, polarity and solubility. However, the spectra in all the species were dominated by 
signals between δH0 - δH2 and δH3 - δH5 indicating the presence of aliphatic groups, 
probably arising from alkyl chains of fatty acids and sugars respectively. However, the 
CR-MeOH extract of the leaves of F. sansibarica (Figure 35a) exhibited an exceptionally 
different profile which showed prominent peaks in the low-field aromatic region. 
3.2.2.2 The Hexane subextracts 
The hexane subextracts clearly showed aliphatic peaks upfield ranging between δH0 - δH2 
in all the extracts (Figure 35B-36B).  Peaks also appeared between δH3 - δH5.5 to indicate 
presence of functional groups with oxygenation and double bond protons.  To compare 
the different plant parts, further down field, peaks were observed from δH7 - δH9.5 in all 
the leaf extracts and only in F. ingens (both stem bark and root bark) which may indicate 
the presence of aldehydes and carboxylic acids. 
3.2.2.3 The Chloroform subextract 
The CHCl3 subextracts were measured in both CDCl3 and CD3OD. Both spectra of the 
subextracts of all the species indicated to be qualitatively similar as in the hexane 
subextracts; except for the subextract of the leaves of F. sansibarica (Figure 35). The 
subextracts measured in CD3OD had the same peaks appearing in the CR-MeOH extracts 
(Figure 35D). Meanwhile, when the subextract was measured in CDCl3, only aliphatic 
groups with signals between δH0 - δH2 were predominant, even though the same peaks 
also appeared in the CD3OD samples although with less intensity. This denotes that the 
peaks in the aromatic region arise from water soluble polyphenolic compounds and their 
glycosides abundant in this species. Notable aromatic peaks were observed in the CDCl3 
samples between δH7.5 - δH8 only in the extracts of F. sansibarica (Figure 35E), F. 
natalensis (as well as root bark), F. ingens and F. lutea stem barks. 
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3.2.2.4 The aq. MeOH subextract 
The aq. MeOH subextracts had predominant peaks in the δ3 - δ5 region in all the species 
(Figure 35E). These signals are likely to arise from anomeric protons of sugars, which 
also give peaks between δH4 - δH5. The subextract of F. sansibarica was dominated by 
the same compounds found in the CR-MeOH and the CD3OD soluble compounds of the 
CHCl3 subextracts. The peaks that appear between δH6.5 - δH7 could be as a result of 
water soluble polyphenolic compounds and their glycosides. 
From these results, we can conclude that F. sansibarica is chemically different 
predominantly possessing aromatic compounds with glycosidic bonds. 
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a) 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 ppm
Sample Ref AGB-FSanL-CR
AGB-FSanL-CR, MeOD, 128 scans, 400MHz
 
b) 9 8 7 6 5 4 3 2 1 0 ppm
Sample Ref AGB-FSan-KHex
AGB-FSan-KHex, CDCL3, 128 scans, 400MHz
 
c) 10 9 8 7 6 5 4 3 2 1 0 ppm
Sample Ref AGB-FSan-KCHCL3
AGB-FSan-KCHCL3, CDCL3, 128 scans, 400MHz
 
d) 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
Sample Ref AGB-FSanL-KMeoH
AGB-FsanL-KMeOH, MeOD, 128 scans, 400MHz
 
e) 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
Sample Ref FSansL-KCHCl3
AGB-FSansL-KCHCl3, MeOD, 128 scans, 400MHz
 
Figure 35: 1H NMR profiles of the CR-MeOH extracts and the liquid-liquid partitioned subextracts 
obtained from the leaves of F. sansibarica. a) CR-MeOH extract (in MeOD). b) hexane subextract (in 
CDCl3). c) CHCl3 subextract (in CDCl3), d) CHCl3 subextract (in MeOD) and e) aq. MeOH subextract (in 
MeOD) 
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a) 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
Sample Ref AGB-FSanB-CR
FSanB-CR, MeOD, 128 scans 400MHz 6/12/10
 
b) 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
Sample Ref AGB-FSanB-KHex
FSanB-KHex,CDCl3, 128 scans 400MHz
 
c) 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
Sample Ref AGB-FSanB-KCHCl3
FSanB-KCHCl3, CDCl3, 128 scans 400MHz
 
d) 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
Sample Ref AGB-FSanB-KMeOH
FSanB-KMeOH,MeOD, 128 scans 400MHz
 
e) 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
Sample Ref FSansB-KCHCl3
AGB-FOvaB-KCHCl3, MeOD, 128 scans, 400MHz
 
Figure 36: 1H NMR profiles of the CR-MeOH extracts and partitioning subextracts obtained from the stem 
bark of F. sansibarica. a) CR-MeOH (in MeOD). b) hexane subextract (in CDCl3). c) CHCl3 subextract (in 
CDCl3), d) CHCl3 subextract (in MeOD) and e) aq. MeOH subextract (in MeOD). 
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3.3 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) 
FINGERPRINTING 
In HPLC, qualitative extract identification can be achieved through comparing retention 
time and UV spectra, such that an HPLC-UV profile of an unknown active principle can 
be useful towards its identification (Springfield et al., 2005). Hence HPLC fingerprinting 
was performed for the eight Ficus species to target phenolic compounds. The separation 
gradient was modified from the established conditions by Giner et al. (1993).  The 
gradient was slightly acidified with 0.2% acetic acid because the more acidic the mobile 
phase, the more precise the separation would be (Plazonić et al., 2009; Andersen and 
Markham, 2006). However, this phenomenon did not apply with our extracts. As 
observed in TLC analysis, because of high ionization, the resolution of the chemical 
constituents in the Ficus species was not precise due as was shown by the tailing. 
However, the further investigation of the optimum pH for which the phenolic compounds 
constituted in the crude extracts would be ideally separated was not done, as we did not 
really know the phytochemical profile of the crude extracts. Crude extracts are a 
consortium of many compounds with different functional groups nonetheless, these 
constituents exhibited to be very closely related as was observed in the phytochemical 
investigation of F. sansibarica which will be discussed in Section 1.3. 
The analysis was first performed on twelve standard phenolic compounds that have been 
reportedly identified and isolated within the genus Ficus. This was done in order to 
establish their retention times (RTs) and their UV spectra. The standards included; Gallic 
acid, Catechin hydrate (unhydrous), Caffeic acid, (-) Epicatechin 90%, EGCG, Rutin, 
Quercitrin (Glucoside + rhamnoside), Apigenin-7-glucoside, Quercetin, Luteolin, 
Genistein and Kaempferol. The cocktail of the standards was also run during the 
sequence analyses of the methanol crude extracts of Ficus species. Since the RTs of the 
standards in the cocktail were known, a correction factor was applied to the unknown 
crude extract chromatograms to monitor any major shifts in the retention time. From the 
results obtained, phenolic compounds appear to be the major chemical constituents of the 
Ficus species, as it has been reported before (Aref et al., 2010). While there is no single 
wavelength ideal for the detection of the peaks of all classes of compounds, given that 
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they display absorbance maxima at different wavelengths (Andersen and Markham, 
2006), two wavelengths were used. The chromatograms were viewed at 254 nm and 360 
nm but were however, extracted using the short wavelength 254 nm because all the 
standards used showed considerable absorbance at this wavelength. 
Phenolic compounds are ubiquitous in the plant kingdom and are thus the most studied 
phytochemicals in plant research (Mradu et al., 2012), however identifying and isolating 
them in plant species that are used for medicinal purposes is imperative. Besides, newer 
ones are yet to be discovered as more than half the plants in the plant kingdom have not 
yet being explored.  These compounds are chemically diverse secondary metabolites, 
which are characterized by aromatic rings with one or more hydroxyl functional groups 
(Harbone et al., 1999). 
3.3.1 Peak identification by Retention time and UV spectra 
UV/Vis spectra have long been used for structural analysis of flavonoids (Atoui et al., 
2005). A flavonoid spectrum normally consists of two maxima ranging between 240–285 
nm for band II and 300 –550 nm for band I. The position and relative intensities of these 
maxima can give information on the nature of the flavonoids including their oxygenation, 
hydroxylation and the degree of substitution of the hydroxyl groups (Švehlíková et al., 
2004). The HPLC profile of the cocktail containing 12 standards exhibited closely related 
retention times and elution sequence as was for standards when they were analyzed 
individually. Thus the peaks in the cocktail were identified and labeled based on the 
retention times (Table 8) and UV spectra of the standards (Figure 37). This data was now 
used to support the identification of the assumed phenolic compounds constituting the 
crude extracts and subextracts of the Ficus species. 
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Figure 37: HPLC chromatograms and UV spectra of standards 
1.Gallic acid; 2. Catechin hydrate (unhydrous); 3.  Caffeic acid; 4. (-) Epicatechin 90%; 5.  EGCG; 6.  
Rutin;  7. Quercitrin (Glucoside + rhamnoside); 8.  Apigenin-7-glucoside; 9.  Quercetin; 10.  Luteolin; 11. 
Genistein; 12.  Kaempferol. 
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Table 8: HPLC retention times (RT) of phenolic standards 
Position on 
chromatogram 
Standards 
 
Retention time 
(minutes) 
1 Gallic acid 6.087 ± 0.127 
2 Catechin hydrate 13.091 ± 0.163 
3 Caffeic acid 15.760 ± 0.004 
4 Epicatechin 17.368 ± 0.248 
5 EGCG 21.859  ± 0.210 
6 Rutin 39.433 ± 0.427 
7 Quercitrin 47.592  ± 0.286 
8 Apigenin-7-glucoside 53.736 ± 0.319 
9 Quercetin 57.954 ± 0.444 
10 Luteolin 63.263 ± 0.466 
11 Genistein 65.874 ± 0.368 
12 Kaempferol 68.906± 0.388 
 
3.3.2 Chemical variation among the Ficus species 
Plants usually contain a series of similar polyphenolics, with slight change in substitution 
patterns or functional groups. These compounds may show very similar properties 
causing their separation be very challenging (Qiao et al., 2011). Much as there is no 
HPLC method that can detect all chemical constituents in particular crude extract using a 
single analysis (Wolfender, 2009), a degree of qualitative chemical variation of the 
predominant and UV detectable compounds was noted among the eight Ficus species that 
were studied and between the plant parts. The authentication of the presence and absence 
of similar compounds is however, tentative as the concentrations of these compounds 
maybe varied among different extracts, a factor that is relevant to the activity of 
medicinal plants but not to their correct identification (Springfield et al., 2005). 
Thus, from the fingerprint results, only the prominent peaks (about 10 peaks in each 
chromatogram) were recorded. The peaks were classified according to their RT and UV 
spectra at 254 nm wavelength to evaluate chemical variations and markers between the 
species. A limitation to this process however, is that some compounds that have weak 
chromophores were not detected and at this wavelength, soluble compounds like tannins 
were also excluded since they do not absorb at this wavelength (Peschel et al., 2012). 
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For the leaf CR-MeOH extracts, the most predominant compound eluted was at about RT 
14.5 for all the species except for F. sansibarica and F. wakefieldii (Table 9). The UV 
spectra for this compound in these species are related to that of the standard caffeic acid, 
and the retention time too is very close. The compounds that eluted at about RT 9.46 
occurred in seven species except for F. sansibarica, and their UV spectra were also 
similar to caffeic acid. The compound eluting at about RT 39.433 ± 0.427 was the most 
predominant in F. sansibarica and F. wakefieldii (with lesser intensity), with their UV 
spectra were resembling those of the standards Apigenin-7-glucoside and quercitrin 
respectively. This echoes the results obtained in the TLC and 
1
H NMR analyses in which 
F. sansibarica extracts exhibited quite an outstandingly different chemical profile. 
Another group of compounds that were common in all the extracts were associated with 
catechin-type derivatives. These were eluted at RT 17.34, and their spectra matched that 
of the standards epicatechin and epi gallocatechin gallate. Three species (F. ingens, F. 
natalensis and F. sycomorus subsp. gnaphalocarpa) did not have any metabolite elute at 
this RT. The compounds that eluted at RT 41.1 had their UV spectra relating to that of 
rutin. This metabolite occurred in all the species. While most of the extracts contained at 
least compounds eluted between RT 45.138 – RT 51.87 with similar UV spectra 
associated with quercetin and kaempferol, F. sansibarica did not have any detectable 
compounds eluted within this RT. 
The CR-MeOH extracts of the leaves were thus grouped into four compound categories 
identified according to the UV spectra. These include; caffeic acid, catechin, rutin and 
apigenin-7-glucoside associates. Beyond 50 minutes RT, the resolution was not very clear 
to categorize the extracted UV spectra. 
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Table 9: HPLC retention times (RT) of the leaf CR-MeOH extracts 
RT (minutes) 
Ficus 
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7
3
 
1
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6
1
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.3
4
1
 
3
2
.5
4
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4
1
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2
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1
.0
9
4
 
6
4
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6
1
 
6
6
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3
 
7
8
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6
 
ingens + + + +     + + + +  + + +  +  +   
lutea + + + + + + + +  + +  +  +    + +   
natalensis + + + + +    + + + +  +   +      
ovata + + + + + + + + + + +  +   +   +    
sansibarica      +  +  + +            
sycomorus 
subsp.gnaphalocarpa 
+  + + +    +  + + +    +      
sycomorus sbsp. 
sycomorus 
+ + + + + +  + +  + +  +       + + 
wakefieldii + + + + + + + + + + + +  + +   +     
 
+  = denotes presence of metabolite eluting at the indicated RT 
 
The HPLC profiles of the CR-MeOH of the stem barks were not very different from those 
obtained in the leaf extracts (Table 9). Similar to the leaf extracts, the compound that 
eluted at RT 14.534 was the highest in concentration in six species except for F. 
sansibarica and F.sycomorus subsp. sycomorus. The UV spectra were similar to that of 
standard caffeic acid. The predominant compound in F. sansibarica and F. sycomorus 
subsp. sycomorus eluted at RT 9.090 and the UV spectra were equivalent to that of the 
standard caffeic acid as well. The UV spectra of the compounds that eluted at RT 8.8 are 
related to that of gallic acid. They occurred in all the species. There are some metabolites 
that were eluted at times exclusively to particular species. For instance, F. ingens extract 
showed a peak at RT 47.8 which was similar to quercitrin both in RT and spectrum 
(Figure 43 and Table 8). From the actual chromatograms (not shown in thesis), it was 
observed that the chemical constituents that elute after RT 40 min were not precisely 
resolved, hence poorly generated peaks in turn made it difficult to identify which 
standard they could be associated with. The RTs 15.8, 16.48, 17.383 and 21.26 based on 
their UV spectra were associated to catechin and epicatechin- type derivatives. This 
category occurred in all the species, except in F. ingens. The compound that eluted at RT 
53.8 was found in F. sansibarica and F. wakefieldii, however the UV spectra were not 
similar. The UV spectrum for F. sansibarica was similar to that of apigenin-7-glucoside 
while that of F. wakefieldii was related to the UV spectrum of quercetin. 
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The extracts of the stem bark were thus grouped into five compound categories that could 
be identified according to UV spectra. These included; gallic acid, caffeic acid, 
catechins/epicatechin, apigenin-7-glucoside and quercetin. 
Table 10: HPLC retention times (RT) of the stem bark CR-MeOH extracts 
RT(minutes) 
Ficus 
8
.8
5
9
 
9
.0
9
0
 
9
.9
4
0
 
1
1
.8
9
4
 
1
2
.0
5
7
 
1
3
.0
5
1
 
1
4
.5
3
4
 
1
5
.8
2
4
 
1
6
.4
8
3
 
1
7
.3
8
3
 
1
9
.0
9
8
 
2
1
.2
6
1
 
2
3
.9
6
8
 
2
9
.4
5
8
 
3
1
.2
1
0
 
3
7
.6
8
0
 
3
9
.5
5
9
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7
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.4
5
8
 
5
3
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8
8
 
5
4
.0
4
3
 
7
7
.1
0
1
 
7
8
.8
9
6
 
ingens + + +    +       +    +      
lutea +  + + +  + +  +   +  + +     +   
natalensis +  +  + + + + +  + +  +         + 
ovata +  + +   + +  + +  +  + +        
sansibarica + + +  +  + +  + + +       + +  +  
sycomorus 
subsp.gnaphalocarpa 
+    +  + + +    + +         + 
sycomorus sbsp. sycomorus  +   +  + +  + + +     +       
wakefieldii +      +   +   +  + + +   +   + 
 
+  = denotes presence of metabolite eluting at the indicated RT 
 
Table 11 shows the results for CR-MeOH extracts of the root barks. There were some 
relative qualitative differences in the chemical constituents of the root bark extracts. Most 
constituents did not absorb well at 254 nm, and like in the stem bark extracts, the 
compound that eluted at RT 8.84 with the UV spectrum similar to that of gallic, was 
common in all the species.  On the other hand, compounds that eluted between RT 12.07 
and RT 17. 01 did not occur in F. sansibarica, and in F. sycomorus subsp. sycomorus, for 
which their UV spectra were similar to caffeic acid. Then all the extracts eluted 
compounds at RT 39. 5 however, they had different UV spectra. The UV spectra of F. 
sansibarica and F. ovata were similar to that apigenin-7-glucoside, while the rest of the 
species showed UV spectra identical to quercetin derivatives. Since catechin-type 
derivatives were not detectable, it can be assumed that they were in very low 
concentration. 
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The extracts of the root barks were thus grouped into five compound categories identified 
according to UV spectra. These included; Gallic acid, caffeic acid, catechins/epicatechin, 
apigenin-7-glucoside and quercetin groups. 
Table 11: HPLC retention times (RT) of the root bark CR-MeOH extracts 
RT (minutes) 
Ficus 
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3
 
9
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7
7
 
9
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0
7
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1
.8
2
7
 
1
2
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3
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2
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4
.9
7
3
 
1
6
.5
6
1
 
1
7
.0
9
0
 
1
7
.3
4
1
 
1
9
.1
3
2
 
2
3
.2
9
2
 
2
5
.6
8
1
 
2
7
.4
7
8
 
2
9
.3
9
6
 
3
5
.0
7
0
 
3
7
.6
6
7
 
3
9
.5
5
9
 
4
4
.8
9
9
 
4
6
.4
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7
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5
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ingens +      +  +   + + + +  + + + + + +   
lutea +  +   + + +        +  +     +  
natalensis + +   +  + +       +         + 
ovata +      +           + +      
sansibarica +  + +      +        +       
sycomorus 
subsp.gnaphalocarpa 
+    +  + +   + +      +       
sycomorus subsp. sycomorus +                 +       
wakefieldii +  +    +  +         +     + + 
 
+  =denotes presence of metabolite eluting at the indicated RT 
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In view of the prominent peaks that were analyzed based on the RT and UV spectra, the 
CR-MeOH extracts of the stem barks and the root barks are qualitatively similar in 
polyphenolic constitution. Meanwhile, the CR-MeOH extracts of the leaves present a 
slightly different chemical profile, with no peaks associated to gallic acid. 
Other than the intrinsic differences between the Ficus species, there are extrinsic factors 
that collectively and significantly determine the presence and concentration of the 
secondary metabolites of interest in a plant extract. These factors include the location and 
geographical conditions like rainfall, temperature and soil type. In addition, the season, 
time of harvesting and extraction method used also contribute to the chemical compounds 
profile. The Ficus species used in this thesis were collected from the same environmental 
structure, except for F. sycomorus subsp. gnapharlocapa which was collected in an area 
with much less rainfall and termite mound-type of soil. To this effect, it can be assumed 
that the qualitative and more so quantitative variation observed in the fingerprints are 
more of intrinsic in nature. 
On the other hand, plant secondary metabolites such as flavonoids contribute to the plant-
environment interactions including plant defense against insects or microbes and abiotic 
stress reactions (Ong et al., 2011; Newton et al., 2002; Stobiecki, 2000). Thus, when the 
plant is exposed to unfamiliar harsh environmental conditions such as excessive UV light, 
wounding or infection, it defends itself or quickly adapts by inducing the biosynthesis of 
more secondary metabolites (Waksmundzka-Hajnos et al., 2008; Bednarek et al., 2001). 
This could explain why the stem back extracts were found to be the most active in most 
of the biological activities that were screened. It is usually the stem barks that are easily 
chiseled for the latex and/or for the bark. These injured plants then develop a defense 
mechanism by igniting the biosynthesis of more metabolites, which become useful with 
medicinal properties. 
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While identification of the peaks in a LC–UV chromatogram is possible by comparing 
retention times and UV spectra with authentic samples or from a databank, we did not 
manage to identify the exact phenolic compounds constituted in the Ficus species studied. 
Hence, to avoid drawing wrong conclusions about the phenolic compounds present, we 
only categorized them into groups similar to the standards based on their retention time 
and UV spectra. These categories include; gallic acid, caffeic acid, catehin/epicatechin, 
rutin, apigenin-7-glucoside and quercetin similarities. We can thus make conclusions that 
qualitative similarity in HPLC profiles was noted intraspecifically albeit infraspecific 
variation in the chemistry of plant secondary metabolites is the one that is mainly 
quantitative (Springfield et al., 2005), which is the reason why the plant species are also 
used indiscriminately. 
Overall, F. sanisibarica is chemically different from the other seven species, as this 
fingerprinting has revealed, confirming the results obtained in the TLC and NMR 
profilling. Our results also demonstrate that HPLC-DAD fingerprints of crude extracts 
can be generated for different medicinal plants by using retention time and UV spectra 
provided a library of specific spectra of standard compounds already exist. Some 
information about the chemical constituents present in a herbal plant extract that is 
needed for validation in its use can be acquired through this method. 
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3.4 BIOLOGICAL ACTIVITY 
This thesis reports for the first time on an array of bioactivities of eight selected Ficus 
species collected in Zambia. The dried crude extracts and subextracts were screened in 
vitro for antimicrobial, antiparasitic and enzyme inhibition activities. The antimicrobial 
activities included antifungal, antibacterial and antimycobacterial assays, while 
antiparasitic activites included antischistosomal, antileishmanial, antitrypanosomal and 
antiplasmodial. 
3.4.1 Antifungal activity 
The CR-MeOH extracts at concentrations of 100 µg extract/disc and 50 µg extract/disc 
were screened using the disc diffusion assay. The extracts of the leaf, stem bark and root 
bark of all the eight Ficus species did not exhibit any antifungal activity against 
Trichophyton interdigitale, Trichophyton tonsurans, Aspergillus fumigatus and Candida 
albicans at both concentrations, hence I did not display the table of results. However, the 
growth of the Trichophytons around the dics was thinner and inconsistent compared to 
the growth away from the discs (Figure 38, plates A and B), suggesting that the extracts 
had some effect on the fungi. There was confluent growth of the A. fumigatus and C. 
albicans and no zones of inhibition were observed in comparison to the positive control 
which was miconazole with the concentration of 10 µg/disc. (Figure 38, plates C and D). 
Miconazole showed zones of inhibition in the ranges between 35 mm against C. albicans 
to 45 mm against T. interdigitale. 
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Figure 38: Antifungal activity of the F. sansibarica CR-MeOH extracts 
A-T. interdigitale; B- T. tonsurans; C - A. fumigatus and D - C. albicans 
 
The results exhibited are in agreement with some earlier studies on F. congensis Engl. 
syn Ficus trichopoda Bak (van Noort et al., 2007). The hexane fraction was found 
inactive against fungi like A. fumigatus (Alaribe et al., 2011). However, in this same 
study (Alaribe and collegues), using the broth dilution method the hexane extract was 
active against C. albicans with a MIC value of 1 mg/ml. Kuete et al. (2009) showed how 
the CR-MeOH extract of the stem bark of F. ovata collected in Cameroon had activity 
against clinical isolates of C. albicans in the broth microdilution method and obtained a 
MIC value of 156 μg/ml. The hexane extract of the stem bark of F. sycomorus has also 
been reported to have weak activity against C. albicans with MIC of 1000 μg/ml 
(Maregesi et al., 2008). In all these instances of recording activity, the method used was 
broth dilution method, which appears to be the effective method to use for the screening 
of fungi. 
In broth microdilution bioassays the concentration of the test compound in the medium is 
defined and available to exhibit its potential in the broth, while the concentration of the 
test compound applied onto a disc may or may not all diffuse through the agar in order to 
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be available to exhibit its potential (Hadacek and Greger, 2000). Disc diffusion method is 
highly depended on water solubility of the test components to diffuse through agar 
(Shane et al., 1999). It would therefore, be assumed that the method used against fungi 
herein was not appropriate and also the concentration might have been insufficient for the 
secondary metabolites constituted in the Ficus species to exert activity. Therefore, the 
compounds of lower solubility in polar solvents would have no activity using this 
method. Our results shown by the nonpolar compounds are clearly an indication of the 
limitation arising in the method used. 
In addition, CR-MeOH extracts are very complex mixtures of compounds of varying 
polarities, and antifungal properties of Ficus species have been attributed to the presence 
of pathogenesis-related (PR) proteins, which are found in the milky latex (Taira et al., 
2005; Ricardo et al., 2004). However, metabolite classes such as flavonoids and 
isoflavonoids have also been reported to have antifungal properties. Cushnie and Lamb 
(2005) reviewed how polar flavonoids possessed activity against C. albicans and some 
Aspergillus species, and how the activity of propolis against dermatophytes and candida 
spp. have been attributed in part to its high flavonoid content. Flavonoids have been 
reported in some of the Ficus species that were screened (Hubert et al., 2011; El-Sayed et 
al., 2010; Kuete et al., 2009). The possible antifungal constituents in the Ficus species 
screened may have been in very minute concentrations to exert noticeable activity. As 
evidenced in the particular flavonoids that have antifungal properties include catechins 
and epiafzelechins which have been isolated from F. ovata (Kuete et al., 2008). 
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3.4.2 Antibacterial activity 
The antibacterial activity of the CR-MeOH extracts was assessed by both broth dilution 
and agar disc diffusion methods. These methods both depend on the effective solubility 
of the extracts in the test medium in order for them to exert maximum activity against the 
organism. In the broth dilution method, activity denoted the total inhibition of bacterial 
growth by the observation of clear broth in the plates. Activity of the extracts using disc 
diffusion method was measured (mm) by the size of clear zones observed around the disc. 
3.4.2.1 Broth dilution method 
There were six organisms that were tested. These were three gram-negative bacteria 
which included Escherichia coli, Acinetobacter baumanii and Pseudomonas aeruginosa, 
and three gram-positive bacteria which included Staphylococcus aureus, Streptococcus 
pneumoniae and Enteroccocus faecalis. 
The only gram-negative organism that was susceptible to some of the leaf extracts at 200 
µg/ml of F. ingens, F. sansibarica and F. wakefieldii (Table 12) was E. coli. Using the 
breakpoint testing, extract concentrations lower than 200 µg/ml did not show activity. 
Other researchers have however, reported activity of different kinds of extracts (dichloro 
methane, petroleum ether, ethanol and water extracts) obtained from the leaves of Ficus 
craterostoma with MIC of 6.25 μg/ml (Madikizela et al., 2012). Alaribe and colleagues 
(2011) also report the hexane extract of F. congensis against E. coli to exhibit an MIC of 
8 mg/ml against E. coli.   
 
As for the gram-positive organisms, Streptococcus pneumoniae was the most sensitive to 
the extracts. It was susceptible to five of the stem bark and two of the leaf crude extracts. 
S. aureus and E. faecalis were only susceptible to four stem bark extracts. Other extracts 
that showed activity were F. lutea and F. wakefieldii leaves. Overall, the stem barks were 
the most active compared to the leaf and root bark extracts. 
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Table 12: Antibacterial activity of the CR-MeOH extracts (200 µg/ml) using the broth 
dilution method. 
Test Organisms 
Leaves Stem bark Root bark 
Gram -ve Gram +ve Gram -ve Gram +ve Gram -ve Gram +ve 
Ec Sa Ef Sp Ec Sa Ef Sp Ec Sa Ef Sp 
F. ingens + - - - - - - - - - - - 
F. lutea - - - + - - - + - - - + 
F. ovata - - - - - - - + - - - - 
F. natalensis - - - - - + - + - - - + 
F. sansibarica + - - - - - - + - - - - 
F. syc. gnaphalocarpa - - - - - + - - - - - - 
F. sycs. sycomorus - - - + - - + + - - - - 
F. wakefieldii + - - + - + - - - - - + 
Clotrimoxazole + + + 
 
- = bacterial growth; + = inhibited bacterial growth; Ec-Escherichia coli; Sa- Staphyloccocus  aureus; Ef- 
Enteroccocus  faecalis; Sp- Streptococcus pneumoniae. 
3.4.2.2 Agar disc diffusion method 
None of the extracts showed activity against the gram-negative bacteria screened. The 
results for gram-negative screening are not shown in Table 13. However, selective 
activity was observed against gram-positive bacteria; S. aureus, MRSA and E. faecalis 
(Table 13, Figure 39). The CR-MeOH of the stem barks was more active against the three 
gram-positive bacteria, while only the leaf CHCl3 subextracts of F. lutea and F. ovata 
were active to only against S. aureus, MRSA and E. faecalis (was generally resistant to 
all except for the CHCl3 subextract of F. lutea). Of the subextracts, antibacterial activity 
was observed mostly in the aq. MeOH subextracts of all the plant parts with inhibition 
zones ranging from 6 mm to 11 mm against the three test organisms. It is interesting to 
note that all, except two (leaf subextracts from F. ingens and F. sycomorus subsp. 
gnaphalocarpa), aq. MeOH subextracts showed activity against E. faecalis, an organism 
that is most susceptible to non polar metabolites. 
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Figure 39: Plates of antibacterial activities of the Ficus species CR-MeOH extracts and 
subextracts 
A- E. faecalis; B- S. aureus; C - MRSA 
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Table 13: Antibacterial activity of the crude extracts and subextracts (100 µg/disc) using 
the disc diffusion method. 
Plant extracts 
 
ZONES OF INHIBITION (mm) 
Type of Extract LEAF STEM BARK ROOT BARK 
Test  organisms  Sa MSa Ef Sa MSa Ef Sa MSa Ef 
F. ingens 
CR-MeOH - 6 - 6 9 6 7 6 - 
Hexane - - - - - - 10 - - 
CHCl3 - - - - - - - - - 
aq. MeOH 8 6 - 9 11 8 - 8 6 
F. lutea 
CR-MeOH 10 9 8 8 8 6 - 8 6 
Hexane - - - - - - - - - 
CHCl3 10 12 7 - - - - - - 
aq. MeOH 10 9 8 10 8 8 8 10 7 
F. natalensis 
CR-MeOH - - - 7 8 - 8 - - 
Hexane - - - - - - - - - 
CHCl3 7 - - 6 6 - - - - 
aq. MeOH 9 8 7 10 10 7 10 6 10 
F. ovata 
CR-MeOH 7 9 - 7 8 - 7 7 - 
Hexane - - - - - - - - - 
CHCl3 7 8 - - - - - - - 
aq. MeOH 11 9 8 10 10 7 11 9 9 
F. sansibarica 
CR-MeOH - - - 8 7 6  - - 
Hexane - - - - - - - - - 
CHCl3 - - - 7 6 - - - - 
aq. MeOH 8 - 8 10 10 7 9 8 6 
F. sycomorus subsp. 
gnaphalocarpa 
CR-MeOH - - - 7 9 6 7 8 6 
Hexane - - - - 6 - - - - 
CHCl3 - - - - - - 7 6 - 
aq. MeOH 8 8 - 9 10 8 9 7 6 
F. sycomorus subsp. 
sycomorus 
CR-MeOH 7 8 - 6 8 6 - - - 
Hexane - - - - - - - - - 
CHCl3 - - - 7 6 - - - - 
aq. MeOH 10 10 8 7 8 7 9 9 9 
F. wakefieldii 
CR-MeOH 7 7 - 8 8 6 7 - 6 
Hexane - - - - - - - - - 
CHCl3 - - - - - - - - - 
aq. MeOH 10 10 7 10 10 7.5 10 8 7.5 
Ciprofloxacin 1µg 22 20 22 22 20 22 22 20 22 
 
(-) implies no inhibition observed. Ec-E. coli; Sa- S.  aureus; Ef- E.  faecalis; Sp- S. pneumoniae 
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The extracts and subextracts showed selectivity in activity against the gram-positive 
bacteria as compared to the gram-negative bacteria. This is consistent with the pattern of 
in vitro inhibition assays emerging from other studies (Anago et al., 2011; Maregesi et 
al., 2008; Zhang and Rock, 2004; Izzo et al., 1995). It is often observed that gram-
negative bacteria such as E. coli and P. aeruginosa have low sensitivity towards plant 
extracts. It has been proposed that the inactivity could be due to the presence of the extra 
outer membrane in the cell wall which acts as a barrier to prevent the influx of foreign 
substances and larger molecules in and out of the cell (Maregesi et al., 2008). In 
particular, E. coli are generally impermeable to ionized or charged molecules, with the 
exception of those for which it possesses specific transport systems (Osman 2012; Leive, 
1965). Certain charged or ionized substances can however, enter E. coli despite the 
general permeability barrier since it possesses a number of active transport systems, and 
the treatment of the E. coli with EDTA before susceptibility testing enhances its 
permeability (Leive, 1965). 
The crude extracts and subextracts of the Ficus species were composed of ionized 
metabolites as was exhibited in the TLC analysis in which there was tailing of some 
components in the extracts. This could be one of the reasons they could not exhibit any 
activity against E. coli. Another possibility is that the active constituents were not made 
available to the microbes due to insolubility and or insufficient concentration of the active 
metabolites. There are several studies that have reported the inactivity of some Ficus 
species extracts against E. coli and other gram-negative bacteria. For instance, 
chloroform extracts of the aerial parts of F. lutea was found inactive against two gram-
negative bacteria E. coli and P. aeruginosa and a gram-positive S. aureus (Marwah et al. 
2006). Yet in another study Aref and colleagues (2010) report that the alcohol extracts of 
the aerial parts of F. carica did not exhibit any activity against E. coli, and a gram 
positive bacteria S. aureus and a fungi C. albicans. In this experiment however, the 
concentration of the extract on the disc was much lower (25 μg/ml) than in our 
experiment (100 μg/ml). In another study, the water extracts of all the plant parts of Ficus 
platyphylla were also reported inactive against E. coli and P. aeruginosa but the ethanol 
extracts exhibited activity with zones of inhibition ranging between 12.3 mm -16 mm 
(Kubmarawa et al., 2009). 
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On the contrary, there are other studies that have shown non-volatile extracts of Ficus 
species to possess antibacterial activity against gram-negative bacteria (Vital et al., 2010; 
Kuete et al., 2008). For example, crude ethanol extracts of F. septica Burm exhibited 
antibacterial activity against E. coli and S. aureus with zones of inhibition of 19.5 ± 1.8 
mm for both bacteria (Vital et al., 2010). 
The disc diffusion results are in line with the broth dilution results for CR-MeOH extracts 
of F. sycomorus subsp. gnaphalocarpa, F. natalensis and F. wakefieldii stem barks, 
against S. aureus and also for F. sycomorus subsp. sycomorus stem bark against E. 
faecalis. Overall, the antibacterial activity was not very significant with the inhibition 
diameters distributed over a narrow range due to the low concentration of the active 
metabolites being availed to exert activity. The crude methanol extracts being a mixture 
of numerous chemical compounds with different functional groups and properties, the 
active metabolites would be in small concentration to exert activity against the 
organisms’ compared to the aq. MeOH subextracts that has more polar metabolites which 
are even easily soluble to be availed to exert activity. In this screening, the aq-MeOH 
subextracts were thus the most active. These extracts are rich in polar components which 
in solution easily diffuse through the agar and inhibit bacterial growth given that the agar 
disc diffusion is depended on water solubility. Among the chemical constituents 
presumably contained in the aq. MeOH subextracts are phenolic compounds, of which 
flavonoids and isoflavonoids are some of the chemical classes reported to exhibit 
antibacterial activity (Kuete et al., 2008). Alkaloids, tannic acid and saponins isolated 
from F. sycomorus have also been reported to have strong antibacterial activity, however, 
highly toxic to the host liver (Garba et al., 2006). These results are quite encouraging in 
that, plant extracts used in traditional herbal preparations are extracted with water in 
which case only the more polar metabolites are extracted. Hence, the moderate 
antimicrobial activity observed in the aq. MeOH fractions indicate that the decoctions 
used traditionally may or may not be effective in the infections they are used for. It has to 
be borne in mind that higher concentrations of the extracts maybe used in traditional 
preparations. 
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3.4.3 Antimycobacterial activity 
As discussed in the introduction, tuberculosis is a prevalent condition in Africa. In 
Zambia, a combination of various parts of F. sycomorus and F. sur are recorded as 
popular remedies against this condition (Fowler, 2007). According to my knowledge, this 
the first time Ficus species collected in Zambia has been screened for antimycobacterial 
activity. Previously only two Ficus species namely Ficus chlamydocarpa and Ficus 
cordata -which are used traditionally in Cameroon in the treatment of tuberculosis- have 
been studied for their antimycobacterial activity (Kuete et al., 2008). 
The antimycobacterial activity was assessed by the ability of actively growing 
mycobacteria to reduce the tetrazolium salt MTT into a blue formazan product within the 
mitochondria. Of the eight Ficus species screened for antimycobacterial activity, five 
were active with MICs ranging between 128 µg/ml and 256 µg/ml (Table 14). 
Interestingly, there is a high variability as to which part of the plant is responsible for this 
biological activity. Overall, the activity can be attributed to nonpolar principles present in 
hexane or chloroform extracts. Only F. lutea may contain more polar active principles 
such as flavonoids (Marwah et al., 2007). Because mycobacterium species are quite 
resistant to pharmacological treatment, some in vitro screenings for antimycobacterial 
activity have generally considered concentrations of up to 500 µg/ml as a positive result 
(Newton et al., 2002). Moreover, many screenings are run with less pathogenic 
Mycobacterium species such as Mycobacterium bovis, M. aurum and M. smegmatis 
which cannot always predict the activity in M. tuberculosis (Kuete et al., 2008; Newton et 
al., 2002). In our case, the genuine human pathogen M. tuberculosis was used, so the 
activities of our samples can be considered quite promising and the stem bark extract 
from F. ovata is the best candidate for a future bioactivity-guided isolation of 
antimycobacterial compounds. Yet F. cordata -with a reported MIC of 39.1 µg/ml 
against M. tuberculosis- is still more potent than the Zambian Ficus species here 
screened. The flavonoids genistein, alpinum, laburnetin and luteolin - isolated from Ficus 
chlamydocarpa- are reported to be active against M. tuberculosis (Kuete et al., 2008). In 
our HPLC analysis we could not detect any genistein in the active samples (see section 
2.4), but the other flavonoids may be present seeing the numerous baseline peaks that 
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were not accounted for. Besides, we did not have these HPLC standards to co-run with 
the samples. 
Our results therefore, do support the reported antimycobacterial ethnopharmacological 
uses of F. sycomorus. In Zambia, the most common subspecies is sycomorus, which did 
not exhibit activity at the highest initial concentration in our tests. However, the root bark 
of the subspecies gnaphalocarpa did show activity. Ethnopharmacological reports are to 
be taken with caution in this case seeing that there is poor distinguishing between the 
species and subspecies, hence different species have the same names, usually mutaba or 
mukunyu, as mentioned in Section 1.6. To further complicate matters all the plant parts 
are reportedly used, echoeing the report by Hubert et al. (2011), and here we show that 
only a very specific part of the plant is active. This correlates with the case of Ficus 
chlamydocarpa and Ficus cordata which are indiscriminately used in Cameroon, in the 
treatment of tuberculosis, but only F. cordata is active upon M. tuberculosis. Further, the 
same authors were able to isolate active metabolites from the inactive extract only, whilst 
they did not do so from the active one (Kuete et al., 2008). 
In terms of convenience, the leaves of F. lutea may provide a more accessible and 
sustainable antimycobacterial herbal remedy although they were less active in vitro than 
F. ovata stem bark, because all the (F. lutea leaves) extracts showed the same level of 
activity.  Perhaps further studies could demonstrate if its in vivo antimycobacterial 
activity could mirror the in vitro one. This brings to the discussion the possible 
differences in bioavailability of chemicals from one or another species and this maybe a 
major factor in the ethnopharmacological uses, although not a consideration in traditional 
use of the plant extracts.  
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Table 14: Anti-mycobacterial activity of extracts from Zambian Ficus species against 
Mycobacterium tuberculosis. Only plant extracts that showed some activity are tabulated. 
Plant species Type of extract Activity (MIC  μg/ml) 
 
Leaves Stem Barks Root Barks 
F. ingens CR-MeOH >256 >256 >256 
Hexane >256 256 256 
CHCl3 >256 >256 >256 
aq. MeOH >256 >256 >256 
F. lutea CR-MeOH 256 >256 >256 
Hexane 256 >256 >256 
CHCl3 256 >256 >256 
aq. MeOH 256 >256 >256 
F. natalensis CR-MeOH >256 >256 >256 
Hexane >256 >256 256 
CHCl3 >256 >256 >256 
aq. MeOH >256 >256 >256 
F. ovata CR-MeOH >256 >256 >256 
Hexane >256 256 >256 
CHCl3 >256 128 256 
aq. MeOH >256 >256 >256 
F. sansibarica CR-MeOH >256 >256 >256 
Hexane >256 >256 >256 
CHCl3 >256 >256 >256 
aq. MeOH >256 >256 >256 
F. sycomorus subsp. 
sycomorus 
CR-MeOH >256 >256 >256 
Hexane >256 >256 >256 
CHCl3 >256 >256 >256 
aq. MeOH >256 >256 >256 
F.  sycomorus subsp. 
gnaphalocarpa 
CR-MeOH >256 >256 >256 
Hexane >256 >256 >256 
CHCl3 >256 >256 256 
aq. MeOH >256 >256 >256 
F. wakefieldii CR-MeOH >256 >256 >256 
Hexane >256 >256 >256 
CHCl3 >256 >256 >256 
aq. MeOH >256 >256 >256 
Streptomycin 0.125 
Isoniazid 0.0625 
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3.4.4 Antischistosomal activity 
The antischistosomal activity was assessed in different stages of the parasite’s growth. 
Firstly, the assay was perfomed on schistosomula  (the migratory larvae stage), and any 
extracts which caused death (evidenced by immotile larvae, often showing a 
characteristic uniform shape and granular appearance) and/or morphological damage was 
considered a hit, and thus tested for IC50 in an ex vivo secondary larval screening. The 
results are presented according to the plant part (leaves, stem barks and root barks) and 
discussed according to the type of subextracts most active. The root barks generally come 
out as the most active with activity being attributed to the less polar fractions. 
For the leaves, Table 15 reveals that only chloroform subextracts were active on the 
larvae stage of the worms with an exception of the subextract of F. lutea.  Thus the seven 
lethal subextracts that caused more than 70% morphological larval damage or deaths 
were then tested in the adult assay. In this assay, none of the extracts were lethal to the 
adult worms. 
The results of the stem bark extracts show that the hexane and the CHCl3 subextracts 
were more active with eight crude and aqueous methanol subextracts, and one hexane 
subextract of F. wakefieldii inducing marked morphological changes (damage or death) 
to the larvae (Table 16).  These active extracts and subextracts were then tested in the 
adult assay, in which only three subextracts showed this level of activity. These include 
hexane (IC50 values of 35 μg/ml) and CHCl3 (IC50 of 17.8 μg/ml) subextracts of F. ovata 
and the hexane subextract of F. sycomorus subsp. gnaphalocarpa (IC50 of 20.3 μg/ml). 
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For the root extracts presented in Table 17, all the extracts and subextracts were 
deleterious to the larvae, except for seven aqueous methanol subextracts. Of these, only 
five were lethal in the adult assay: the CHCl3 subextracts of F. ovata, F. sycomorus 
subsp. sycomorus and F. sycomorus subsp. gnaphalocarpa; the hexane subextracts of F. 
sycomorus subsp. gnaphalocarpa and F. natalensis. The later gave the lowest IC50 value 
of 3.8 μg/ml for the larvae stage and IC50 of 71.2 μg/ml for the adult stage. Notably, 
CHCl3 subextract of the stem bark of F. ovata was most active against the adult worms 
17.8 μg/ml, followed by its hexane subextract and that of F. sycomorus subsp. 
gnaphalocarpa. 
To compare the results between the plant parts, most of the stem and root bark extracts 
demonstrated strong antischistosomal activity. The aq-MeOH subextracts were the least 
active with only three species causing damage to over 70% larvae. As for the subextract 
types, the most active were the CHCl3 subextracts, which are generally composed of 
compounds that have medium polarity. These results agree with already published data 
reported by Abdel-Hameed et al. (2008), in which the CHCl3 fraction had the highest 
activity, and the EC84 values were 42.6 and 47.1 μg/ml against male and female adult 
worms respectively. 
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 Table 15: Antischistosomal activity of the leaf extracts 
Plant species 
 
Type of 
Extract 
Larval assay Adult assay 
% dead larvae IC50 (100 to 
1.23 μg/ml) 
% Motility 
reduction 
(at100 μg/ml) 
IC50 (100 
to 3.7 
μg/ml) 
F. ingens 
CR-MeOH 0 - - >100 
Hexane 39.1 - 0 >100 
CHCl3 100(dead)*
 64.4 - >100 
Aq. MeOH 30.8 - - >100 
F. lutea 
CR-MeOH 39.9 - - >100 
Hexane 100(dead) 62.1 0 >100 
CHCl3 46.7 - - >100 
Aq. MeOH 52 - - >100 
F. natalensis 
CR-MeOH 9.4 - - >100 
Hexane 0 - - >100 
CHCl3 34.5 - - >100 
Aq. MeOH 41.3 - - >100 
F. ovata 
CR-MeOH 34.3 - - >100 
Hexane 0 - - >100 
CHCl3 100(dead) 36.3 50 100 
Aq. MeOH 36.9 - - >100 
F. sansibarica 
CR-MeOH 10.1 - - >100 
Hexane 0 
 
- >100 
CHCl3 100(dead) 37.8 0 >100 
Aq. MeOH 6.4 - - >100 
F. sycomorus 
subsp. 
gnaphalocarpa 
CR-MeOH 19.5 - - >100 
Hexane 0 - - >100 
CHCl3 100(dead) >100 50 100 
Aq. MeOH 0 - - >100 
F. sycomorus 
subsp.  sycomorus 
CR-MeOH 26.2 - - >100 
Hexane 29.7 - - >100 
CHCl3 100(dead) 33 0 >100 
Aq. MeOH 30.1 >100 43.1 >100 
F. wakefieldii 
CR-MeOH 27 - - >100 
Hexane 14 64.4 25 >100 
CHCl3 100(dead) - - >100 
Aq. MeOH 59.5 - - >100 
 
 *Larvae dead within the 3 days of the assay; (-) implies not active; (0) implies no mortality observed 
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Table 16: Antischistosomal activity of the stem bark extracts 
Plant species 
(Stem barks) 
Type of 
Extract 
Larval assay Adult assay 
% dead larvae IC50 (100 to 
1.23 μg/ml) 
% Motility 
reduction (100 
μg/ml) 
IC50  
(100 to 3.7 
μg/ml) 
F. ingens 
CR-MeOH 100(dead)* >100 33.3 >100 
Hexane 100(dead) 34.9 0 >100 
CHCl3 100(dead since day 1)
 32.4 41.7 >100 
Aq. MeOH 63.1 - - >100 
F. lutea 
CR-MeOH 100(dead) 36.4 48.2 >100 
Hexane 100(dead since day 1) 12 37.5 >100 
CHCl3 100(dead since day 1) 33.4 37.5 >100 
Aq. MeOH 64.4 - - >100 
F. natalensis 
CR-MeOH 100(dead since day 1) 33.1 20 >100 
Hexane 100(dead since day 1) 64.4 0 >100 
CHCl3 100(dead since day 1) 35.8 43.8 >100 
Aq. MeOH 71.9 >100 51.3 100 
F. ovata 
CR-MeOH 100(dead since day 1) 36.2 37.5 >100 
Hexane 100(dead since day 1) 11.4 80 35 
CHCl3 100(dead since day 1) 11.1 100 17.8 
Aq. MeOH 64.2 - - >100 
F. sansibarica 
CR-MeOH 54.7 79.1 33.8 >100 
Hexane 100(dead ) 64.4 0 >100 
CHCl3 100(dead) 36.1 56.3 100 
Aq. MeOH 71 - - >100 
F. sycomorus subsp. 
gnaphalocarpa 
CR-MeOH 100(damaged) 61.2 65.6 100 
Hexane 100(dead since day 1) 10.3 100 20.3 
CHCl3 100(dead since day 1) 12.1 50 100 
Aq. MeOH 57.3 - - >100 
F. sycomorus subsp.  
sycomorus 
CR-MeOH 61.3 - - >100 
Hexane 100(damaged) >100 12.5 >100 
CHCl3 100(dead) 64.4 61.6 97.7 
Aq. MeOH 76 >100 66.7 100 
F. wakefieldii 
CR-MeOH 70.9 >100 46.3 >100 
Hexane 35.00 - - >100 
CHCl3 100(dead) 34.8 35.8 >100 
Aq. MeOH 53.9 - - >100 
 
*Larvae dead within the 3 days of the assay; (-) implies not active; (0) implies no mortality observed 
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Table 17: Antischistosomal activity of the root bark extracts 
Plant species 
(Root barks) 
Type of 
Extract 
Larval assay Adult assay 
% dead larvae IC50 (100 to 
1.23 μg/ml) 
% Motility 
reduction  
(100 μg/ml) 
IC50  
(100 to 3.7 
μg/ml) 
F. ingens 
CR-MeOH 100(dead)* 34.7 13.3 >100 
Hexane 100(dead since day 1) 21.5 0 >100 
CHCl3 100(dead)
 12.2 41.7 >100 
Aq. MeOH 66.2 - - >100 
F. lutea 
CR-MeOH 90.3 75.8 25 >100 
Hexane 100(dead) 14.6 32.5 >100 
CHCl3 100(dead) 31.8 25 >100 
Aq. MeOH 59.3 - - >100 
F. natalensis 
CR-MeOH 100(dead since day 1) 31.9 46.9 >100 
Hexane 100(dead since day 1) 3.8 87.5 71.2 
CHCl3 100(dead since day 1) 8.2 100 32.6 
Aq. MeOH 70.4 65.6 55.6 100 
F. ovata 
CR-MeOH 100(damaged) 37.2 58.1 100 
Hexane 100(dead since day 1) 36.2 46.3 >100 
CHCl3 100(dead since day 1) 21.5 79.2 98.6 
Aq. MeOH 38.6 - - >100 
F. sansibarica 
CR-MeOH 100(dead) 64.4 51.7 >100 
Hexane 100(dead) 34.3 29.2 >100 
CHCl3 100(dead since day 1) 21.5 75 >100 
Aq. MeOH 0 - - >100 
F. sycomorus subsp. 
gnaphalocarpa 
CR-MeOH 100(dead) 36 50 100 
Hexane 100(dead since day 1) 19.7 100 31.7 
CHCl3 100(dead) 11.7 80 60.8 
Aq. MeOH 60.8 - - >100 
F. sycomorus subsp.  
sycomorus 
CR-MeOH 100(dead) 64.4 50 100 
Hexane 100(dead in 3 days) 35.8 0 >100 
CHCl3 100(dead since day 1) 12 77.1 58.8 
Aq. MeOH 16.5 - - >100 
F. wakefieldii 
CR-MeOH 95.7 64.4 70 71.2 
Hexane 86.2 78.3 25 >100 
CHCl3 100(dead since day 1) 21.5 50 100 
Aq. MeOH 62.7 - - >100 
 
*Larvae dead within the 3 days of the assay; (-) implies not active; (0) implies no mortality observed 
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Members of the genus Ficus have been reported to possess antihelminitic activities, 
especially by the milky latex (Lansky and Paavilainen, 2011; de Amorin, 1999) and there 
are some pharmacological studies that have been performed to confirm their use. For 
example the crude methanol extract of the bark of F. trijuja was the only species with 
activity amongst others (F. bengalensis, F. benjamina, F. racemosa, F. microcarpa, F. 
oblique, F. pyriformis) that were screened against schistosoma. The activity was reported 
with LC50 and LC90 values of 14.4 μg/ml and 39.5 μg/ml (Yousif et al., 2012). In another 
study by Abdel-Hameed et al. (2008), the CHCl3 fractions exhibited some activity against 
the worms. It was further shown that male worms are more susceptible to the extracts 
than female worms. However, in our screening, we did not record the results according to 
the sex of the worms, to further make a comparison. The milky latex of F. insipida and F. 
carica have also been found to exhibit mild activity against the adult worms, and 
exhibited very high toxicity in mice (de Amorin, 1999). 
Since Praziquantel (PZQ) has been the only available treatment for schistosomiasis for 
many years, there have been efforts to develop alternative therapies such as vaccines and 
novel drugs (Coultas and Zhang, 2012). Praziquantel however, has little or no effect on 
larvae and immature forms, but eliminates mature worms. It could therefore be assumed 
that the hexane and CHCl3 subextracts that exhibited high activity against the larvae and 
not against the adult worms have a different mode of action to that of praziquantel.  Also, 
the subextracts that demonstrated being lethal against both the larvae and the adult worms 
may have another mode of action. 
As suggested by Coultas and Zhang (2012), developmental stages of the schistosome life 
cycle, such as schistosomules and adult worms should be targeted. From the screening 
results, we have observed that the schistosomules are very susceptible, as already 
reported in earlier studies (Coultas and Zhang, 2012). It is thus the ideal target for drug 
development. There are some trioxane-containing drugs that are being tested against 
schistosomes and these have shown to be potent (Portela et al., 2012), and depending on 
what maybe obtaining in our extracts, they may offer a different class of active 
metabolites and hence broaden the choice of drugs to use against schistosoma.  
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3.4.5 Antiprotozoal activity 
There are no data about the antiprotozoal activity of the selected Ficus species collected 
in Zambia or abroad, apart from one report on F. ingens of Saudi Arabian origin (Al-
Musayeib et al., 2012). The CR-MeOH extracts and subextracts were screened for 
antiprotozoal activity against the amastigote stages of Leishmania donovani MHOM-ET-
67/L82 and Trypanosoma cruzi Tulahuen C4. Also for screening was the trypomastigotes 
stage of Trypanosoma brucei rhodesiense STIB 900 and the P. falciparum K1 blood 
stage (IEF) parasites. The cytotoxicity activity was determined against rat skeletal 
myoblast cell line-L6 cells, for which the selective index (SI) against P. falciparum 
parasites was calculated. The results of the cytotoxicity data of all the extracts and 
subextracts revealed that most of the extracts were not entirely safe towards mammalian 
cells as the selective indices (SI) were less than 10 for almost all the parasites. There are a 
few exceptions which have been highlighted. 
The results are categorized in terms of the most susceptible protozoan, the most active 
plant parts used and thirdly the type of extraction which was more active. P. falciparum 
was the most sensitive parasite towards all the extracts (Table 20). Of the 32 extracts and 
subextracts, there were nine aerial subextracts and 18 stem bark extracts and subextracts 
that exhibited IC50 values lower than 10 μg/ml. The most active subextract was the 
lipophilic hexane subextract of the leaves of F. ingens with IC50 of 5.76 μg/ml. The next 
sensitive parasites were T. brucei rhodesiense and L. donovani with hexane and CHCl3 
subextracts of F. sycomorus also showing IC50 values lower than 10 μg/ml (IC50 values of 
7.46 μg/ml and 6.54 μg/ml for hexane and CHCl3 respectively against L. donovani). 
Meanwhile, T. cruzi was the least sensitive protozoan. 
In terms of the extracts, those obtained from the stem barks were the most active. 
Eighteen crude methanol extracts had IC50 values below 10 μg/ml. The most active 
species was F. ovata with IC50 4.76 µg/ml followed by F. ingens (IC50 7.24 µg/ml), while 
F. sansibarica was the least active with IC50 value of 23.6 µg/ml (Table 19). 
The CHCl3 subextracts were the most active type of extract with three having IC50 values 
less than 2 µg/ml. The highest activity was observed in F. ovata stem bark (IC50 1.14 
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µg/ml), followed by the same plant part of F. sycomorus subsp. gnaphalocarpa (IC50 1.49 
µg/ml) and F. wakefieldii (IC50 1.92 µg/ml). The aq. MeOH subextracts showed moderate 
activity in comparison to the hexane and CHCl3 subextracts. 
As for cytotoxity, the extracts and subextracts showed some degree of toxicity, as all 
showed cytotoxic IC50 values higher than 10 µg/ml except for CHCl3 subextract of the 
root bark of F. wakefieldii which was very toxic with IC50 value of 7.57 µg/ml. The 
impact of the cytotoxicity was further evaluated in terms of the selectivity index (SI) 
which is the selective activity of the extracts against the parasite compared to its toxicity 
for the L6 cells. In this case the SI values were calculated against P. falciparum blood 
stage. The SI corresponds to the ratio between cytotoxic IC50 values and the PfK1 
parasitic IC50 values.  A value greater than 1 implies more selective against the L6 cells, 
while a value lower than 1 is considered to be more selective to the parasite. The 
selectivity indices for T. brucei rhodiense, T. cruzi and L. donovani were all below the 
value of 10, suggesting a level of toxicity against the L6 cells. This indicates the Ficus 
extracts would not be safe to use against these protozoans.  However, the leaf extracts did 
not show selectivity except for the hexane extracts of F. ingens and F. ovata which 
exhibited mild selectivity with SI index ratios of 10.5 and 10.6 respectively. The rest had 
SI index ratios lower than 10. The CHCl3 subextracts of the root barks of F. ingens and F. 
ovata showed a bit more selectivity with SI index ratios of 14.2 and 16.3 respectively. 
The CHCl3 subextract of F. wakefieldii was found to be the most selective against P. 
falciparum with the selecitivity index ratio of 22.8. Another six subextracts with SI ratio 
above 10 included the CHCl3 subextracts of F. ingens (14.6), F. lutea (18.5), F. ovata 
(13.9), F. sycomorus subsp. gnaphalocarpa (15.6) and F. sycomorus subsp. sycomorus 
(11.7). 
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Table 18: Antiprotozoal activity and cytotoxic activity on (IC50 in µg/ml) of the leaf 
extracts 
Plant species Type of extract T.b. rhod
α 
T. cruz
β
 L. dono
γ
 P.falc 
δ
 Cytot
ε
 SI 
F. ingens CR-MeOH 31.1 79.9 45.6 23.8 70.5 3.0 
Hexane 21.3 41.8 11.7 5.76 60.5 10.5 
CHCl3 27.3 62.5 37.4 14.1 67.5 4.8 
Aq. MeOH 27.5 66.4 86.2 29.6 76.9 2.6 
F. lutea CR-MeOH 35.5 73.3 96.7 21 67.9 3.2 
Hexane 24.3 52.6 18.9 8.29 54.4 6.6 
CHCl3 33.3 76.2 43.3 21 65.7 3.1 
Aq. MeOH 37.2 64.7 >100 17.9 51.9 2.9 
F. natalensis CR-MeOH 30.7 79.5 72.4 27.3 60.1 2.2 
Hexane 25.1 47.5 16.7 6.65 59.9 9.0 
CHCl3 30.5 54.5 21.2 8.93 59.2 6.6 
Aq. MeOH 37.8 73.7 >100 23.3 70.4 3.0 
F. ovata CR-MeOH 31.4 70.9 70.1 19.4 52.2 2.7 
Hexane 15.3 50.6 15.8 6.04 64.3 10.6 
CHCl3 22.2 67.2 10.5 18.1 69.8 3.8 
Aq. MeOH 38.7 72.1 >100 27 70.4 2.6 
F. sansibarica CR-MeOH 34.5 78.8 68.6 28.6 72.6 2.5 
Hexane 32.2 42.2 20.5 10.4 45.1 4.3 
CHCl3 30.1 58.6 55.3 15.2 73.1 4.8 
Aq. MeOH 34.8 79.7 >100 43.4 >100 2.3 
F. sycomorus 
gnaphalocarpa 
CR-MeOH 31.1 72.6 48.7 26.2 70.1 2.7 
Hexane 27.6 47.9 15.9 8.54 71.8 8.4 
CHCl3 27.1 64.2 19.1 9.41 73.2 7.8 
Aq. MeOH 36.9 66.8 >100 32.7 75.8 2.3 
F. sycomorus. 
sycomorus 
CR-MeOH 25.9 63.9 59.1 18.8 48.4 2.6 
Hexane 11.3 51.9 7.46 6.78 58.9 8.7 
CHCl3 9.63 21.3 6.54 5.88 57.8 9.8 
Aq. MeOH 27.6 57.1 >100 20 47.5 2.4 
F. wakefieldii CR-MeOH 28.3 70.4 56.3 22.1 49.7 2.2 
Hexane 14.5 58.7 10.3 11 70.9 6.4 
CHCl3 16.7 54.8 14.8 10.8 61.8 5.7 
Aq. MeOH 38.4 75.9 99.9 21.1 70.1 3.3 
Reference drugs 0.005
1 
0.464
2 
0.171
3 
0.073
4 
0.007
5 
 
 
Note: αTrypanosoma brucei rhodesiense;  βTrypanosoma cruzi; γLeishmania donovani; δplasmodium 
falciparum; εcytotoxic L-6 cells; 1Melarsopro; 2Benznidazole; 3Miltefosine; 4Chloroquine; 
5Podophyllotoxin 
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Table 19: : Antiprotozoal activity and cytotoxic activity (IC50 in µg/ml) of the stem bark 
extracts 
Plant species Type of extract T.b. rhod
α T. cruz
β
 L. dono
γ
 Pf K1δ Cyt L6ε SI 
F. ingens CR-MeOH 32.1 45.5 23.4 7.24 59.2 8.2 
Hexane 12.3 16.9 14.3 3.3 36.9 11.2 
CHCl3 15.9 18.3 7.95 2.27 33.1 14.6 
Aq. MeOH 37.1 60.3 >100 20.7 63.2 3.1 
F. lutea CR-MeOH 33.9 32.8 57.3 8.9 67.9 7.6 
Hexane 5.99 10.6 8.79 3.36 19.5 5.8 
CHCl3 11.4 17.8 10 2.5 46.3 18.5 
Aq. MeOH 40.4 61.7 >100 17.9 45.7 2.6 
F. natalensis CR-MeOH 20.6 37.8 28.2 7.52 48.4 6.4 
Hexane 39.1 11.3 44 19.9 75.5 3.8 
CHCl3 31.4 52.9 36.2 7.93 68.8 8.7 
Aq. MeOH 38.2 61.5 >100 18.8 45.9 2.4 
F. ovata CR-MeOH 14.9 18.5 30.1 5.89 44.8 7.6 
Hexane 4.14 6.33 6.12 2.85 19.8 6.9 
CHCl3 4.48 5.59 4.12 1.14 15.9 13.9 
Aq. MeOH 31.4 55.7 >100 17.3 43.4 2.5 
F. sansibarica CR-MeOH 11.9 85.3 83.8 24 43.1 1.8 
Hexane 18.6 26.9 37.9 19.7 45.1 2.3 
CHCl3 16.3 66.1 36 7.5 46.9 6.3 
Aq. MeOH 14.6 69.1 >100 21.9 37.2 1.7 
F. sycomorus 
gnaphalocarpa 
CR-MeOH 36.9 53.7 53.7 9.79 53.8 5.5 
Hexane 10.2 8.61 6.84 2.76 16.7 6.1 
CHCl3 8.48 11.1 6.57 1.49 23.3 15.6 
Aq. MeOH 39.5 55.5 >100 18.6 44.7 2.4 
F. sycomorus. 
sycomorus 
CR-MeOH 33 70.3 >100 23.2 46.4 2.0 
Hexane 24.7 35.3 15.7 18.8 55.9 3.0 
CHCl3 15.7 >100 >100 8.53 >100 11.7 
Aq. MeOH 16.6 63.2 >100 22.5 39.5 1.8 
F. wakefieldii CR-MeOH 37.2 65.3 69.2 12.7 69.5 5.5 
Hexane 12.9 46.8 14.2 8.89 19.9 1.5 
CHCl3 12.4 23.3 7.34 1.92 43.7 22.8 
Aq. MeOH 37.6 55.9 >100 16.5 44.2 2.7 
Reference drugs 
0.005
1 
0.464
2 
0.171
3 
0.073
4 
0.007
5 
 
 
1
Melarsopro, 
2
Benznidazole, 
3
Miltefosine, 
4
Chloroquine, 
5
Podophyllotoxin 
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Table 20: Antiprotozoal activity and cytotoxic activity (IC50 in µg/ml) of the root bark 
extracts 
Plant species Type of extract T.b. rhod
α 
T. cruz
β
 L. dono
γ
 Pf K1δ Cyt L6ε SI 
F. ingens CR-MeOH 10.6 53.8 32.3 8.35 46.5 5.5 
Hexane 5.35 20.6 11.9 6.15 33.2 5.4 
CHCl3 6.89 18.9 6.37 2.24 31.8 14.2 
Aq. MeOH 16.3 75.9 >100 22.5 70.4 3.1 
F. lutea CR-MeOH 17.6 53.9 43.3 15.1 71.3 4.7 
Hexane 16.5 52.2 48.4 16.5 53.6 3.2 
CHCl3 15.6 30.9 14.6 6.04 40.8 6.7 
Aq. MeOH 18.4 63.6 >100 33.7 41.9 1.2 
F. natalensis CR-MeOH 8.95 49.7 34.8 13.4 42.7 3.2 
Hexane 2.07 11.8 11.1 5.99 15.4 2.6 
CHCl3 2.04 13.5 8.61 2.62 14.2 5.4 
Aq. MeOH 18.1 62.9 >100 23.8 35.2 1.5 
F. ovata CR-MeOH 18.6 58.1 43.7 13.9 73.8 5.3 
Hexane 6.3 24.0 28.3 7.78 40.2 5.2 
CHCl3 13.9 36.7 9.97 2.66 43.3 16.3 
Aq. MeOH 16.5 78.7 >100 31.8 74.3 2.3 
F. sansibarica CR-MeOH 16.9 55.5 32.2 14.6 44.5 3.0 
Hexane 6.29 9.75 10 6.09 13.2 2.2 
CHCl3 17.7 34.1 10.8 2.8 17.1 6.1 
Aq. MeOH 17.9 75.4 >100 37.7 74.3 2.0 
F. sycomorus 
subsp 
gnaphalocarpa 
CR-MeOH 16.7 46.5 28.7 11.2 44 4.0 
Hexane 6.01 17.9 12.1 6.46 43.1 6.7 
CHCl3 3.14 13.3 5.85 2.92 17.4 6.0 
Aq. MeOH 18.2 70.1 86.7 23.7 37.1 1.6 
F. sycomorus. 
sycomorus 
CR-MeOH 16.2 43.6 20.6 6.42 24 3.7 
Hexane 13.4 40.5 22.7 7.94 47.2 6.0 
CHCl3 6.83 20.1 7.39 2.01 4.62 2.3 
Aq. MeOH 17.1 88.8 >100 46.8 72.1 1.5 
F. wakefieldii CR-MeOH 14.2 61.4 47.8 12.4 46.9 3.8 
Hexane 36.6 56.9 30.1 17.9 23.2 1.3 
CHCl3 9.49 47.4 10.4 2.32 7.57 3.3 
Aq. MeOH 15.1 70.7 >100 20.3 40.9 2.0 
Reference drugs 
0.005
1 
0.464
2 
0.171
3 
0.073
4 
0.007
5 
 
 
1
Melarsopro, 
2
Benznidazole, 
3
Miltefosine, 
4
Chloroquine, 
5
Podophyllotoxin 
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The results in the antiprotozoal assays reveal that P. falciparum was the most susceptible 
parasite towards all the extracts. The chloroform subextracts were the most active, while 
it is the stem barks which exhibited more activity than the other plant parts. The IC50 data 
of the extracts in the cell line L6 helps to determine whether an activity is specific or just 
general in toxic effect (“non specific activity”). When the selectivity index is calculated, 
we observed that the active extracts against T. cruzi showed nonspecific affects. 
The CR-MeOH extract of the three plant parts of F. ingens (leaves, stem bark and root 
bark) showed activity against P. falciparum with IC50 values of 23.8 (SI 3.0), 7.24 (SI 
8.2) and 8.35 (SI 5.5) μg/ml respectively, with low SI values. These findings are in 
agreement with literature data published recently by Al-Musayeib et al. (2012) who 
reported the antiprotozoal activity against P. falciparum of the methanol extract of F. 
ingens growing in Saudi Arabia to be IC50 8.4 ± 2.3 with SI 3.87. While the variation in 
the area of collection and ecological factors has an effect on the quality and quantity of 
chemical constituent of the plants, it seems not to have been the case with F. ingens. The 
probable active metabolites could be inherent and can be identified as markers for the 
species. The activity of CR-MeOH extracts of F. ingens for other protozoans ranged 
from, T. cruzi 31.2 ± 4.3, SI 1.04 to T. brucei 8.0 ± 2.2, SI 4.08 (Al-Musayeib et al., 
2012). The IC50 values of T. brucei rhodiense and T. cruzi also tally with those obtained 
by Al-Musayeib et al. (2012). T. cruzi has been generally reported less sensitive than T. 
brucei rhodiense because it has an intracellular test system (Jensen et al., 2012; Mokoka 
et al., 2011). This echoes already published data (Mokoka et al., 2011), in which the 
dicloromethane/methanol [1:1] extract of Agathosma apiculata was 140 times more 
active against P. falciparum than against T. cruz (with IC50 value of 17 μg/ml), 53 times 
more active than against L. donovani and 37 times active than against T. brucei 
rhodiense. 
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3.4.6 Enzymology- Enzyme purification and SDS-PAGE 
The recombinant enzymes FabI, FabG, and FabZ were purified by Nickel-NTA-Affinity-
chromatography method (Porath et al., 1975) after being disrupted by a French press. The 
purification was documented by 15% SDS-PAGE, which was performed to verify the 
successful purification of the protein. The disrupted protein samples were collected from 
the cell lysate (T) to confirm the numerous types of proteins contained in the sample. 
After centrifuging the cell lysate, the supernatant (S) which contained all soluble protein 
was documented. This is the portion in which the proteins of interest were also captured. 
The pellet (P) which had insoluble proteins and other cell debris was next, followed by 
the flow through (F) which was collected after passing through the nickel-NTA column. 
The protein in the portion does not have the His-tag. The column was washed (W) with 
50 mM imidazole to remove all protein in volumes of 1 ml , 3 times (E3, E4, E5) with  
500 mM imidazole.  The protein was then loaded onto a PD-10 column for desalting and 
collected 3 times (E1*, E2* E3*). All these collected samples were then ran on an SDS-
PAGE. 
The purified enzymes gave homogenous bands, and the molecular weights of the proteins 
were estimated by comparing with the low range SDS marker protein standard which was 
the first and last bands (m) on the gels. The contents of the marker (m) are indicated in 
kDa and were (top to bottom) BSA, ovalbumin, carbonic anhydrous, trypsin inhibitor and 
lysozyme. The size of rhe protein subunit of FabG was estimated to be about 32 kDa 
(Figure 40), while that of FabI was 45 kDa (Figure 41) which is typical of the molecular 
weight of FabI (average of 45.3 kDa). The protein band of FabZ was estimated to be 21 
kDA as shown in Figure 42.  
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Figure 40: SDS-PAGE for FabG purification. 
m: Low range SDS-Standard, T: cell lysate, P: insoluble protein fraction, S: soluble protein fraction, F: 
flow-through, W: combined washing fractions, E: elution fractions from Nickel-NTA column, E*: elution 
fractions from PD-10 column 
 
Figure 41: SDS-PAGE for FabI purification. 
m: Low range SDS-Standard, T: cell lysate, P: insoluble protein fraction, S: soluble protein fraction, F: 
flow-through, W: combined washing fractions, E: elution fractions from Nickel-NTA column, E*: elution 
fractions from PD-10 column 
 
Figure 42: SDS-PAGE for FabZ purification. 
m: Low range SDS-Standard, T: cell lysate, P: insoluble protein fraction, S: soluble protein fraction, F: 
flow-through, W: combined washing fractions, E: enzyme fractions from Nickel-NTA column, E*: enzyme 
fractions from PD-10 column after desalting
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3.4.7 Plasmodial FAS-II enzyme inhibition 
The malaria liver stage is asymptomatic, and yet it is the best stage for prophylaxis 
because it avoids the development of the symptomatic blood stage. This makes it a good 
target for intervention against malaria through liver stage PfFAS-II enzyme inhibition. 
The assay was thus performed spectrophometrically and a total of 96 extracts were 
assayed for the activity of three recombinant enzymes (FabG, FabI and FabZ) that are 
part of the enzyme cascade involved in the type II fatty acid synthesis elongation process. 
The plant extracts were assayed at two concentrations, firstly at 10 µg/ml as the initial 
concentration, then at 1 µg/ml. At higher concentrations the colour intensity of the plant 
extract most often interfered with the measurement and it thus led to a positive slope, in 
which case measurements were done at a lower concentration (in this case 1 µg/ml). 
The CR-MeOH extracts of the root barks at 1 µg/ml recorded the least activity with FabZ 
being the most susceptible (Table 21). The inhibition was up to 96.6% for F. sycomorus 
subsp. sycomorus. The leaf and stem bark extracts were inactive against all three 
enzymes, except for F. wakefieldii stem bark with FabZ inhibition of 79.6%. The only 
CR-MeOH to inhibit FabI was F. sansibarica leaf extract (62%). 
Enzyme activity was also measured for the liquid-liquid paritioned subextracts. The 
hexane subextracts showed inhibition less than 50% except for four notable inhibition 
results recorded for F. natalensis root extract (97.8%) and F. sycomorus subsp. 
sycomorus (97.3%) against FabI, while F. ingens (94.7%) and F. sansibarica (92.5%) 
inhibited FabG. The inhibition activity of the CHCl3 subextract was just about 50% on 
average as well, with the roots showing the least activity. 
Overall, the aq. MeOH subextracts were the most active, among them the leaves 
exhibited more significant activity against FabI. The aq. MeOH subextracts recorded the 
highest inhibition of up to 98.6% for F. ingens, so was that of  the stem bark of F. 
sycomorus subsp. sycomorus (over 90 % against all FAS-enzymes; FabG, FabI and 
FabZ). FabZ was more sensitive than FabG which had an inhibition of over 90% for leaf 
and root subextracts of F.ingens, F. sansibarica and F. sycomorus subsp. sycomorus. 
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Table 21: Plasmodial FAS-II enzyme (FabG, FabI and FabZ at 1µg/ml) inhibition in 
Percentage (%). 
Plant species 
Type of 
Extract 
(μg/ml) 
LEAF STEM BARK ROOT BARK 
FabG FabI 
Fab
Z 
FabG FabI FabZ FabG FabI FabZ 
F. ingens CR-MeOH - - - - - - - - 40.7 
Hexane 0 7.9 11.6 9 0 9.4 94.7 2 0 
CHCl3 39 64.9 65.2 44.3 6 41.6 83.5 0 0 
Aq. MeOH 0 98.6 91 66.1 0 89.3 47.5 52.5 80.3 
F. lutea CR-MeOH 0 0 0 - - - 0 - 90.6 
Hexane 5 29.3 33.8 31.5 0 0 88.6 7 33.8 
CHCl3 59 89 75 70.7 57.9 66.2 4.9 27.1 7.9 
Aq. MeOH 61.8 92.2 84.4 75.7 73.9 83.9 9.5 92.7 91.8 
F. natalensis CR-MeOH 0 0 0 - - 0 0 - - 
Hexane 0 35.2 14.2 33.4 16.1 18.5 25 97.8 0 
CHCl3 22.5 57.6 48.4 84 78.4 84.1 25.3 49.9 12.6 
Aq. MeOH 76.2 95.8 88.3 89.9 19.1 88.5 30.1 79.6 85.3 
F. ovata CR-MeOH 0 0 0 0 0 0 0 0 - 
Hexane 9.3 59 21.9 29.6 0 7.4 2.3 29.2 0 
CHCl3 0 77.6 66.9 30.8 0 27 65.3 0 0 
Aq. MeOH 46.4 97.6 88.4 84.9 70.4 92.4 2.3 49.9 28.5 
F. sansibarica CR-MeOH - 62 - - - - - - - 
Hexane 0 45.2 0 44.4 0 0 92.1 59.9 0 
CHCl3 1.3 34.9 0 71.1 0 62.8 1 22.4 0 
Aq. MeOH - 50 14.1 92.6 90.9 0 90 82.9 0 
F. sycomorus. 
gnaphalocarp
a 
CR-MeOH 0 - 0 0 - 0 0 - 96.6 
Hexane 0 41.4 11.9 33 8.5 22.2 64.9 0 0 
CHCl3 48 81 65.7 49.5 0 57.8 62.2 65.3 41.3 
Aq. MeOH 63 95.6 83.2 92.2 85.7 0 80.4 85.9 90.4 
F. sycomorus. 
sycomorus 
CR-MeOH - - - - - - 0 - 65.8 
Hexane 13.6 39.7 5.1 40.1 0 0 4.1 97.3 0 
CHCl3 0 44.4 23.2 76.8 62.9 70.2 0 0 0 
Aq. MeOH 3.7 98.8 85.3 91.2 90.3 96.2 39.9 95.8 43.2 
F. wakefieldii CR-MeOH - - - - - 79.6 - - 87.1 
Hexane 0 45.1 0 45.8 12.4 1.6 3.1 0 0 
CHCl3 0 52.7 28 57.3 0 48.5 39.9 0.6 29.6 
Aq. MeOH 52.9 86 73.1 77.8 66.7 93 47.6 97.5 72.9 
IC50  values of  
Standard drugs (µg/ml) 
0.71 0.0172 0.21 0.61 0.032 0.31  0.032 0.341 
 
1Epigallocatechin gallate (EGCG), 2Triclosan, - implies no activity, in most cases self absorbance. 0 – 
implies no activity at 1µg/ml. 
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The results show that the extracts were most active against the FabZ enzyme, while the 
least activity was observed against FabG. The most extracts being the aq. MeOH extracts. 
These extracts were mainly composed of very polar metabolites to which the FAS-II 
enzyme activity could be attributed to.  Since the Ficus species screened herein have 
clearly indicated constituting an array on flavonoids in the phytochemical profiling 
(Section 3.3), enzyme inhibition could therefore be attributed to the presence of these 
flavonoids. Compounds such as luteolin, catechins and gallocatechins have been isolated 
from the genus Ficus and are reported to exhibit significant enzyme inhibition (Tasdemir 
et al., 2006). Catechin-type metabolites have been identified in our extracts. In particular, 
it is reported that isoflavonoids show moderate activity against FabZ, while epicatechin 
gallates and gallocatechin gallates are potent inhibitors of all three enzymes (Tasdemir et 
al., 2006; Zhang and Rock, 2004). In addition highly hydroxylated and planar 
polyphenols have shown good enzyme inhibition with minimal selectivity. As Cushnie 
and Lamb (2005) suggests, flavonoids with homogenous structures inhibit a variety of 
biochemical enzymes while Tasdemir et al. (2006) argues that flavonoids (such as 
catechins and epicatechins) that carry a free hydroxyl group at C-3, neither have enzyme 
nor antiplasmodial activity. 
The mechanisms by which the enzymes are inhibited by polyphenols are not the same for 
all the enzymes. Enzyme activity is due to the interaction of enzymes with the different 
parts of the substrates and/or the inhibitors or enhancers (Cushnie and Lamb, 2005). 
Inhibition against FabG is noncompetitive with regard to the substrate and cofactor 
(Tasdemir et al., 2006). For FabI, the mechanism depends on whether it is extracted from 
E. coli or P. falciparum because there are differences in the NADH-protein interactions in 
the enzymes of the two organisms. Bacterial FabI is competitively inhibited with respect 
to NADH (Zhang and Rock, 2004), while PfFabI is noncompetitively inhibited. Inhibitors 
against FabZ are competitive, in that they compete with the substrate for the same 
binding site. Other researchers have used FabZ models to show that larger molecule 
inhibitors such as flavonoids bind differently to FabZ in comparison to smaller ones 
(Jensen et al., 2012). In this case, the overall activity by our extracts against the enzymes 
culminates from factors including the differences of the FAS-II enzyme inhibition 
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mechanisms and the chemical constituents of the extracts. F. ovata has emerged as the 
most active in the inhibition of the three FAS-II elongation enzymes. 
The FAS-II activity did not correlate well with the antiplasmodial activity. For instance, 
the CHCl3
 
subextracts exhibited the highest antiplasmodial activity with some having 
IC50 lower than 2 μg/ml. The stem bark of F. ovata exhibited an IC50 of 1.14 μg/ml 
against chloroquine resistant strains of P. falciparum K1 and then the percentage of 
inhibition against FabG, FabI and FabZ was 30% and below. However, the aq. MeOH 
subextract of this particular species showed significant FAS-II enzyme inhibition of 70% 
and above. The lack of correlation between enzymatic and antiparasitic in vitro activities 
was already observed in several studies. For instance, in a study by Tasdemir et al. 
(2006), a number of polyphenols with in vitro activity against chloroquine-sensitive and 
chloroquine-resistant Plasmodium parasite strains NF54 and K1 respectively, did not 
inhibit any of the FAS-II target enzymes. Zhang and Rock (2004) as well reported how 
antibacterial activity did not correlate with the inhibition of FAS-II enzymes in E. coli 
fatty acid biosynthesis. This suggests that the extracts may have other targets in the 
Plasmodium other than the FAS-II enzymes. Also the FAS-II pathway in the enzyme 
assay is an isolated entity which is ideal in its operation, while in the antiplasmodial 
assay, there ae many metabolisms or pathways which are taking place in the parasite that 
have enhance or inhibit the viability of the parasites. 
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3.5 PHYTOCHEMICAL INVESTIGATION OF FICUS SANSIBARICA 
As discussed in section 3.2; TLC, NMR and HPLC analyses have shown that F. 
sanisbarica has a different chemical profile from the other seven species, even though its 
biological activities were moderate. Despite this activity profile, it was selected for 
detailed phytochemical investigation coupled with FAS-II enzyme inhibition testing 
because of its different phytochemical profile.  
3.5.1 Large scale extraction and liquid-liquid partitioning 
The crude methanol extraction and liquid-liquid partitioning of the dried and ground 
aerial parts of Ficus sansibarica (321g) was performed as described in Chapter 2.2.2 to 
yield crude MeOH extract (75g), hexane subextract (3.4g), CHCl3 subextract (10g) and 
aq. MeOH subextract (40g) (Figure 43). 
 
 
Figure 43: Extraction scheme for F. sansibarica for phytochemical investigation. 
Ground aerial parts   
(321g)  
 
hexane subextract 
(3g) 
 
 
100% MeOH 
aq. MeOH 
subextract (40g) 
 
 
chloroform 
subextract (10g) 
 
 
Partition 
against hexane 
Partition against CHCl3 
cold extraction with 
100% MeOH 
crude MeOH 
extract (75g) 
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3.5.2 FAS-II inhibition assay 
The F. sansibarica extracts and subextracts were tested for inhibition activity against 
FAS –II enzymes and the results are presented in Table 22. The aq-MeOH subextract was 
the most active with IC50 values close to the standards at 0.13 μg/ml for FabG, 1μg/ml for 
FabI and 0.25 μg/ml for FabZ.  The hexane and CHCl3 subextracts both showed 
inhibition over IC50 of 50 μg/ml for FabG and FabI, while IC50 of 2 μg/ml for FabZ. 
Meanwhile, FabZ was found to be the most susceptible with IC50 values of 0.25 -2 μg/ml 
for the hexane and aq. MeOH subextracts respectively. 
 
Table 22: FAS-II inhibition assay (IC50 in μg/ml) of the crude extract and subextracts of 
F. sansibarica 
Extract FabG FabI FabZ 
Crude MeOH - > 50 - 
Hexane > 50 > 50 2.0 
Chloroform > 50 > 50 2.0 
Aq. methanol 0.13 1.0 0.25 
Standards 0.21
 
0.01
2 0.31
 
 
EGCG1 and Triclosan2 
3.5.3 Phytochemical profiling of F. sansibarica sub-extracts obtained by large scale 
extration 
The extracts and subextracts were then analyzed by TLC (Figure 44) and 
1
H NMR 
(Figure 45). The mobile solvent systems used for the TLC analysis was 
hexane/ethylacetate (8:2) for n-hexane subextract and chloroform/ethylacetate (6:4) for 
chloroform subextract. Both analyses showed the same chemical profile as obtained in 
the screening (Section 3.3.1 above), revealing a strong presence of aromatic compounds. 
From the 
1
H NMR profiles of the CR-MeOH, CHCl3 and aq. MeOH extracts, there 
appear to be similar metabolites in high concentration. Thus, further evaluation of the 
CHCl3 and aq-MeOH subextracts was performed to isolate the most predominant 
metabolites. The TLC analysis was performed on silica gel 60 F254 plates and sprayed 
with 4% vanilin /sulphuric acid for visualization, while the NMR analysis was performed 
as has been outlined in Section 2.4.2.1. 
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Figure 44: TLC analysis of the crude and sub-extracts of F. sansibarica leaves 
 
 
Figure 45: 
1
HNMR spectra (500MHz) of F. sansibarica leaf crude and sub-extractions. 
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3.5.4 Investigation of the chloroform subextract 
The CHCl3 subextract (about 10 g) was fractionated by open column chromatography 
(OCC) with sephadex L-20. One hundred and fifty grams sephadex filling a 6 cm 
diameter column was used for every 1g of the CHCl3 subextract to the separated. An 
isocratic mobile flow of 100% MeOH was applied resulting in fourteen fractions as the 
TLC plate in Figure 46 shows after being pooled following TLC (normal silica gel) and 
1
H NMR analyses. The TLC showed fraction 10 to be well separated with fairly distinct 
components and fraction 9 which was very different from the other fractions in its 
response to the mobile phase and solubility in methanol. Fraction 4 had a distinct dark 
blue spot. 
Further attempt to separate and isolate components in fraction 4 was launched with a two 
step silica VLC run. The first run was performed with the initial mobile phase of 100% 
methanol and then the second run was with a step-gradient mobile phase from CHCl3 to 
methanol (in 10% increments). Unfortunately, the isolation process did not yield any pure 
metabolites as further isolations were not possible due to diminished sample size. The 
1
H 
NMR however, revealed that compounds in this fraction were rich in nonpolar principles 
as the chemical shifts were concentrated in the regions δH 0 - δH2 and δH3 -   δH4. 
 
Figure 46: TLC (sprayed with VS) for the sephadex fractions of F. sansibarica  leaves. 
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All the fractions showed some enzyme inhibition activity, with FabZ being the most 
inhibited (Table 23). The first six fractions showed higher rate of inhibition against FabZ 
such that IC50 values were calculated in the ranges 0.5 - 4 μg/ml. The rest exhibited 
moderate inhibition. In particular, fraction 4 did not show considerable activity against 
the FabG and FabI, while it exhibited inhibition of FabZ with IC50 of 4 μg/ml.  Fractions 
9 and 10 exhibited IC50 values of 3.5 μg/ml and 8 μg/ml respectively, against FabI. 
Fraction 11 also showed significant inhibition of IC50 of 2.3 μg/ml against FabI. 
Table 23: FAS-II inhibition assay (IC 50 in μg/ml) of the sephadex fractions of chloroform 
subextracts of F. sansibarica 
Fractions 
FabG FabI FabI FabI FabZ FabZ 
Inhibition %  
at 10 µg/ml 
Inhibition %  
at 10 µg/ml 
Inhibition %  
at 1 µg/ml 
IC 50 
Inhibition %  
at 10 µg/ml 
IC 50 
1 74.1 69.1 35.6 nd 
 
0.5 
2 66.9 na Na nd 
 
1 
3 90.3 88.3 49.8 nd 
 
1 
4 42.1 na 61.6 nd 
 
4 
6 98 
88.4 0 4.6 
 
0.9 
7 90.3 99.4 86.4 nd 96.5 1 
8 66.8 92.7 57.3 nd 92 0.4 
9 35.9 69.6 25.6 3.5 58 na 
10 25.7 51.7 27.2 8 34.7 7 
11 65.5 85.35 35.6 2.3 88.7 0.6 
12 95.4 99 78 nd 98.4 0.01 
13 
92.7 93.7 81.4 nd 0  
IC50 of  
standards 
0.271  0.0152 0.191  
 
1 EGCG; 2 Triclosan; na- not active; + slope; nd – not determined 
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1
27mg
2 3 4
Sephadex (150g)
100% MeOH
Ø6cm, 72.5 cm H
Chloroform subextract
10.103g
1 6 7 8 9 10 11 12 132 4 53
Sephadex (150g)
100% MeOH
Ø6cm, 72.5 cm L
SPE Silica
Hexane →Ethylacetate(20%)
10mg/60ml
1 6+7 7 8 9 102 4 53
99.9mg
61 2+3 4 5
VLC Silica (50g) CHCl
2→MeOH(10%)
1 6 7 82 4 53
VLC Silica (50g)
CHCl 2→Ethyacetate (10%)
51 2 3 4
CC Silica (50g)
Toluene→MeOH (5%)
RP-SPE Strata C18-E
H2O →MeOH(10-20%)
10mg/60ml
71+2 3 4 5 6
 
Figure 47: Fractionation scheme of the chloroform subextract. 
 
3.5.4.1 Further separation of Fraction 10 
Fraction 10 (460 mg) was also subjected to further separation by silica SPE (for every 
150 g plant extract, a 10g/60 ml SPE SI-1 silica column was used) with an increase in 
polarity of the mobile phase by step-gradient from hexane to ethyl acetate (20% 
increment) to yield 10 fractions, with a pure component of Fraction 3 (99 mg). Figure 48 
below shows the TLC analysis that led to arrive at F10-3. This compound yielded as F10-
3 appeared as whitish solid. Further separation of the combined fractions 6 and 7, 
however it did not yield any purer chemical components. The isolation procedure of 
fraction 10 is outlined in Figure 47 above. 
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Figure 48: The TLC plate of F10-3, sprayed with 4% vanillin/sulphuric acid spray 
(Mobile phase was ethylacetate: MeOH: H2O, 6:3:1) 
 
Since the crude CHCl3 subextract did exhibit some FAS-II enzyme inhibition, the 
subfractions of fraction 10 were tested for FabG, FabI and FabZ inhibition. The first three 
fractions 1, 2 and 3 showed inhibition with IC50 values ranging between 0.35 μg/ml to 
11.6 μg/ml (Table 24). FabI and FabZ were the most susceptible, while FabG was not. 
F10-3 exhibited appreciable activity against FabI and FabZ with IC50 values of 4.2 μg/ml 
and 3.5 μg/ml respectively, while it did not exhibit activity against FabG. 
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Table 24: FAS-II inhibition assay (IC50 in μg/ml) of the CHCl3 subextract fraction 10 of 
F. sansibarica 
Fractions FAB G FAB I FAB Z 
Fr. 1 n.a* 11.6 0.35 
Fr. 2 15 5.4 0.4 
Fr. 3 n.a 4.2 3.5 
Fr.4 24 3 4.0 
Fr.5 6.4 n.a 6.0 
Fr. 6 10.6 n.a n.d 
Fr. 7 
 
n.a n.a 4.3 
Fr. 8 2.8 n.a 8.7 
Fr. 10 10.8 n.a 9 
EGCG 
0.4 - 0.04 
Triclosan - 0.02 - 
    
n.a = not active; n.d = not determined. 
 
There seems to be particular attention attached to the compounds in high concentration as 
the active agents against microorganisms. This, however, may not be the case because 
their action could be a result of the combined effect of more than one compound which, 
with another contributes to the increased or maybe reduced pharmacological activity. 
Thus, the minute compounds which maybe active or inactive may tend to influence 
bioavailabilty of the active metabolite to the pharmacokinetic reactions that will be 
undergone (Svoboda and Hampson, 1999). Thus the chemical constituents may have 
synergistic effects, which agree with Chalchat et al. (1997) who pointed out that 
correlating biological activity to the extracts’ chemical composition should be tentative, 
because the involvement of less abundant compounds should be considered. It is worth 
noting that biological activities could be due to single compounds in a very complicated 
concert of synergistic or antagonistic activities (Svoboda and Hampson, 1999). With 
regard to the above statement, the isolated compound F10-3 as epicatechin exhibited the 
inhibitory potential against FabZ and FabI enzymes with IC50 of 3.5 μg/ml and 4.2 μg/ml 
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respectively (shown as Fr. 3 in Figure 48). The isolated epicatechin was however, not 
100%pure, hence the activity can be attributed to the principle compound of the isolate, 
the epicatechin or to the minute ‘impurities’ that were providing synergistic or added 
effect on the main compound. In literature, it has been reported by Tasdemir et al. ( 2006) 
that pure epicatechin (Buchs, Switzerland) standard does not exhibit any inhibition 
against any of the three Fas-II enzymes.  Tasdemir et al. (2006) alludes to the fact that 
methylation of the hydroxyl groups on the flavones or flavonol moiety removes almost all 
activity against all FAS-II enzymes. Thus catechins and epicatechins, carrying a free 
hydroxyl group at C-3, neither inhibit the enzymes nor have antiplasmodial activity. 
Meanwhile, epicatechin gallates and gallocatechin gallates are potent inhibitors of all 
three enzymes (Tasdemir et al., 2006). Thus, it is essential to co-test the isolated pure 
compound with the relevant standard to ascertain the source of activity that can be 
claimed. 
Most often than not it has been proven in many studies that isolated compounds that are 
not pure are active while the purified forms lose activity (Lansky and Paavilainen 2011; 
Weathers et al., 2011). This explains why many traditional remedies are potent in many 
instances even though cytotoxicity is not taken into consideration; it is the ‘chemical 
impurities’ that may help reduce any toxic effects (Lansky and Paavilainen, 2011). Hence 
a huge challenge comes in when the active metabolites cannot be identified during the 
process of bioactivity-guided isolations because they may lose efficacy along the process 
or the sample be lost in the process. The natural products that are known to inhibit FAS- 
II enzymes are cerulenin and thiolactomycin which target FabB, FabF and FabH 
(Kırmızıbekmez et al., 2004). 
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3.5.4.1.1 Structure elucidation of compound F10-3 
The compound F10-3 (Figure 49) was isolated from the chloroform extract of the leaves 
of F. sansibarica. It was obtained as a whitish amorphous powder with the ESI-MS 
spectrum showing molecular ion peak at m/z 291 (M+H
+
). Other analyses included 
1
H 
NMR, 
13
C NMR and TLC to obtain an Rf value of 0.8 in ethylacetate: MeOH: H2O, 6:3:1 
mobile phase. All these analyses together with the molecular weight indicated the 
compound had a molecular formula C15H1406, suggesting it is a flavonoid.  Figure 49 
shows the proposed structure for F10-3 to be an epicatechin with the elucidation 
information outlined.  
 
 
Figure 49: Proposed structure of F10-3 as Epicatechin 
 
The 
1
H NMR spectrum (Figure 50) evidenced two aromatic rings with a pair of meta-
coupled aromatic signals on ring A(δH 5.95, H-6) and (δH 5.92, H-8) and a set of protons 
in the ABD system on ring B (δH 6.98, d, J =1.6 Hz, H-2’; δH 6.81, dd, J = 2, 8.4 Hz, H-
5’; δH 6.77 d, J=8, H-6’). On the C ring, the characteristic signals included two non-
equivalent double doublets of methylene (δH 2.86 dd, 2.73 dd) and two oxymethines (δH 
4.8, H - 2; δH 4.18, H - 3). 
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Figure 50: 
1
H NMR spectrum of F10-3 analysed in methanol – d4 
 
The 
13
C NMR spectrum (Figure 51) revealed the presence of 12 carbon signals in the 
aromatic region which falls between 110 and 160 ppm. Two oxymethines at δC 79.97 and 
67.51 and one methylene at δC 29.34 were also revealed as in the proton signals, which 
were confirmed in the DEPT-35 analysis (Figure 52). The DEPT-135 spectrum showed 
seven positive signals, one negative signal to confirm the methylene mentioned earlier, 
and six quaternary carbons (δC 158.08, 157.78, 157.48, 145.88, 145.03 and 132.38) all in 
the aromatic region. The 
1
H NMR, 
1
C NMR and DEPT-35 data suggested that the 
compound was a flavonoid of the type flavan-3-ol.  
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Figure 51: 
13
C NMR of F10-3 methanol – d4 
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Figure 52: Dept-135 spectrum for F10-3 
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Figure 53: Cosy spectrum of F 10-3 
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Figure 54: HMQC spectrum of F 10-3 
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Figure 55: HMBC spectrum of F 10-3 
 
Table 25: 
1
H (400 MHz) and 
13
CNMR (100 MHz) spectral data of F10-3 recorded in 
methanol – d4 
Position 
1
H (ppm) J/Hz 
13
C 
1 - -  
2 4.75 s - 79.95 
3 4.1 m - 67.5 
4a 2.76 dd 2.8 29.33 
4b 2.89 dd 4.4 29.33 
5 - - 157.44 
6 5.95 d 2.4(m) 96.55 
7 - - 157.75 
8 5.92 d 2.4(m) 96.2 
9 - - 157.75 
10 - - 100.21 
1’ - - 132.5 
2’ 6.98 d 1.6(m) 115.98 
3’ - - 145.87 
4’ - - 146.08 
5’ 6.81 dd 2, 8.4 (m,o) 115.35 
6’ 6.77 d 8 (o) 119.45 
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3.5.5 Investigation of the aq. MeOH subextract 
The chromatographic fractionation of 10 g aqueous methanol subextract of the leaves of 
F. sansibarica was performed by a series of techniques, which included reversed phase 
VLC and SPE by step-gradient mobile phase of 100% water to 100% methanol in 10% 
increments. Three fractions A, B and C were realized. 
1
H NMR analyses for the fractions 
revealed that fraction A (6 g) was characterized by very polar white crystalline principles, 
which were dominated with  peaks in the δH 3 - δH 5 region likely to arise from anomeric 
protons of sugars. Fraction B revealed a strong presence of aromatic signals with peaks 
arising from chemical shifts δH 6.98, δH 6.814, δH 6.77, δH 5.95 and δH 5.92.  These signals 
are equivalent to the catechin-type of flavonols. Fraction C on the other hand was also 
dominated with aromatic signals slightly further downfield (δH 8 - δH 6) compared to 
fraction B, and dense anomeric proton signals arising between δH 5 - δH 3. The 
fractionation scheme of the aqueous methanol subextract is illustrated in Figure 56 below. 
 
Figure 56: Fractionation scheme of the aq.methanol subextract. 
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Upon testing these fractions for FAS-II enzymes inhibition, fractions B and C showed 
rather significant activity, while fraction A was not active at all (Table 26). Fraction B 
was more active than C against all the three FAS-II enzymes tested. Fractions B and C 
were further subjected to chromatographical isolations. 
Fraction B (1.67g) was loaded onto a sephadex L-20 column with the mobile phase 
consisting of water and methanol in the ratio of 30% to70%. Five fractions were obtained 
which were very closely related, however due to small quatities realised, we did not 
proceed with the separation to get pure compounds 
Fraction C was also subjected to further isolation by preparatory HPLC with an isocratic 
gradient mobile phase consisting of methanol and acetonitrile. The conditions were as 
outlined in Chapter 2.4.1.5. The fractionation yielded three fractions; C1, C2, and C3. 
These fractions, upon being tested against FAS-II enzymes exhibited activity (Table 26) 
with IC50 values which ranged from 0.75 μg/ml to 6.0 μg/ml.  Fraction C2 was the most 
active with IC50 values of 4 μg/ml, 4.6 μg/ml and 0.75 μg/ml against FabG, FabI and 
FabZ respectively. According to the HPLC-UV spectra of this fraction, it showed 
richness in compounds related to apigenin glucoside derivative and is the fraction from 
which another pure compound proposed to be either apigenin-8-C-glucoside or its isomer 
was isolated. As it was mentioned in Section 3.4.7, FabZ was the most sensitive to the 
fraction (IC50 of 0.75 μg/ml), and apigenin glucosides being large molecules fail to enter 
the narrow active site tunnel of the enzyme tending to block the entrance of the tunnel. 
This eventually inhibits the substrate from accessing the active site (Zhang et al., 2008).  
A series of flavonoids have been published to be inhibitors of Plasmodium falciparum 
(PfFabZ) (Tasdemir et al. 2006) and Helicobacter pylori (HpFabZ) (Zhang et al., 2008) 
FabZ enzyme, in which apigenin show activity against FabI and FabZ respectively. It is 
however, reported that the activity against FAS-II enzymes increased as the aglycone 
became more hydroxylated (Tasdemir 2006). Suffice to say that correlations of little 
alterations in the structures of flavonoids e.g., positional changes of OH groups or 
glycosidation, bring about dramatic changes in their biological effects. Since our isloltaed 
compound (C2-4) has a similar parent chemical structure as that of apigenin, it would be 
assumed that its in vitro activity increases due to the increase of hydroxyls in the 
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structure. In this case, we can argue that comparing the activities of a glycoside to its 
respective aglycone is not feasible as the glycosidic residue can be crucial for their 
activity or can only improve pharmacokinetic parameters.  
Table 26: IC50 values in μg/ml of the RP-VLC aq. MeOH subextracts 
Fraction 
 
FAB G 
 
FAB I 
 
FAB Z 
 
A Na na na 
B 3 2.5 4.4 
C 4.8 2.5 8 
B1 15 3.8 9 
B2 5 2.8 5.8 
B3 12 6.4 na 
B4 4 2.9 3.7 
C1 5.5 2.8 6 
C2 4 4.6 0.75 
C3 5 4.8 3.2 
EGCG 0.23  0.25 
Triclosan  0.027  
na- not active 
 
Fraction C2 was then further separated into five subfractions by preparatory HPLC, with 
conditions as follows; The gradient elution was set at 0-5 % A (0-10 mins), 5-40% A (10-
15 mins), 40-100% A (15-25 mins),  100-5% A(25-26 mins), 5% (26-30 min), with 
solvent A being methanol and solvent B was acetonitrile. The other conditions remained 
the same as outlined in Chapter 2. However, the extract was set at a concentration of 40 
μg/ml. From this analysis five fractions were obtained, labelled C2-1, C2-2, C2-3, C2-4 
and C2-5. And a pure compound C2-4 was realized, which was obtained as a yellow 
amorphous solid. Due to the very small amount obtained and time constraints, we were 
unable to test it for activity against FAS-II enzymes, but was analysed by 
1
H NMR, 
13
C 
NMR, DEPT COSY, HMQC and HMBC. The NMR analyses of Fraction C2-5 was 
found to be similar to C2-4, however when analysed by HPLC, two distinct peaks 
appeared at RT 17.5 and RT 19.3. This baseline chromatographic separation could imply 
a compound and its isomer isolated together. This fraction was also subjected to 
spectroscopic analysis for structure elucidation, and the structure proposed was the same 
as that of compound C2-4, only that it had more baseline peaks. Both samples were 
analysed for accurate mass measurement on the [M+H] + ions and the results obtained 
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were 433.1132 for C2-4 and 433.1149 for C2-5, however, with the same theoretical mass 
of 433.1135. C2-4 was proposed to be either apigenin-8-C-glucoside (vitexin) or 
apigenin-6-C-glucoside (isovitexin). However, from the analyses, we can tentatively say 
that fraction C2-5 could be a mixture of apigenin-8-C-glucoside with its isomer 
(apigenin-6-glucoside) or that it had a lot other impurites. This was evidenced by the two 
peaks that appeared in the HPLC analysis 
3.5.5.1.1 Structure elucidation of compound C2-4 
Compound C2-4 was isolated from the aqueous methanol subextract of the leaves of F. 
sansibarica. It was obtained as a yellow amorphous solid. The TLC analysis of C2-4 on 
silica gel 60 F254 plate showed a yellow spot with Rf = 0.43 (with mobile phase of CHCl3: 
MeOH, 6:4) after spraying with 4% vanillin/H2SO4 reagent and heating for about 5 
minutes (Figure 57).  
The accurate mass measurement on the [M+H] + ion was 433.1132, with Cortisone being 
used as an internal standard, [M+H] + =361.2015 in this experiment.  Moreover, a direct 
infusion of the sample in positive ESI-MS mode gave a prominent molecular ion of m/z 
433 [M+H]
+
, thus again suggesting a Mr = 432. Interestingly, The fragmentation pattern 
of the isolated compound included a peak at m/z 313 [M+H-120]
+
 indicating a glycoside 
attached by a C-linkage.  
In a HPLC analysis under the conditions described previously in Section 2.3.1.5, it was 
eluted at RT 43.39 min and it showed a similar UV spectra and diagnostic shifts as the 
standard apigenin-7-O-glucoside which eluted at RT 53.4 min. Generally, flavone C-
glycosides elute faster than their corresponding iso-glycosylflavones and O-glycosides 
(Andersen and Markham, 2006). There were two maxima of the UV spectra at λ=268.6 
nm and λ=336.5 nm, while those of apigenin-7-O-glucoside appeared at λ=262 nm and 
λ=333 nm. At this point we hypothesised a flavone C-glycoside. Vitexin and isovitexin 
have been previously identified in many Ficus species although not yet in F. sansibarica. 
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Figure 57: TLC analysis plate of C2-4 
 
For further elucidation and confirmation of the structure, 
1
H NMR, 
13
C NMR and 2D 
NMR experiments were performed initially in Methanol-d4 (MeOD), then in DMSO-d6 
The 
1
H NMR spectrum (Figure 58) revealed two signals with ‘ortho coupling’ at δ 6.93 
(2H, d, J=8.5 Hz) and 7.85 (2H, d, J=9Hz), which could be preliminary assigned to the 
H-2′, H-3′, H-5′ and H-6′ of the B ring of an hypothetical apigenin C-glycoside.  
This spectrum also evidenced a possible anomeric hydrogen signal at δH = 4.9, correlated 
to chemical shifts δc 72.7 (HMQC), δc 80.4,  δc 109.5, δc 162.2 and δc 165.7 (HMBC) 
which were assigned to ring A, thus consistent with the presence of a sugar moiety. We 
may assume this signal to be a doublet, although the signal is obstructed by a water 
residue peak which arises at chemical shift δc 4.8)  
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NAME     agb1-Mar18-2013-4
EXPNO                10
PROCNO                1
F2 - Acquisition Parameters
Date_          20130319
Time              20.55
INSTRUM           av500
PROBHD   5 mm CPQNP 1H/
PULPROG            zg30
TD                65536
SOLVENT            MeOD
NS                  512
DS                    2
SWH           10330.578 Hz
FIDRES         0.157632 Hz
AQ            3.1720407 sec
RG                 35.9
DW               48.400 usec
DE                 6.00 usec
TE                300.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.00 usec
PL1                2.00 dB
PL1W         6.41881752 W
SFO1        500.1330885 MHz
F2 - Processing parameters
SI                32768
SF          500.1300104 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00
Sample Ref AGB-Fsans
C2-4, MeOD, 512 scans, 500MHz, 18/3/13
 
Figure 58: 
1
H NMR spectrum of C2-4 analysed in methanol – d4 
 
The structural assignment of C2-4 was further substantiated by its 
13
C NMR spectrum 
(Figure 59) which revealed the presence of 21 carbon signals with an indication of 15 
carbons arising from the flavonol skeleton with plausible chemical structure of 
C21H20O10. In addition, the DEPT-135 spectrum in Figure 60 revealed eight quaternary 
carbons (δC 184.1, 166.3, 163.1, 162.2, 158.9, 123.3, 109.5 and 104.0) and one methylene 
(δC 63.21). The HMQC (Figure 62) and HMBC (Figure 63) spectra were analysed to 
identify the C-H and C-C-H connectivity respectively. The B-ring carbons resonate at 
123.3 (C1’), 129.6 (C2’ and C6’), 117.3 (C3’ and C5’) and 163.0 (C4’).  
The findings of a δH 6.6 linked directly to δC 104.0 and correlated with δC 184.1 (C=O) 
and δC 166.3 conforms with C3, C4 and C2 of a C-ring structure, respectively. All these 
data are consistent with previous data of apigenin derivatives analysed in MeOD 
(Svehliková et al., 2004) (Table 26).  
Results 
180 
 
200 180 160 140 120 100 80 60 40 20 0 ppm
2
4
.
5
0
3
0
.
7
5
3
1
.
6
0
3
7
.
2
6
4
3
.
4
9
6
3
.
0
4
7
1
.
9
3
7
2
.
7
2
7
5
.
4
1
8
0
.
3
5
8
2
.
7
2
9
5
.
5
5
1
0
4
.
0
4
1
0
5
.
0
9
1
0
9
.
5
0
1
1
7
.
2
7
1
2
3
.
3
2
1
2
9
.
5
7
1
5
8
.
9
1
1
6
2
.
1
8
1
6
3
.
0
2
1
6
5
.
6
7
1
6
6
.
2
8
1
8
4
.
1
4
Current Data Parameters
NAME     agb1-Mar18-2013-4
EXPNO                11
PROCNO                1
F2 - Acquisition Parameters
Date_          20130319
Time              22.43
INSTRUM           av500
PROBHD   5 mm CPQNP 1H/
PULPROG          zgpg30
TD                65374
SOLVENT            MeOD
NS                 2000
DS                    4
SWH           30030.029 Hz
FIDRES         0.459357 Hz
AQ            1.0885438 sec
RG              11585.2
DW               16.650 usec
DE                50.00 usec
TE                300.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                11.75 usec
PL1                5.00 dB
PL1W        27.88092041 W
SFO1        125.7703643 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             80.00 usec
PL2                2.00 dB
PL12              17.78 dB
PL13              20.50 dB
PL2W         6.41881752 W
PL12W        0.16961136 W
PL13W        0.09066821 W
SFO2        500.1320005 MHz
F2 - Processing parameters
SI                32768
SF          125.7576009 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
Sample Ref AGB-Fsans
C2-4, MeOD, 2000 scans, 500MHz, 18/3/13
 
Figure 59: 
13
CNMR spectrum of C2-4 analysed in methanol – d4 
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Figure 60: Dept-35 spectrum of C2-4 
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Figure 61: Cosy spectrum of C 2-4 
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Figure 62: HMQC spectrum of C 2-4 
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SI                 1024
MC2                  QF
SF          125.7577890 MHz
WDW                SINE
SSB                   0
LB                 0.00 Hz
GB                    0
Sample Ref AGB-Fsans
C2-4, MeOD, 64 scans, 500MHz, 18/3/13
 
Figure 63: HMBC spectrum of C 2-4 
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Table 27: Chemical shifts (ppm) reported in literature for a series of five different 
apigenin-7-O-glycosides in MeOD compared with those of C2-4.  
 
Apigenin-7-O-glycosides 
(Svehliková et al., 2004) 
 Average
a
 C2-4
a
 
C-2 164.5 166.9 166.9 166.8 166.8  166.38 166.3 
C-3 103.3 103.7 104.1 103.4 104.1  103.72 104.0 
C-4 182.2 184.2 184.2 182.2 184.2  183.4 184.1 
C-5 161.5 162.9 163.3 162.7 163.0  162.68 158.9 
C-6 99.8 101.0 100.6 99.6 101.1  100.42 95.6 
C-7 162.9 164.6 164.6 164.5 164.4  164.2 165.7 
C-8 95.0 95.6 96.3 95.0 96.0  95.58 109.5 
C-9 157.2 159.0 158.8 157.1 158.8  158.18 162.2 
C-10 105.6 106.7 106.7 105.7 106.8  106.3 105.1 
C-1 121.2 122.2 122.9 121.2 122.8  122.06 123.3 
C-2 / 
C-6 
128.8 129.5 129.8 128.8 130.0  129.38 129.6 
C-3 / 
C-5 
116.2 117.2 117.2 116.2 117.4  116.84 117.3 
C-4 161.3 163.8 163.3 161.5 163.0  162.58 163.0 
aIn bold, signals which differ more than 1 ppm. 
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The elucidation of the A-ring, however, may be interpreted in two ways, depending on 
the assumption of a C6- or C8-glycoside (isovitexin or vitexin, respectively). On one 
hand, the anomeric proton is correlated in the HMQC with δC 109.5, and with two more 
carbons (δC 165.67 and δC 162.18) according the HMBC experiment. On the other hand, 
the aromatic proton δH 6.5 -which is attached directly with the carbon resonating at δc 
95.6- shows correlations with 5 carbons, namely δC 105, 109.5, 158.9, 165.67 and –
although with less intensity- 184.1. 
According to all previously reported data on flavones, the chemical shift of the C10 
always ranges between 105-106 ppm and so δC 105.1 can be confidently assigned to this 
position (Svehliková et al., 2004).  
From here, two scenarios can be envisaged: 
1. If we assume that C2-4 is vitexin, then C8 is 109.5, which is not a quaternary 
carbon as was shown in the DEPT experiment (Figure 60). This carbon does not 
directly attach to the carbon of the glycoside through. Meanwhile, C7 and C9 
could be δC 165.67 and δC 162.18 or vice versa (Figure 64). 
 
Figure 64: Theoretical allocation of NMR signals to fit the structure of vitexin 
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2. If we assume that C2-4 is isovitexin, then C8 is 95.6, while C7 and C9 may take 
any of the values δC 165.67 or δC 158.9 (Figure 65). 
 
 
Figure 65: Theoretical allocation of NMR signals to fit the structure of isovitexin 
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To ascertain the most likely compound, Table 28 summarizes both scenarios together 
with the compound C2-4 spectral data, which could be equally acceptable in theory.  
Table 28: 
1
H (500 MHz) and 
13
CNMR (125 MHz) spectral data of C2-4 recorded in 
methanol – d4 
F 
F                                                                                                                      C2-4 
Position 
1
H (ppm) J values 
(Hz) 
COSY 
HMBC 
13
C 
2    3, 2’, 6’ 166.3 s 
3 6.59 s   2, 3, 10, 1’ 104.0 d 
4    3 184.1 s 
5    6 162.2 s 
6 6.49 s   5,7,8,10 109.5s 
7    6, 1” 165.7 s 
8    6, 1’’ 95.6 d 
9    1’’ 158.9 s 
10    3, 6 105.1 s 
1’    3, 3’, 5’ 123.3 s 
2’ 7.85  d 9 3’  129.6 d 
3’ 6.93 d 8.5 2’ 2’ 117.3 d 
4’    2’, 3’, 5’, 6’ 163.0 s 
5’ 6.93 d 8.5 6’ 6’ 117.3 d 
6’ 7.85 d 9 5’  129.6 d 
1” 4.90 d  2’’ 2’’,5”,7,8,9 75.41d 
2” 4.18 m  1’’, 3’’ 1’’ 72.72 d 
3” 3.48 m  2’’, 4’’ 2’’, 4’’ 80.4 d 
4” 3.48 m  3’’, 5’’ 3’’, 5’’, 6’’ 71.9 d 
5” 3.42 m  6’’ 6’’ 82.7 d 
6”a 3.72 dd 5.5, 7 6’’a-6’’b, 5’’  63.0 t 
      
 
Burns, Ellis and March (2007) demonstrated that the 
13
C NMR chemical shift of flavones 
is diagnostic and sufficient for identification of such a subclass of flavonoids. One of 
their key observations is that glycosylation is always found to deshield the 
13
C nuclei at 
the site of the substitution about 10 ppm without significantly affecting the remaining 
chemical shifts. Importantly, these authors noticed some cases of wrong assignments of 
the C9 in literature, where some authors swapped the values of C5 and C9, thus resulting 
in C5 being below δC 160 and C9 above 160. All of them used DMSO-d. However, while 
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the spectra analysed in MeOD-d4 and DMSO-d6 show similarities in the chemical shifts, 
there are slight shifts in which because of the increased hydrogen bonding (Choo et al., 
2012), the alcohol analysed substrates tend to move downfield more compared to when 
analysed in DMSO-d. Still, literature using MeOD-d4 reports consistently the value for 
C9 at below 160 ppm (Svehliková et al., 2004).  
As a conclusion, the second scenario is more consistent with all these considerations, and 
therefore it is more likely that C2-4 may be isovitexin. 
To unambiguously confirm the identity of C2-4, the sample was dissolved in DMSO-d6 
and further NMR experiments were run. These were done in April 2014. A first attempt 
with similar number of scans as with the previous experiments resulted in very poor 
spectra. A second attempt with 4,000 scans yet failed to yield better spectra. Finally, we 
managed to secure a time slot to run the sample 10,000 scans in August 2014. This time 
we obtained better spectra but still some of the expected signals were obscured by the 
noise. Specially the C=O at position 4, which although could be “seen” was not 
automatically assigned by the software because the noise-to-signal ratio was not 
favourable. Moreover, the signal at around δC 104-105 corresponding to C10 and the 
signal corresponding to C2 are also missing. This made us to fear that degradation after 
all the time in DMSO-d (4 C) occurred. The HMBC shows the anomeric proton 
correlating with δC 109 and δC 160.7. The proton of a phenolic group is now visible at 
ppm 13.4 correlating with δC 102.56, 109 and 160.7 suggesting H-5 or H-7. It is striking 
though the lack of correlations of a proton signal at 6.2, whilst the proton at 6.5 does 
correlate with the carbon at 102.56 suggesting it could be H-3.  
This time, a standard of vitexin (Sigma-Aldrich) was also analysed in the same solvent 
and Table 28 shows the assignation of the obtained signals compared with literature 
values of different flavones C-β-D-glucosides. The characteristic signal that make us to 
think that the structures of C2-4 conforms more with isovitexin than with vitexin is the 
fact that the carbon appearing at 93 ppm matches with a non glycosylated C8 whilst non 
glycosylated C6 always are more deshielded (98 ppm). 
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Table 28: 
13
CNMR (125 MHz) spectral data of C2-4, vitexin, isovitexin, orientin and 
homoorientin recorded in DMSO – d6. 
  Flavone C8-glycosides Flavone C6-glycosides 
Position C2-4 4 Vitexin
a 
Vitexin
b
 Vitexin
c 
Orientin
b
 Isovitexin
c
 Homoorientin
b
 
2 - 163.96 163.5 1664.4 164.1 163.8 163.6 
3 102.56 102.46 102.2 102.9 102.3 103.9 102.6 
4 - 182.12 181.8 182.5 182.0 182.0 181.7 
5 160.7 160.4 160.2 160.9 160.3 161.1 160.6 
6 109 98.14 97.9 98.7 97.9 108.8 108.9 
7 161 162.56 162.2 163.1 162.5 163.5 163.1 
8 93 104.05 104.3 105.1 104.5 93.6 93.2 
9 156.4 156.01 155.7 156.5 155.9 156.2 156.1 
10 - 104.62 103.8 104.5 104.0 104.6 103.4 
1’ 121.15 121.62 121.3 122.1 122.0 121.5 121.4 
2’ 128.31 129.0 128.7 129.5 113.9 128.8 113.1 
3’ 115.96 116.06 115.5 116.2 145.9 115.9 145.8 
4’ 161 161.15 160.8 161.6 149.7 162.8 149.7 
5’ 115.96 115.8 115.5 116.2 115.5 115.8 115.7 
6’ 128.31 129.0 128.7 129.5 119.2 128.8 118.7 
1” 73.26 73.4 73.2 73.9 73.3 73.4 72.8 
2” 70.6 70.8 70.6 71.3 70.6 70.9 69.9 
3” 78.98 78.7 78.4 79.2 78.6 78.6 78.7 
4” 70.2 70.5 70.3 71.1 70.5 73.1 70.4 
5” 81.48 81.87 81.5 82.3 81.7 81.7 81.4 
6” 61.47 61.3 61.0 61.8 61.4 61.3 61.2 
        
a) Standard obtained from Sigma-Aldrich 
b) Data reported by Burns, Ellis and March, (2007). 
c) Data reported by Muppaneni,  (2013). 
In any case, it would be the first time that the identification of any of these compounds 
are reported in F. sansibarica . It is however, interesting to note that the identification 
and isolation of vitexin (apigenin-8-C-glucoside), from other plant species is mostly 
coupled with the identification of its isomer, isovitexin (apigenin-6-C-glucoside) and of 
luteolin-8-C-glucoside. These closely related metabolites are difficult to separate and 
isolate, however, vitexin in particular, has been more frequently isolated from other Ficus 
species, such as; from the ethanol extract of the leaves of F. microcarpa (Wang et al., 
2010) and the leaf aqueous methanol and butanol extracts of F. deltoidea (Choo et al., 
2012; Omar et al., 2011). Also the aglycone, apigenin has only been reportedly identified 
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from some Ficus species (Lansky and Paavilainen, 2011). While there is no report of the 
isolation of apigenin-7-glucoside from the members of the genus Ficus, apigenin-6-
neohesperidose has been isolated from F. pumila (Sirisha et al., 2010; Abraham et al., 
2008). Vitexin is also reported to be in higher concentrations in the plant species it has 
been identified than it isomeric form (Choo et al., 2012). It however, falls short of being 
the identified compound in this thesis with the analysis that has been discussed.  
Flavones, in particular apigenin and some of its derivatives are active components in 
many herbs that have been found to have impact on human health. Apigenin possesses a 
number of pharmacological activities which include antioxidant, antiviral, anti-
inflammatory, anti-cancer and cellular autoimmune properties (Omar et al., 2011; Shui 
and Leong, 2004). Noteworthy, vitexin has shown to be 10-300 times more active than 
isovitexin in in vitro leishmanicidal and antitrypanosomal assays against Leishmania 
donovani amastigotes and Trypanosoma brucei rhodensiense trypomastigotes, 
respectively (Lagnika et al., 2009). As these parasites lack the FAS-II enzymes, the 
activities of vitexin may be due to either multitarget capabilities or unspecific toxicity. 
The fraction from which C2-4 was isolated exhibited notable activity against FAS-II 
enzymes. Therefore, the FAS-II inhibitory activity of vitexin and isovitexin warrant 
further research in order to confirm this mechanism of action, or better to explore their 
mechanism of action. 
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4. CONCLUSION 
The genus Ficus is a promising hub for more phytochemical and biological studies as it 
has more than 750 species for which many have not yet been studied. As drug discovery 
research is particularly critical today because of the rise in cases of infectious diseases, 
the results of the biological screening together with the chemical profiling revealed that 
the eight Ficus species from Zambia have potential for further phytochemical and 
biological studies. The antimicrobial, antimycobacterial and antiprotozoal results of the 
screenings provide some evidence for the use of the genus Ficus as a source of primary 
care in this country. 
From a phytochemical point of view, the analyses of the crude methanol extract and 
subextracts did not show significant qualitative differences. Only the HPLC 
fingerprinting revealed more subtle quantitative differences in terms of phenolic 
metabolites. The fact that the crude extracts of all the plant parts of F. sansibarica and 
only the root bark of F. ovata had predominant apigenin derivatives makes these 
derivatives be identified as markers for the chemical constituent of these species. In 
addition, the absence of caffeic acid and catechin/epicatechin derivatives in the 
fingerprints can also be strong indicators to specific species. For instance; the leaf 
extracts of F. sansibarica and F. wakefieldii; the root extracts of F. sansibarica and F. 
sycomorus subsp. Sycomorus and the leaf extract of F. ingens did not exhibit the 
aforementioned derivatives. Overall, F. sansibarica stands-out as the most chemically 
different species of the eight investigated. Still, these variations may well be due to 
environmental factors and, therefore, the indiscriminate use of these Ficus species may be 
correlated to a similar phytochemical profile. 
In terms of biological activity, our results show that the Ficus crude extracts and 
subextracts show in vitro activity against microbial, mycobacterial and protozoal 
causative agents. Overall, the antibacterial and antifungal value of the Zambian Ficus 
samples was mild and do not seem to explain their traditional use in microbial infections. 
Unless these herbal extracts have a symptomatic effect or their antimicrobial activities are 
somehow enhanced in vivo, something that would have to be investigated. 
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On the other hand, most of the Ficus species showed moderate antimycobacterial activity. 
In particular all plant parts of F. lutea are active upon the human pathogens. However, F. 
ovata stem bark was the most active and may hold promise. 
The screening against Schistosoma afforded an interesting result. The activity of most 
Ficus species is retained by the hexane and choloroform subextracts. Among them, the 
ones from F. ovata were not only the most active but may act through a different 
mechanism from that of Praziquantel, the current first choice drug targeting only the adult 
forms. 
The antiprotozoal (Leishmanial, trypanosomal and Plasmodial) activities are here 
attributed to the hexane and chloroform subextracts of the stem back of F. ovata which 
was the most active against all the three protozoa with IC50 values lower than 10 µg/ml. 
Of particular mention, F. ovata showed very significant activity against P. falciparum 
with IC50 of 1.14 µg/ml and also a favourable selective cytotoxicity index of 13. 
As for their in vitro activities upon pfFAS-II enzymes, we found that there is no species 
showing consistent significant inhibition of all three enzymes but all the aqueous 
methanol extracts exhibited a degree of selectivity towards FabG, FabI or FabZ, pointing 
out to polar compounds as inhibitors of this promising therapeutic target. The bioactivity-
guided isolation of active principles against pfFAS-II enzymes was attempted on F. 
sansibarica. As discussed earlier in the thesis, this is because the other seven species 
showed variability in chemical terms but this species (F. sansibarica) was different in 
that apigenin derivatives were more pronounced in the crude extract. In fact, one of the 
most active fractions which showed significant pfFAS-II inhibition with IC50 values 
ranging from 4 µg/ml to 0.75 µg/ml contained likely apigenin C-glucosides. From it, a 
compound (C2-4) was isolated. Spectroscopic analyses may indicate that it is isovitexin. 
If confirmed, it would be the first time it is reported from the leaf extracts of F. 
sansibarica. However, due to time constrains the activity of apigenin-8-C-glucoside upon 
the enzymes was not performed. What is even more encouraging is that these fractions 
significantly inhibit all the three enzymes, offering a great advantage over compounds 
that would selectively act against only one enzyme, in which case resistance against it 
would easily develop. So the triple inhibition action is very advantageous as it would be 
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unlikely that resistance would develop against all three enzymes at the same time, seeing 
that they catalyze different stages of the FAS-II pathway. Another, interesting result is the 
activity of the isolated epicatechin (F10-3) against FabZ and FabI with IC50 values of 3.5 
µg/ml and 4.2 µg/ml respectively. Since we did not test it upon the enzymes together with 
a pure standard, we can only hypothesize that the recorded activity was due to the effect 
of the main compound and the ‘impurities’, which in this case creates another door to 
further investigations. 
In summary, we here provide a comprehensive set of data which will serve to establish 
the true therapeutical potential of Zambian Ficus species in the frame of traditional 
medicinal use. Some of the biological activities are very promising and they serve as 
baseline data meriting further work as detailed in the next section. Also we provide some 
directions to further work towards the chemical standardisation, and chemotaxonomy of 
these similar species, and report for the first time on two of the secondary metabolites for 
one of the species. 
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4.1 FURTHER WORK 
To discover new potent drugs for various diseases discussed herein this thesis, the 
combination of biological and chemical screening is not adequate; therefore, bioactivity-
guided isolation is required to identify the metabolites responsible for the activity. It is 
however, imperative to keep in mind that some activity is as a result of synergy. For the 
FAS-II enzyme inhibition, IC50 values should be generated to establish same comparisons 
with other crude extracts. In particular, FAS-II enzyme activity and cytotoxicity should 
be performed on the pure compounds that were isolated. 
While in vitro assays can be sensitive, quick and inexpensive, the results that are obtained 
may not necessarily predict in vivo activity as observed by Wright (2010), therefore, there 
will be need to further screen the active extracts found in the antibacterial, 
antimycobacterial, antischistosomal and antiprotozoal screenings using suitable in vivo 
assays, more so for the extracts and subextracts which were found to have antiprotozoal 
activity, pfFAS-II inhibition activity and antischistosomal activity. 
From the phytochemical work that has been presented in this thesis, it is apparent that 
more work needs to be done to profile by identification, the chemical constituents of 
Ficus species, in particular the appealing F. sansibarica and also of F. ovata which 
exhibited remarkable activities against all the protozoal and the Mycobacterium 
tuberculosis screening. 
With the phytochemical techniques that have been explored in this thesis, and considering 
that Zambian Ficus species plants have not been investigated pharmacologically and 
phytochemically, an opportunity lies open to further the cause to investigate Zambian 
Ficus as potential sources for drug development. 
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